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Abstract 
In this thesis the development of several novel gold-catalysed transformations are reported. 
Two intermolecular atom transfer processes have been designed and developed to access 
gold carbenoid reactivity. The latter reactive species allowed the synthesis of various α,β-
unsaturated carboxylic acid derivatives and trisubstituted oxazoles. 
 
Numerous nitrogen- and oxygen substituted alkynes have been prepared and employed in 
oxygen transfer processes promoted by gold complexes. Using pyridine N-oxide, both 
ynamides and ynol ethers underwent regioselective intermolecular oxidation reactions under 
mild gold catalysis conditions. During the transformation, an α-oxo gold carbenoid 
intermediate is accessed which develops through a rapid 1,2-insertion reaction to yield α,β-
unsaturated imides and vinylogous carbimates. The strategy has proved to be a valid 
alternative to the use of hazardous α-oxo diazo compound when carbene reactivity is desired. 
 
Appling a similar strategy, N-imido pyridonium ylides have been used as an O,N-dipole onto 
gold activated ynamides and ynol ethers. The overall [3+2] cyclisation occurred through a 
nitrene transfer process followed by a cycloisomerisation step. Under this approach, 
ynamides and ynol ethers have been converted into highly functionalised trisubstituted 
oxazoles. The mild gold catalysis conditions allowed the use of a wide range of functionality. 
Moreover, the α-imido gold carbenoid involved as a reaction intermediate displayed the 
possibility to utilise such protocol to access α-imido carbene reactivity. 
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1.1 Gold: a central metal in human history 
Gold has played a major role in the history of mankind, society and its development. From the 
beginning of human civilisation, gold was used by artisans to manufacture coinage, jewellery 
and other arts long before written history and for millennia it had represented a symbol of purity, 
value and royalty. From a symbol of health and prestige, it later became the vehicle for 
monetary exchange, both directly and indirectly. It still maintains a vital role in modern times, in 
that a nation’s reserve of gold protects against economic disruptions.1 In addition to its symbolic 
and monetary values, gold has more recently found practical applications in many different 
fields, including electronics and dentistry.2 This utility is due to it possessing a numbers of 
favourable physical characteristics, such as high malleability, ductility, resistance to corrosion 
and electrical conductivity. Gold can also undergo a diverse range of reactions. Gold 
compounds have performed a key role in the medical field where they show excellent 
biocompatibility and biological activity. For example, “gold salts” are gold compounds (mainly 
gold complexes) used in chrysotherapy and aurotherapy, primarily to slow disease progression 
in patients with rheumatoid arthritis and to reduce inflammation. 3  More recently, gold 
nanoparticles have been widely studied as drug delivery systems to target organs in diseases 
like cancer.4 The potential use of gold as a transition metal catalyst in organic reactions had on 
the whole been ignored for a long time while the chemistry community focused on the 
development of other transition metals (e.g. palladium, platinum, rhodium). This lack of interest 
was due to the assumption of a relative chemical inertness of gold. In the last few decades the 
dramatic increase in the use of homogeneous catalysis to achieve convenient chemical 
modifications on organic molecules finally gave gold the attention it deserved, where its specific 
type of chemoselectivity often proves an advantage and is used to gain higher selectivity and 
control over chemical transformations. Major advances in the field have led to gold being 
routinely used in heterogeneous and homogeneous catalysis. 5  In the next sections, only 
selected examples of the latter will be covered, providing some theoretical and experimental 
studies which will be helpful in rationalising the reaction manifolds available in this catalysis. 
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1.2 General reactivity of gold in homogeneous catalysis 
Gold (Au) in homogeneous catalysis is found in the ionic forms of the Au(I) and the Au(III) 
oxidation states. The starting point of this discussion must be the electronic structure of Au 
which determines its behaviour. Relativistic effects strongly influence the electron distribution of 
gold and these effects can be used to rationalise the observed reactivity for gold complexes.6 
Relativistic effects are determined by two opposite tendencies: s-orbitals tend to contract with 
increasing atom number, while d and f orbitals tend to expand because of the shielding effect 
caused by the contracted core. The relativistic contraction of 6s orbitals results in a 
strengthening of the Au-L bond in comparison to other metals (e.g. Pt and Hg).7 These effects 
are highest for gold comparing to its atomic neighbours and they are more significant than for 
any other metal (Figure 1).  
 
Reprinted by permission from Macmillan Publishers Ltd: D. J. Gorin, F. D. Toste, Nature 2007, 446, 395-403. 
http://www.nature.com/nature/index.html 
Figure 1. Calculated relativistic contraction of the 6s orbital. The relativistic and non-relativistic 6s 
orbital radii were determine computationally.8 
The relativistic effects held accountable for the expansion of the d orbitals explain the 
chemically “soft” character of Au, with its cations being involved in orbital rather than charge 
interactions.9 For this reason, gold catalysts are preferentially active as π-Lewis acids to “soft” 
nucleophilic systems like alkynes, alkenes and allenes. Theoretical studies also indicate that 
due to the diffuse Au 5d electrons, electron-electron repulsion is decreased, resulting in a less 
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nucleophilic character of Au species. A direct consequence of this latter point accounts for 
gold’s tendency not to readily undergo oxidative addition,10 although such reactivity can be 
accessible under specific conditions.11  
The propensity of gold to activate π-systems, especially alkynes, towards nucleophilic addition 
has been extensively studied and reviewed.12 Kinetic discrimination allows nucleophiles to 
select between different electrophilic species in favour of the Au-alkyne A (Scheme 1), such that 
gold complexes catalyse transformations of alkynes preferentially over other π-systems. This 
latter characteristic is commonly referred as gold “alkynophilicity”. 
Back bonding is another crucial aspect that needs to be considered when analysing gold 
catalysis intermediates, especially when the latter is compared to its transition metal 
neighbours. In the view of the Dewar-Chatt-Duncanson model,13 σ-bonding is formed by the 
donation of electron-density from the π-system to an empty orbital of the metal catalyst. Electron 
density is then backdonated from the catalyst d-orbitals to the π*-antibonding orbitals of the 
ligand to create a π-interaction (this aspect will be discussed in more detail in the next section). 
In the case of Au(I), backbonding cannot meaningfully occur because the π*-antibonding 
orbitals are too high in energy. The reluctance of the metal centre to back-donate electrons 
results in a deficiency of electron density in the π-system and this promotes the addition of the 
nucleophile. The vinyl-Au intermediate B formed is subject to proto-demetallalation or trapping 
by other appropriate electrophiles (path a, Scheme 1). However, based on theoretical studies, 14 
another destiny for the vinyl-gold species can be hypothesised. According to the computational 
data obtained, it was envisaged that backbonding from the relativistically expanded 5d orbitals 
into the non-bonding p orbitals occurs. These p orbitals are more suitable for overlap because 
they are lower in energy compared to the π*-antibonding orbitals mentioned above. It can 
therefore be envisaged that backbonding into the non-bonding p orbitals of the developing 
conjugated carbocation in B can facilitate trapping of electrophiles in another fashion (path b, 
Scheme 1). 
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Scheme 1. Different electrophile addition pathways onto vinyl-gold complexes. 
Experimentally, the latter manifold has been proved independently by the Echavarren group,15 
the Fürstner group16 and the Toste group17 in the cycloisomerisation of 1,5-enynes promoted by 
gold(I) catalysts which in some cases proceed through cationic intermediates.  
In the cycloisomerisation of 1,5-enynes of type 1, the olefin acts concertedly as a nucleophile 
and electrophile onto the gold-alkyne complex 3 to form a cyclopropylcarbinyl cation 
intermediate 5 (Scheme 2). It was hypothesised that a stabilising delocalisation of the positive 
charge by backbonding electrons from the gold (resonance form 5’) could potentially play a role 
in lowering the energy barrier for the cycloisomerisation to occur and also could confer carbenic 
character to the gold intermediates. 
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Scheme 2. Gold catalysed cycloisomerisation of 1,5-enynes. 
Although the 1,2-hydride shift on the gold intermediate 5 and 5' (vide supra) was proved by 
deuterium labelling experiments (Scheme 3), the extent of carbocation character as opposed to 
carbene character could not be distinguished. It was not possible to exclude a concerted versus 
stepwise mode for the cyclisation and therefore some other intermediates might also be 
suggested. 
 
Scheme 3. Deuterium labelling experiments for the cycloisomerisation of 1,5-enynes. 
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This ambiguous gold stabilised carbocation vs. gold stabilised carbene nature of such 
organogold species has attracted great interest in the organic chemistry community.  
1.3 Gold carbenoid: an ongoing debate 
Metal stabilised carbenes, or metal carbenoids, are potent reactive units for carbon-carbon and 
carbon-heteroatom bond formation and are involved in many reactions of high synthetic interest 
(Figure 2, M equal e.g. Rh, Cu, Pd). Standard methods for the generation of this moiety depend 
upon the use of sacrificial functionalities such as diazo units 8. These decompose in the 
presence of certain transition metal catalysts affording the desired metal stabilised carbene 
species.18 
 
Figure 2. Formation of metal stabilised carbenes from diazo compounds and some generic 
reactions in which they are involved. 
The distinction between gold carbenoids and gold-stabilised carbocations of gold intermediates 
is more than just a semantic discussion; as it will be shown in this section, it is needed for 
predicting, modulating and explaining their reactivity. Until recently, the majority of theoretical 
investigations and experimental observations on organogold species mostly support the cationic 
resonance forms,19 but those arguments did not bring the discussion to a conclusion.  
The cycloisomerisation mechanism of 1,n-enynes, which was briefly mentioned in the previous 
section, is the perfect example to explain such controversy. After the initial attack of alkene 10 
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onto the activated gold-alkyne complex 9, different mesomeric/tautomeric intermediates of non 
classical carbocations F-I can be envisioned (Figure 3). Among the different mesomeric cationic 
forms, gold stabilised carbocation G can be seen in mesomeric relationship with carbonic 
resonance from I. 
 
Figure 3. Mesomeric and tautomeric organogold intermediates in reaction between gold-activated 
alkynes and alkenes. 
In the gold catalysed intermolecular cyclopropanation of 1,6-enynes and alkenes, Echavarren et 
al. were able to intermoleculary trap different gold carbenoids with alkenes (e.g. norbornene and 
cyclohexene) providing for the first time what they thought to be a compelling evidence for the 
existence of the carbene nature of the intermediate 12, 16 and 17 (Scheme 4). 20  The 
stereospecific formation of cyclopropane frameworks in the product 14 and 18 should endorse 
the carbene-character of the organogold species based on similar outcomes from the behaviour 
of traditional carbenes.21 
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Scheme 4. Intermolecular cyclopropanation of enynes and alkenes. 
Nolan and co-workers also contributed in supporting carbene-like intermediates and achieved 
the first gold catalysed decomposition of diazo compounds.22 As shown at the beginning of this 
section, this is the traditional strategy to access transition metal stabilised carbene (vide supra). 
N-heterocyclic gold catalyst complex [(IPr)AuCl] (Au-II) promoted the transfer of a carbene unit 
from ethyl diazoacetate 20 to styrene 19 (Scheme 5). A mixture of different products was 
obtained: cis and trans cyclopropanes 21 and a mixture of monosubstituted styrenes 22.  
This outcome strongly suggests a carbene species transfer being involved in the transformation 
since cyclopropanes are easily accessible through the reaction between carbenes and alkenes.  
Moreover, the formation of a mixture of o-, m- and p- aromatic addition products (22) suggests a 
non-regioselective insertion pathway of the gold-carbenoid species into the aromatic C-H bonds 
rather than a more regiospecific electrophilic aromatic substitution reaction of a carbocation 
species. 
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Scheme 5. Carbene unit transfer from diazo compounds onto alkenes promoted by gold. 
Decisive work was published by Toste et al., who performed theoretical studies on various gold 
catalysis key intermediates in order to fulfil the lack of understanding of the Au-C bond nature.23  
The bond rotation energy barriers were considered as a practical indicator of the π character of 
the bond. Transition metal-free allyl cations 23 and 25 were compared with gold allyl cations 24 
and 26 in order to estimate the carbenoid resonance form contribution for these latter two 
entities (Scheme 6). For example, if we consider the resonance forms 24 and 24’, a high energy 
barrier for C1-C2 bond rotation implies more C1-C2 double bond character, which would in turn 
indicate a major contribution of resonance form 24’. It was calculated that when carbocation 
stabilising atoms were present (e.g. oxygen atoms), the C1-C2 rotation energy values for 
organogold species of type 24-24’ were close to the ones calculated for 23 rather than 25-25’, 
indicating a strong predominance of gold-carbocation species 24 over 24’ (Eq. 1, Scheme 6). 
Therefore, this means that the gold-carbon bond possesses more single bond character. In the 
absence of carbocation stabilising atoms, the rotation energy values for gold intermediates of 
type 26-26’ were similar to the ones calculated for 25-25’ rather than 23, showing that in this 
instance the AuL would have an allylic cation stabilisation activity comparable to the methoxy 
group (Eq. 2, Scheme 6). It can be concluded the resonance form 24 is a better descriptor of 
cation 24-24’, while it can also be concluded that 26’ represents in a better way the situation of 
cation 26-26’. 
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Scheme 6. Comparison of different gold allyl cations. 
Experimentally this was confirmed by cyclopropanation reactions promoted by gold on two 
different cyclopropenes 27 and 30 (Scheme 7). In the case of dioxane 27, no reaction was 
observed, suggesting a predominance of an oxygen-stabilised cationic gold intermediate of type 
29’ and 29’’ (strong vinylic stabilisation) versus gold-carbenoid species 29’’’. The latter is the 
active species that would have led to the formation of the cyclopropylic product 28. Conversely, 
dioxepane 30 reacted with cis-stilbene 31 in a "carbene fashion" (weak vinylic stabilisation) due 
to the effective formation of gold intermediate 33’. The latter reaction also showed a great 
dependence on the nature of the ligand complexed with the gold atom (see Table in Scheme 7). 
A carbocation-like reactivity is expected with π-acid ligands which decrease the gold to carbon 
σ-donation as in the case of P(OMe)3. Conversely, N-heterocyclic ligand IPr decreases the σ-
donation bond favouring a more carbene-like reactivity in virtue of its weak π-acidity and strong 
σ-donating capability. 
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Scheme 7. Cyclopropanation reactions promoted by gold catalysts. 
This latter observation was explained by considering the filled gold d-orbitals from which 
electrons can be donated to π-acceptors. The π-backbonding to the spectator ligand and to the 
substrate is not mutually exclusive but rather a distribution of gold electro-density between 
these two systems (Figure 4). Therefore, the competing electrophilicity of the ligand is not 
innocent but participates in determinating the degree of backbonding from gold to the substrate. 
In fact, weak π-acid N-heterocyclic ligands (e.g. IPr in Scheme 7 and Scheme 5, IMes in 
Scheme 4) performed best in comparison to the others tested in the cyclopropanation reaction 
(Scheme 7). These electron donating ligands increased the π-donation from the gold to the 
alkylidene and ultimately promoted a more carbene-like reactivity. 
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Figure 4. Schematic representation of the ligand-gold-substrate complex electronic distribution. 
In conclusion, gold stabilised carbocation/carbene dualistic reactivity is influenced by a series of 
different factors that always need to be taken in consideration: the ligand electronic properties, 
the substrate substituents and the electronic effects involved with gold. 
1.3.1 Atom-transfer gold catalysed processes 
An atom transfer process consists of the relocation of an atom, or a group of atoms, within a 
molecule; the formal “delivery system” is not bonded anymore to the delivered atom in the final 
product. Some of these processes have shown to allow the access of gold-carbenoid 
intermediate. As seen in the previous section, metal carbenoids are extremely useful reactive 
species which are capable of promoting unique transformations. Moreover, traditional methods 
require the use of hazardous diazo compounds and expensive catalysts. Therefore, the 
development of new ways to engage their reactivity has gained great attention. Gold complexes 
in atom transfer processes have proved in some cases to be a valid alternative. For these 
reasons, this section will focus on atom transfer processes promoted by gold that form gold 
carbenoid species and a selection of published examples will be given. 
As shown in the previous section, cyclisation of 1,n-enynes have, depending on the substrate 
and the gold catalysis conditions, allowed access to gold-carbenoids (see before). Later, other 
methods were developed. Among them the use of propargylic carboxylates allowed the 
formation of gold intermediates of type L and N (Scheme 8). The cyclisation mode was shown 
to be dependent on the nature of the substrate; terminal or electro-withdrawing substituted 
alkynes are capable of forming carbenoid species of type N through a 5-exo cyclisation to 
access gold intermediate of type P and Q. 
 14 
 
Scheme 8. Intermediates derived from the gold activation of propargylic carboxylates. 
From our research group24 and others,25 this reactivity has been studied with a series of 
propargylic acetyl, pivaloyl and benzoyl esters of type 33, which were reacted with different 
allylic sulfides 34 under gold catalysis conditions (Scheme 9). As predicted, the nucleophilic 
oxygen of the carboxylic group attacked the gold activated alkyne unit. It was suggested that the 
5-exo cyclisation is followed by backbonding of electrons from the catalyst to generate an α-oxo 
gold carbenoid 37. These reactive intermediates have recently gained enormous interest in the 
organic chemistry community due to their comparable reactivity with α-oxo carbenes, which are 
usually accessed through expensive and limited preparation procedures. Intermolecular 
reaction between the generated gold carbenoid and the thioester 34 led to the formation of 
sulfonium ylide 38 which elaborated through a sequential rearrangement of the allyl fragment 
followed by demetallation to afford substrate 35.  
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Scheme 9. Gold catalysed reaction between propargylic esters and allylic sulfides.  
An alternative way to access gold carbenoids was published in 2005 by Toste and co-workers26 
who achieved the first gold-catalysed intramolecular acetylenic Schmidt reaction (Scheme 10, 
Eq. 1). Different homopropargyl azides 39 were successfully transformed into multiply-
substituted pyrroles 40 under mild gold catalysis conditions. This new transformation promoted 
by gold indicated the possibility of a new reactive strategy to access gold carbenoids of type V. 
In Toste’s example, the leaving group (LG) is pendant to the nucleophile and when the 
“electron-push” occurs, this assists the electrophile release. Overall, under a general strategy 
overview, the LG-system can be seen as a nucleophile delivering group. The whole mechanism 
is reminiscent of an intramolecular nitrene transfer process catalysed by a gold catalyst 
(Scheme 10, Eq. 2).  
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Scheme 10. Gold-catalysed intramolecular acetylenic Schmidt reaction. 
After Toste’s example, many transformations in a similar fashion have been developed towards 
heteroatom transfer to alkyne units π-activated by gold complexes.  
For instance, the reactivity of sulfoxides and alkynes to be engaged in internal redox promoted 
by gold has also been extensively studied in our group.27 In light of the S=O bond polarisation 
which confers nucleophilic character to the oxygen, a series of alkynyl tethered sulfoxides of 
type 41 underwent intramolecular 5-exo cyclisation when treated with gold catalyst of type Au-
III.28 This step simultaneously provided both a gold carbenoid and an allyl sulfide functionality 
which then reacted to form cyclic sulfur ylide 45 (Scheme 11). This zwitterionic species would 
progress through a 2,3-sigmatropic rearrangement to afford sulfur heterocyclic product 42 as 
the only product. 
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Scheme 11. Internal redox reaction of alkynyl-sulfoxide catalysed by gold complexes. 
Toste29 and Zhang30 explored independently a gold-catalysed intramolecular oxygen transfer 
cyclisation with tethered alkynyl sulfoxides of type 46 (Scheme 12). In this case, the gold 
intermediate 49 evolved through a formal Friedel-Crafts type alkylation forming the 1-
benzothiepin-4-one 47 with the release of the gold catalyst. Different benzothiepinones and 
benzothiopines were obtained depending on the alkyne substituents present, which control the 
5-exo versus 6-endo gold cyclisation mode. Remarkably, very recently Toste proved that the 
same strategy could also be applied to the rearrangement of sulfimine of type 50. The transfer 
of a tosylamino unit was consistent with the previous results and provided N-tosyl enamine 51 in 
88% yield under the same reaction conditions optimised for sulfoxides. 
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Scheme 12. Synthesis of benzothiepines 47. 
Asensio and co-workers explored the intermolecular version of the gold promoted redox 
reaction between sulfoxides and acetylenes. 31  Different arylsulfides 52 regioselectively 
functionalised ortho to the sulfur position were obtained in good yields (Scheme 8). Surprisingly, 
in all cases a different regioisomer from the expected Friedel-Crafts regioselectivity was 
observed as the only product (Scheme 13). DFT studies were carried out to explain the unusual 
outcome and Asensio’s group proposed an alkenyl gold intermediate 56 as the key 
intermediate. It was suggested that the vinyl-gold species 55 would evolve to intermediate 56 
via [3,3’]-sigmatropic rearrangement rather than evolving to the carbene that undergoes a 
Friedel-Crafts electrophilic aromatic substitution. 
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Scheme 13. Intermolecular reaction between alkynes and arylsulfoxide. 
Epoxides have also been used as a source of an oxygen atom in intramolecular redox reactions 
promoted by gold. In a study by Li and co-workers,32 different epoxy tethered enynes were π-
acid activated by gold catalysts and underwent intramolecular nucleophilic attack from the 
epoxide oxygen onto the acetylenic fragment (Scheme 14). Under optimised conditions, gold 
catalysis straightforwardly promoted the conversion of alkynyl epoxide of type 57 to tetracyclic 
2H-pyran derivatives 58 through a consecutive internal redox, Nazarov rearrangement and 
protodemetallation.  
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Scheme 14. Cycloisomerisation of epoxy-enynes. 
In an effort to access α-oxo gold carbenoid reactivity, Shin33 employed readily available nitrones 
as an oxygen delivery system. For example, simple nitrone tethered alkynes of type 62 were 
transformed into isoindoles 67 under optimised gold catalytic conditions. The proposed 
mechanism envisaged a fast 7-endo-dig cyclisation followed by a redox step, which formed gold 
intermediate 64 (Scheme 15). The imine group reacted with the proposed carbenoid to form 
azomethine ylide 66, from which the catalyst is regenerated to afford the product. 
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Scheme 15. Nitrones in the synthesis of isoindoles. 
The methodology proved to be successful for the preparation of different isoindoles and also 
related nitrogen-containing heterocycles. Shin elegantly showed the potential of this 
transformation in an internal redox/dipolar cycloaddition cascade (IR/DC) of tethered nitrone 
enynes to afford azabicyclo[3.2.1]octanes 71 in a highly diastereoselective manner (Scheme 
16).34 
 
Scheme 16. Synthesis of azabicyclo[3.2.1]octanes 71. 
Liu and co-workers used a similar IR/DC transformation intermolecular approach where 1-
ethynyl-2-nitrobenzene derivatives 72 and alkenes 73 reacted under gold catalytic conditions to 
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afford azacyclic compounds 74 (Scheme 17).35 The key step in the mechanism was the 
formation of ketonyl oxonium 76 which underwent a [3+2] cycloaddition reaction via transition 
state 77. An excess of alkene and a slow addition of the nitro alkyne are required for optimal 
reaction conditions; this precaution circumvents the gold-catalysed dimerisation of the olefin 
which forms undesired product 78. 
  
Scheme 17. Redox/dipolar cycloaddition cascade reaction between nitrobenzene derivatives and 
dienophiles. 
In 2009 Zhang et al. explored a new intramolecular oxygen atom transfer from amine N-oxides 
to alkynes promoted by a gold complex.36 A range of different homopropargyl amines 79 were 
easily oxidised with m-chloroperbenzoicacid (m-CPBA) and straightforwardly submitted to gold 
catalysis reaction conditions to give piperidin-4-ones 80 in a one-pot manner (Scheme 18). The 
proposed mechanism envisaged a subsequent gold-catalysed intramolecular alkyne oxidation 
and a ring opening step to form organogold 82. An intramolecular N-methylene hydride 
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migration from the pendent amino group provided the imminium intermediate of type 83, which 
then underwent a Mannich-type cyclisation with the gold enolate to provide the desired product. 
  
Scheme 18. Synthesis of piperidin-4-ones from the oxidation of homopropargyl amines. 
Successively, Zhang’s and Houk’s groups carried out a computational investigation on the 
mechanism of gold catalysed rearrangement of acetylenic amine N-oxide previously reported.37 
It was calculated that a more energetically favoured mechanism would involved a 
heteroretroene reaction. In light of this study, intermediate 86 undergoes a 1,6-hydride shift 
leading to gold species 87 which further rearranges through a cyclisation to release the catalyst 
and form the product 80 (Scheme 19). The study has also highlighted a syn oxygen-gold 
addition to the alkyne unit rather than the most widely reported anti version suggested for 
similar transformation. This unusual behaviour was explained in virtue of a more favourable 
gold-coordinated N-oxide species 85 rather than a gold-alkyne complex. 
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Scheme 19. 
The strategies presented in this section show various methodologies for atom transfer 
processes catalysed by gold catalysts, which allow access to overall carbene-like reactivity. The 
nature of the gold-intermediate involved in these transformations has been suggested to be 
represented by a gold carbenoid species, although care must be taken as different mechanism 
pathways could also be possible. 
1.4 Ynamides as versatile tools in gold chemistry 
Heteroatom-substituted alkynes represent a versatile and interesting class of substituted 
alkynes. The presence of the heteroatom electron-donating ability strongly polarises the triple 
bond, which allows access to exceptional differentiation between the two sp-carbon atoms in 
the catalysis. This is reflected in a predictable regioselectivity to the addition of electrophiles or 
nucleophiles onto the triple bond as in the case of ynamines (Scheme 20).38  
 
Scheme 20. Possible resonance forms for ynamines and their reactivity with nucleophiles and 
electrophiles. 
 25 
The first synthesis of ynamines, nitrogen-substituted alkynes, was reported by Zaugg et al. 
while studying the unusual reaction between propargyl bromide and phenothiazine.39 Although 
the first ynamine had finally been isolated and characterised, a practical synthesis was only 
achieved five years later by Viehe.40 Despite the ynamides synthetic potential was immediately 
recognised by the organic community, their use in organic synthesis remained rather limited 
compared with, for example, closely related enamines.41 Difficult preparations and intrinsic 
instability were accountable for limiting their employment. Adding a N-electron-withdrawing 
substitution to access ynamides enhanced stability in comparison to ynamines whilst 
maintaining to a good degree the triple bond polarisation (Scheme 21). 
 
Scheme 21. Possible resonance forms for ynamides. 
Furthermore, ynamides survive aqueous work-up, silica gel purifications and thermal conditions.  
1.4.1 Ynamide synthesis	  
For ynamides to be efficiently employed as organic chemistry tools, a reliable method for their 
synthesis was required. Over the years different methods have been optimised which utilised 
elimination processes, isomerisation reactions and the use of alkynyliodonium salts, but it was 
only until the discovery of copper-mediated N-alkylynation process that more general ynamide 
syntheses have finally been accomplished. 
1.4.1.1 Preliminary ynamide preparations 
In 1972 Viehe and co-workers published the first synthetic methods to obtain urea-derived 
ynamides 91 by elimination of HCl from the corresponding α-chloroenamide 90 in the presence 
of a base (Scheme 22).42 Although the procedure suffered from several limitations (e.g. limited 
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substrate scope, use of harsh reagents), this elimination based synthetic protocol was the first 
preparation method where ynamides could be obtained in good yield.  
 
Scheme 22. The first ynamide synthesis. 
It was almost 30 years later, in 2001, that Hsung et al. improved the procedure by employing a 
more easily available enamide 92 which, on bromination, provided β-bromoenamides 93. The 
elimination of HBr from 93 afforded different pyrrolidinine-, oxazolidinone-, and imidazolidinone-
derived ynamides 94 in good yield (Scheme 23).43 Employing the elimination approach, β,β-
dicholoroenamides 96 were also found to be suitable starting materials which are smoothly 
synthesised by treatment of formamides 95 with tetrachloromethane and triphenylphosphine. 
The use of BuLi as a strong base promoted the elimination of HCl and the Li-exchange, forming 
the cationic precursor of ynamide 97 which could be trapped with a series of electrophiles 
similar to a modified Corey-Fuchs protocol. When terminal ynamides are obtained (E=hydrogen 
atom), different Sonogashira and Negishi functionalisation protocols can be applied as 
described for the preparation of ynamides of type 98. 
Although these and other methods44 (Scheme 23) have provided access to a number of 
ynamides in good yield, all of them suffer important limitations such as low substrate scope, 
difficult access to the starting materials, harsh reaction conditions or multistep preparation. 
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Scheme 23. Different preparations of ynamides. 
1.4.1.2 Amidative cross-coupling copper mediated for ynamide synthesis 
Balsamo and Domiano serendipitously observed the formation of ynamides 106 from the 
reaction between β-lactam 104 and copper(I)-propiolic ester complex.45 The latter was formed in 
situ by the treatment of propiolic ester 105 in the presence of equimolar amount of copper(I) 
chloride (Scheme 24). 
 
Scheme 24. First copper-mediated preparations of ynamides. 
The first copper-catalysed coupling between amides 107 and alkynylbromide 108 was reported 
by Hsung et al. in 200346 and represented a major breakthrough over the existing methods. This 
protocol based on Buchwald's approach 47  copper catalysed N-arylation of amides was 
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successful for oxazolidinone and lactam ynamide derivatives but it was found unsatisfactory 
when imidazolidinones and sulfonamides were employed as the amide compound.  
 
Scheme 25. Hsung’s first generation ynamide preparation protocol. 
In the same year, the Danheiser group48 also developed a copper-mediated coupling of amides 
with alkynyl bromides (Scheme 26, Eq. 1). A wide range of different amides 110 could now be 
employed under much milder conditions but preformation of the copper amide intermediate with 
a stoichiometric amount of CuI was required.  
Hsung et al.49 improved their previous reported method by employing a better catalytic system 
(cheaper and more environmentally friendly copper source), which improved the previous 
reported reaction conditions, scope of the reaction and overcome some of the limitations 
previously experienced (Scheme 26, Eq. 2).  
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Scheme 26. Danheiser’s protocol (top) and Hsung’s second generation ynamide preparation 
(bottom). 
Continuing with the study reported by Balsamo and Domiano (vide supra), a new copper 
catalysed coupling between amides 101 and terminal alkynes 117 has also been proved a very 
successful and convenient strategy for the synthesis of ynamides. This particularly elegant 
alkynylation procedure was developed by Stahl and co-workers and employs molecular oxygen 
as the terminal oxidant (Scheme 27).50 This new protocol attracted great attention due to the 
very wide scope of the reaction; different amides and alkynes can be employed with good to 
excellent yield. Like Hsung's strategy, a catalytic amount of copper was used but the 
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employment of terminal alkynes rather than their brominated derivatives represented a welcome 
advantage. 
To avoid the competing alkyne homodimerisation side processes that lead to the formation of 
diyne 119, slow addition of the alkylynating agent and an abundant excess of amide is required. 
  
Scheme 27. Stahl’s ynamide preparation. 
Evano et al. were able to obtain ynamides from the copper-catalysed coupling between amides 
101 and vinyl-dibromides 121 (Scheme 28).51 This efficient alternative method employed vinyl-
dibromides as a synthetic equivalent to bromo alkynes. Oxidative addition of 101 with a copper 
catalyst and reductive elimination-amination affords α-bromoenamide 123. The ynamide 
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formation is mediated by a HBr elimination step promoted in the presence of the base. This 
proposed mechanism was confirmed by the isolation of side product 123a which on treatment 
with Cs2CO3 produced ynamide 94a as the only product.  
  
Scheme 28. Evano’s ynamides preparation. 
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1.5 Selected example of ynamides under gold catalysis 
conditions 
Although ynamides have only been used intensively in the last decade,52 some gold catalysed 
reactions have already been discovered and optimised (Figure 5). Herein, we report a selection 
of examples which show the similarities between ynamide and alkyne reactivities in reactions 
promoted by gold catalysis. Moreover, we are going to highlight the advantages that the 
nitrogen presence confers to the triple bond system.  
 
Figure 5. Publications on ynamides and ynamides in gold catalysis in the last decades.53  
A study focused on the cycloisomerisation of 1,6-ene-ynamides of type 125 (n=1) promoted by 
platinum led to the formation of a so called “formal metathesis product” 124 in excellent yield 
while 1,7-ene-ynamides 125 (n=2) produced cyclobutanone 127 as the only product (Scheme 
29).54  
 
Scheme 29. Cycloisomerisation of 1,6- and 1,7-ene-ynamides promoted by platinum. 
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The reactivity of platinum catalyst π-acids is established to be closely related to the one 
observed for gold complexes.12a Based on this assumption, Cossy and co-worker published one 
of the first gold catalysed cycloisomerisation reactions of 1,6-ene-ynamides. 55  They 
hypothesised that under the milder conditions required by gold catalysis 1,6-ene-ynamides 
would lead instead to a cyclobutanone product 129. They envisaged that ynamide of type 128 
would undergo a regioselective gold-promoted cycloisomerisation as seen for enynes in Section 
1.3 to form gold intermediate 130, which would rearrange to form the desired product. 
Optimised conditions allowed the successful synthesis of cyclobutanones 129a in good yield. 
More interestingly, 1,6-ene-ynamides bearing a propargylic alcohol such as 132 diverted the 
course of the reaction to an alternative ketone product of type 133. This different reaction 
outcome derived from a 1,2-hydride shift assisted by the hydroxyl group followed by 
protodeauration (Scheme 30).  
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Scheme 30. Cycloisomerisation of 1,6-ene-ynamides promoted by gold. 
Later on, Gagosz reported the conversion of N-alkylnyl tert-butyloxycarbamates 135 in the 
presence of a gold(I) complex into a range of functionalised bicyclic carbamates 136 (Scheme 
31).56 The formal [4+2] cycloaddition was derived from cycloisomerisation of the enynes and 
intramolecular attack of the tert-butyloxycarbamates to stereoselectively trap the gold 
intermediate. In absence of the olefinic unit, the ynamide would instead undergo nucleophilic 
addition from the tert-butyloxycarbamate unit.57  
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Scheme 31. Intramolecular cyclisation of N-alkylnyl tert-butyloxycarbamates. 
Hashmi’s gold-catalysed phenol synthesis has been proven to be a powerful tool for the 
synthesis of various phenol derivatives.58 Hashmi et al. considered ynamides as a possible 
alkyne substitutes for their strategy in order to extend the pool of different phenolic structures 
that can be accessed. Various dihydroindoles (n=0) and tetrahydroquinolines (n=1) of type 140 
were synthesised from pendant furan ynamides 139 using different gold complexes and 
reaction conditions (Scheme 32).59 
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Scheme 32. Hashmi’s gold-catalysed phenol synthesis using ynamides. 
The powerful intrinsic regioselective control of ynamides has been further proven by Skrydstrup 
and co-workers.60 Ynamides 144 underwent regioselective hydroamination with anilines 143 
providing a useful imidoyl precursor 145 for indole synthesis (Scheme 33). The regiocontrol 
provided by the nitrogen atom overcomes the scope limitations often seen in similar indole 
preparations using alkynes, which often lack of regioselectivity. 
  
Scheme 33. Regioselective amination of ynamides. 
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1.6 Conclusion 
Homogeneous gold catalysis has proved to be a successful tool in organic chemistry. Mild 
reaction conditions, high tolerance towards various chemical functionalities and selective 
activation of C-C triple bonds by gold complexes are triggering a wider interest in this noble 
metal. In the last decade, new methodologies have been discovered and optimised, providing 
new procedures to form C-C and C-heteroatom bonds and therefore increase molecular 
complexity. In this respect, intermolecular atom transfer processes catalysed by gold catalysts 
have been shown to be a potentially useful approach amongst the different strategies available 
especially for potentially accessing gold carbenoid reactivity. 
Ynamides have recently been discovered as useful substrates in organic chemistry and new 
reliable procedures for the synthesis of stable ynamides have led to an increased interest in 
such molecules. Due to the presence of a C-C triple bond, ynamides have emerged as suitable 
functionalities to be efficiently employed in gold catalysis. Over the last few years this 
hypothesis has been proven, different reactivity pathways have been discovered and more 
applications of ynamides in gold catalysis should emerge in the near future. 
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1.7 Aim and objectives 
The aim of this study is to develop a novel gold-catalysed atom transfer process. Adapting the 
synthesis so that it proceeds in an intermolecular fashion will enhance the synthetic flexibility of 
atom transfer processes, which is usually limited to intramolecular versions. By virtue of their 
triple bond polarisation, ynamides were chosen as a suitable π-system in order to provide 
control over the regioselective installation of the heteroatom across the acetylene fragment. 
Activation of an ynamide by a gold complex would increase its electrophilicity allowing the 
addition of a nucleophilic heteroatom delivery system (Scheme 34). Based on previous 
knowledge of related intramolecular processes involving alkynes, we envisaged that the 
backbonding occurring from the gold species B would cause the cleavage of the delivery 
system (DS) to form the desired gold-carbenoid intermediate C/D.  
 
Scheme 34. Proposal of intermolecular atom transfer onto ynamides promoted by gold complexes. 
A useful gold carbenoid species should be generated and this can react further depending on its 
carbocation versus carbenoid nature, the functionalities present and the reaction conditions.  
To study this proposal, a series of ynamides with suitable substitutions such as allyl, aryl, alkyl 
and allyloxy were designed and prepared. These installed functionalities should react 
intramoleculary with the gold carbenoids generated during the atom transfer processes to 
access typical carbene transformations, such as cyclopropanation, ylide formation and C-H 
insertion reaction. 
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Chapter 2: Gold-catalysed synthesis of α ,β-unsaturated 
carboxylic acid derivatives from ynamides and ynol 
ethers 
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2.1 Introduction 
In light of the previously introduced advances in gold-catalysed atom-transfer processes on 
alkynes, an intermolecular regioselective atom-transfer transformation onto ynamides was 
proposed. It was envisaged that through the reaction intermediates, gold carbenoid reactivity 
would be accessible (Figure 6). 
 
Figure 6. Proposal of gold-carbenoid access from ynamides. 
Among the different metal carbenoid species, α-oxo metal stabilised carbenes F have been 
widely studied and employed in organic chemistry but their preparation normally requires the 
use of potentially hazardous and toxic diazocompounds of type E (Figure 7). Employing such 
undesirable reagents is usually labour intensive and often comes at the expense of the 
efficiency of the overall process. For these reasons the development of new flexible and reliable 
methods to generate α-oxo metal stabilised carbenes through alternative routes is highly 
attractive. Many of the atom-transfer processes onto alkynes catalysed by gold complexes 
present in the literature have demonstrated an easy and straightforward alternative method to 
access α-oxo gold carbenoids.24-36 Although the great utility of these processes is indisputable, 
they rely on an intramolecular approach that requires the pre-installation of a suitable 
functionality in the substrate and a favourable tether length between the delivered oxygen atom 
and the reactive centre (Figure 7, G). These major limitations would be overcome by an 
intermolecular approach, increasing flexibility and synthetic applicability of the transformation. 
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Figure 7 
In order to apply our intermolecular concept for the generation of such valuable species, 
pyridine N-oxide derivatives were selected as a suitable commercially available O-nucleophilic 
oxidant. According to this proposal, the employment of a ynamide would ensure regio-control 
over the oxygen installation. Under suitable conditions, formation of complex 150 should 
therefore be possible. The electron pull would lead to the cleavage of the N-O bond and the 
formation of gold intermediate 152, which should be carbenoid in nature (Scheme 35). As 
shown in the previous chapter, these gold carbenoid species can undergo different reactivity 
pathways depending on the other functionalities present.  
 
Scheme 35. Proposed gold intermediate reactivity pathways for the selected ynamides to be 
studied. 
To explore different gold-carbenoid outcomes, ynamides 153-156 were prepared as suitable, 
readily obtainable and simple ynamides bearing appropriate functionalities. These ynamides 
should allow, after revealing the gold carbenoid reactivity, the reproduction of carbene 
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quenching pathways described in the literature, such as 1,2-hydride shift, ylide formation, C-H 
insertion onto the aryl unit and cyclopropanation (Scheme 36) (see section 1.2 and 1.3). 
 
Scheme 36. Functionalised ynamides for reactivity testing. 
2.2 Preparation of ynamide substrates 
From the different synthetic preparations of ynamides available, we focused our attention on the 
previously described second-generation copper-catalysed coupling developed by Hsung and 
co-workers.49 
For the synthesis of ynamide precursor 161 and 164, tosyl substituted allyl amine 158 was 
prepared in good yield by a slow addition of tosyl chloride to a solution of allyl amine and 
pyridine in CH2Cl2 at 0 °C. Bromination of 1-hexyne 159 with N-bromo succinimide catalysed by 
silver nitrate in acetone afforded bromoalkyne 160 in good yield. Under Hsung's reaction 
conditions, the coupling between 158 and 160 produced ynamide 161 in decent yield (Scheme 
37). 
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Scheme 37. Preparation of ynamide 161. 
The same approach was also employed for the preparation of ynamide precursor 164. Phenyl 
acetylene 162 was converted to its brominated derivative 163 and then submitted to copper-
catalysed coupling conditions with allyl sulfonamide 158, affording the desired N-alkynyl 
sulfonamide 164 in good yield (Scheme 38).  
 
Scheme 38. Preparation of ynamide 164. 
For the preparation of ynamide 153, 2-bromobenzaldehyde was treated with phenylboronic acid 
in a Pd-catalysed Suzuki coupling reaction to obtain bisarylaldehyde 167. Treatment of 167 with 
triphenylphosphine and carbon tetrabromide in dichloromethane provided dibromoalkene 168 in 
excellent yield. In order to obtain the desired bromoalkyne derivative 169, an elimination 
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process promoted by tert-butoxide was employed and afforded the desired product in good 
yield. Unfortunately, the copper catalysed ynamide forming reaction with 2-oxazolidinone 170 
afforded the product in very low yield (Scheme 39). Hsung's second-generation ynamide 
synthesis protocol has been reported to be significantly affected by the quality of the reagents 
used,61 and this could explain the poor result observed in the synthesis of ynamide 153.  
 
Scheme 39. Synthesis of ynamide 153 under Hsung's reaction conditions.  
Due to this disappointing result, we decided to execute a comparative study in order to evaluate 
the efficiency of the different ynamide preparation methodologies available. In order to explore 
alternative preparations, iodoalkyne 171 was prepared employing N-iodosuccinimide, as an 
electrophilic source of iodine, with phenyl acetylene 162 and silver nitrate in acetone (Scheme 
40). 
 
Scheme 40. Preparation of iodoalkyne 171. 
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Different copper and metal catalysed coupling processes were then tested for the preparation of 
oxazolidinone ynamide 172. In the case of Hsung's coupling conditions, both halogenated 
phenylacetylene 163 and 171 proved to be unsuccessful (Entries 1 and 2, Table 1). Moreover, 
the iron-based procedure developed by Zhang also did not provide the ynamide 172 formation 
(Entry 3) even though this product was reported. 62 Instead, the aerobic copper-catalysed 
protocol developed by Stahl and co-workers50 was the only successful protocol and yielded the 
product in 85% of yield (Entry 4).  
Table 1. Ynamides preparation methods-comparison study. 
 
 Entry Phenylacetylene derivative Conditions 172 Yield[a]  
      
 1 163 (X=Br) Cu2SO4·5H2O, 1,10-phenanthroline, K2CO3, toluene, 75 °C -
[b]  
 2 171 (X=I) Cu2SO4·5H2O, 1,10-phenanthroline, K2CO3, toluene, 75 °C 
-[b]  
 3 171 (X=I) FeCl3, TMEDA, K2CO3, toluene, 90 °C -[b]  
 4 162 (X=H) CuCl2, O2, pyridine Na2CO3, toluene, 70 °C 85%  
[a]Reactions executed on 1 mmol scale of 2-oxazolidinone 170. [b]No reaction was observed. 
Therefore, it was decided that the preparation of ynamide 153 should be performed under 
Stahl's reaction conditions which employ copper (I) chloride as a catalyst in the presence of 
pyridine, sodium carbonate and molecular oxygen as oxidant in toluene. Terminal alkyne 173, 
prepared using a Corey-Fuchs protocol from the previously prepared dibromo derivative 168, 
was then submitted to the aerobic copper-catalysed coupling with 2-oxazolidinone, which finally 
afforded ynamide 153 in good yield (Scheme 41). 
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Scheme 41. Preparation of ynamide 153 with Stahl’s method. 
Ynamide 156 was prepared in a similar manner. Commercially available o-iodobenzyl alcohol 
was coupled with trimethylsilylacetylene under Sonogashira conditions using PdCl2(PPh3)2 and 
copper (I) iodide as a catalytic system. The silylphenylacetylene 175 was allylated with allyl 
bromide in solvent free conditions and the crude reaction mixture was treated with a solution of 
potassium carbonate in MeOH to afford desilylated alkyne 176 (Scheme 42). Under aerobic 
copper catalysis, allyl ether with 176 led to the formation of ynamide 156 in good yield. 
 
Scheme 42. Preparation of ynamide 156. 
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2.3 Preliminary studies of gold-catalysed intermolecular oxygen 
transfer onto ynamides  
To test the gold-catalysed intermolecular oxidation reaction on the selected ynamides, 
commercially available p-methoxy pyridine N-oxide hydrate was initially employed as the 
external oxidant. It was hypothesised that the presence of the electron-donating group would 
increase the nucleophilic character of the N-oxygen atom which is fundamental for the addition 
onto the electrophilic activated ynamide’s triple bond. As standard catalytic conditions, 
PPh3AuCl was chosen as a gold catalyst activated by silver salt AgSbF6 through an in situ 
chloride abstraction in CH2Cl2 (Scheme 43). The cationic gold species H, bearing an empty 
coordination site, is the active form of the catalyst that would promote the reaction. 
 
Scheme 43. Metathesis reaction between PPh3AuCl and AgSbF6. 
Under the unoptimised gold catalysis conditions, ynamides 164 and 153 led to the formation of 
dioxidated oxoacetamide products 177 and 181 respectively (Scheme 44). Access to the 
dioxidised products was a result of a second oxidation step occurring on the intermediate 179; 
surprisingly this intermolecular process was apparently faster than any other intramolecular 
rearrangement that could have taken place. The reaction did not proceed to completion 
because an insufficient amount of pyridine N-oxide was employed to achieve full conversion to 
the dioxidised products.  
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Scheme 44. Dioxidation processes on ynamide 164 and 153 catalysed by gold complexes. 
An equivalent oxidation of a gold carbenoid has been reported by Toste et al., who trapped a 
gold catalysed 1,6-enyne cycloisomerisation carbenoid intermediate 183 with an external 
sulfoxide 184 as the oxidant (Scheme 45).63  
 
Scheme 45. 
Dioxidation processes on ynamides have also been reported by Hsung and co-workers using 
electrophilic oxidising reagents (i.e. RuO2-NaIO4 and DMDO) (Scheme 45).64  
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Scheme 46. 
Ynamide 156 was also tested under the conditions previously employed. In this instance, the 
formation of a gold complex promoted a 6-endo cyclisation following by an overall ally migration 
to form product 191 (Scheme 47). This is consistent with the allyl shift observed for a similar 
reaction catalysed by platinum employed as π-acid,65 although a Claisen-type rearrangement 
could not be excluded since it was proved for the cycloisomerisation of ynenyl allyl ethers in the 
presence of a gold (I) catalyst.66 
 
 50 
 
Scheme 47.  
Under gold catalysis, ynamide 161 led to the formation of α,β-unsaturated carboxylic acid 
derivatives of type 195 (Scheme 48). This latter product was consistent with the hypothesized 
regioselective intermolecular transfer of an oxygen atom from the pyridinium system to the 
ynamide triple bond. The cleavage of the N-O bond led to the formation of an α-oxo gold 
intermediate of type that could be responsible, either via a gold stabilised carbocation or a gold 
stabilised carbene, for the observed 1,2-hydride shift. The presence of a hydrogen atom in the 
γ-position diverts the evolution of the gold intermediate, with the hydride shift process is faster 
than the previously observed second oxidation step of the gold intermediate.  
 51 
 
Scheme 48. Synthesis of 195 under gold-catalysed oxidation conditions. 
The formation of the vinylogous amide 195 represents a novel alternative method for preparing 
α,β-unsaturated carboxylic acid derivatives and also an alternative protocol to access α-oxo 
gold carbenoids as it was proposed.  
The α-oxo carbene formation from an ynamide in an oxidation reaction has also been reported 
in the literature, 67  but interestingly the opposite regioselectivity upon installation of such 
functionality was observed when DMDO is used as an oxidant (Scheme 49). The opposite 
outcome of oxygen atom installation-carbene formation is due to the electrophilic nature of the 
oxidant used.  
 
 
Scheme 49. Opposite regioselective oxidation outcomes with electrophilic and nucleophilic 
oxidant on ynamides. 
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Intrigued by the possibilities to access different α,β-unsaturated imide derivatives via a two-step 
procedure starting from electron-deficient amides and terminal alkynes, 68 , 69  further 
investigations were carried out. Notably, under this novel protocol, ynamides could be viewed 
as a direct equivalent of α-oxo gold stabilised carbenoids 199 representing a valid alternative to 
the use of α-oxo diazo compounds of type 200 (Figure 8). 
 
Figure 8. 
2.4 Survey of the catalytic conditions for the gold-catalysed 
oxidation of ynamides 
It was decided to conduct a screening study on the different reaction conditions of the gold-
catalysed oxidation reported above by using ynamide 202 as a test substrate. This was 
prepared from commercially available sources (Scheme 50).  
 
Scheme 50. Preparation of ynamide 202. 
1H-NMR analysis of the crude reaction mixture containing a known amount of internal standard 
(1,2,4,5-tetramethylbenzene) was performed in order to evaluate the catalysis system efficiency 
(Table 2). Formation of the product 203 as a mixture of E:Z isomers was observed under mild 
gold catalysis conditions (Entries 2, 3, 4 and 5) in poor yields, with the exception of AuBr3 (Entry 
6). Interestingly, the switch from the p-methoxy pyridine N-oxide hydrate to anhydrous pyridine 
N-oxide appeared to increase the efficiency of the reaction (Entries 1 and 6 vs. Entries 7 and 8 
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respectively). The presence of the water in the oxidant species might interfere with the reaction 
and therefore exclusion of water through the use of anhydrous reagents would be preferable. In 
order to ameliorate the reaction conditions, the temperature was varied. It was noted that at 
higher temperature, the catalytic system	   AuPPh3Cl/AgOTs (Entry 12) performed better than 
AuPPh3Cl activated by other silver salts (Entries 10 and 11), although additional increase in 
temperature worsened the catalyst's performance (Entry 13). AuBr3 performed efficiently at 
room temperature but its activity was reduced by an increase in temperature (Entries 8 and 16). 
A comparison of different solvents showed THF to be the most suitable when AuBr3 was 
employed. Au catalyst Au-III28 at moderately high temperature also catalysed the transformation 
and gave the α,β-unsaturated imide product in good yield (Entry 15).  
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Table 2. Survey of the reaction conditions.  
 
 
Entry Catalyst Oxidant (equivalents) 
Solvent 
 
Temperature 
(°C) 
Starting 
material 
remaining  
203 Yield 
(E:Z ratio)[a],[b] 
 
 1 AuPPh3/AgSbF6 A (1.1) CH2Cl2 RT 54% -[c]  
 2 AuPPh3/AgSbF6 A (2) CH2Cl2 RT 54% 9% (1:0)  
 3 Au-III A (1.1) CH2Cl2 RT 68% 14% (1:0)  
 4 AuBr3 A (1.1) CH2Cl2 RT 22% 12% (1:0)  
 5 AuPPh3/AgOTf A (1.1) CH2Cl2 RT 55% 8% (1:0)  
 6 AuCl3 A (1.1) CH2Cl2 RT -[c] 65% (5.5:1)  
 7 AuPPh3/AgSbf6 B (1.1) CH2Cl2 RT 56% 6% (1:0)  
 8 AuBr3 B (1.1) CH2Cl2 RT -[c] 71% (4.6:1)  
 9 AuCl B (1.1) CH2Cl2 RT 60% 30% (1:0)  
 10 AuPPh3/AgSbf6 B (1.1) ClCH2CH2Cl 70 19% 31% (2.9:1)  
 11 AuPPh3/AgOTf B (1.1) ClCH2CH2Cl 70 17% 23% (4.6:1)  
 12 AuPPh3/AgOTs B (1.1) ClCH2CH2Cl 70 12% 50% (3.5:1)  
 13 AuPPh3/AgOTs B (1.1) toluene 90 -[c] 47% (2.2:1)  
 14 Au-III B (1.1) ClCH2CH2Cl 50 (7h) -[c] 58% (5.1:1)  
 15 Au-III B (1.1) ClCH2CH2Cl 70 (3h) -[c] 69% (5.5:1)  
 16 AuBr3 B (1.1) ClCH2CH2Cl 70 -[c] 71% (7.9:1)  
 17 AuBr3 B (1.1) THF RT -[c] 61% (12.8:1)  
 18 AuBr3 B (1.1) toluene RT -[c] 65% (12.0:0)  
 19 AuBr3 B (1.1) MeCN RT 43% 33% (7.2:1)  
A= p-methoxypyridine N-oxide hydrate, B= pyridine N-oxide. [a]Reactions were performed 
employing 0.1 mmol of ynamide 202, A or B (as shown), Catalyst (5 mol%), Solvent (0.1 M), 24 h. 
[b]NMR yield were calculated against a known amount of internal standard and ratios were 
determined by 1H-NMR analysis. [c]Not observed in the crude mixture. 
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Considering all the gold catalytic conditions tested, two promising sets of conditions were 
identified: 
• System A: air-stable dichloro(pyridine-2-carboxylato)gold (III) Au-III precatalyst in 1,2-
dichloroethane at 70 °C (Table 2, Entry 15) which led to the higher yield. 
• System B: AuBr3 in THF at room temperature (Table 2, Entry 17), which led to high (E)-
selectivity while maintaining good yield. Moreover this system avoids the use of 
chlorinated solvents. 
A parallel study was also performed by Nicolas Martin, a former member of the Davies’ group, 
employing ynamide 204 and comparable results were observed (Scheme 51).70 Moreover, it 
was found that platinum(II) salts, Brønsted acids and an electrophilic bromine source gave no 
reaction and/or degradation. 
 
Scheme 51. 
Because of the relative advantages to each system it was therefore decided that both systems 
would be applied to a selection of different ynamides to investigate reaction scope and 
functional group tolerance. 
2.5 Ynamide preparation 
In order to explore the scope of this novel intermolecular gold catalysed oxygen transfer 
reaction, a series of ynamides bearing different functional groups was prepared. 
A variety of amides were synthesised following literature procedures (Scheme 52). Amide 208, 
Boc-protected 209, sulfonyl amide 211 and 212 were prepared in good yield by simple addition 
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of the appropriate acid derivatives in the presence of a base when required. Propargyl 
sulfonamide 214 was obtained using a similar strategy and was further elaborated by silylation 
at the terminal alkyne position with n-BuLi and TMSCl to afford silyl derivative 215 in good yield. 
This alkyne protection step was necessary to avoid possible competition with the alkynylating 
reagent employed in the copper-catalysed coupling synthesis of ynamides.  
 
Scheme 52. Preparation of amides. 
It was decided to prepare a wide range of teminal alkynes, which included different functional 
groups such as propargylethers, silyl alkynes and different protected alcohols.  
Propargylic ether 217 was readily synthesised from cyclohexyl aldehyde and subjected to a 
methylation-desilylation protocol to afford the propargyl ether 217 in good yield. Unsymmetrical 
dialkynyl ether 221 was obtained from propargyl bromide and 3-butynyl-1-ol via a phase transfer 
process in the presence of TBAHS. Regioselective silylation of the propargyl unit over the 
butynyl framework involved the use of a catalytic amount of 1,10-phenanthroline and yielded the 
silyl protected alkyne. Propargylic ether 223 was readily obtained by reacting propargyl alcohol 
and (E)-cinnamyl bromide 222 under basic conditions (Scheme 53).  
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Scheme 53. Preparation of terminal alkynes 218 and 221.	  
Propargyl silane 224 was synthesised according to a known procedure using 1-hexyne 159 and 
TMSCl (Scheme 54). Silylation of commercially available 2-phenyl propargyl alcohol with TBSCl 
in the presence of 1-H-imidazole led to the formation of silyl ether 226 in good yield.  
 
Scheme 54. Preparation of alkynes 224 and 226. 
Deprotonation of 4-pentenyl-1-ol 218 with sodium hydride followed by treatment with benzyl 
bromide produced benzyl ether 227 in excellent yield. 4-pentenyl-1-ol was also silylated with 
TBSCl in the presence of 1-H-imidazole affording silylether 228. For the synthesis of thioester 
230, a Mitsunobu protocol was applied starting from the commercially available corresponding 
alcohol 229, activated with DIAD and thioacetic acid. 
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Scheme 55. Preparation of alkynes 227, 228 and 230. 
With different amides and terminal alkynes in hand, coupling reactions were performed following 
Stahl's methodology to synthesise a wide range of N-alkynyl amides (Table 3 and Table 4).  
Amides 208 and 209 (Entries 1 and 2, Table 3) and alkynes 223 did not allow the synthesis of 
the corresponding ynamides (Entries 3, 4 and 7) and these results were thought to be 
dependent on the limitations of the method employed; in fact, no amination reaction under 
Stahl’s method have been reported in the literature for such precursors. Good yield were 
instead obtained in the preparation of ynamides 235, 236 and 238. 
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Table 3. Ynamide synthesis from amides and terminal alkyne.  
 
 Entry Amide  Alkyne Product (Yield)[a],[b] Ynamide  
 
1 208 1-hexyne 232 (-)[c] 
 
 
 
2 209 1-hexyne 233 (-)[c] 
 
 
 
3 212 223 234 (-)[c] 
 
 
 
4 211 221 235 (59%) 
 
 
 
5 212 1-hexyne 236 (42%) 
 
 
 
6 212 224 237 (-)[c] 
 
 
 
7 215 1-hexyne 238 (70%) 
 
 
[a]All reactions were executed on a 2 mmol scale related to the alkyne employing amine (10 mmol), 
CuCl2 (5 mol%), Na2CO3 (4 mmol), CuCl2 (0.4 mmol) and toluene (0.1 M). [b]Yields refer to isolated 
product after column chromatography. [c]No product formation was observed in the crude mixture. 
While sulfonyl amides were further investigated by former colleague Nicolas Martin, attention 
was given in preparing different oxazolidinone derivatised ynamides. As shown in Table 4, 2-
oxazolidinone proved to be a suitable commercial available substrate for ynamide preparation 
 60 
(Entries 1-11). Although ynamide 241 was prepared in good yield and partly characterised, the 
high instability of the substrate led to its rapid degradation. 
Table 4. Ynamide synthesis from 2-oxazolidinone and terminal alkyne. 
 
 Entry Alkyne Product (Yield)[a],[b] Ynamide  
 1 3-acetoxyprop-1-yne 239 (92%) 
 
 
 2 cyclopropilacetylene 240 (59%) 
 
 
 3 226 241 (70%)[c] 
 
 
 4 1-hexyne 242 (43%) 
 
 
 5 3-methoxyprop-1-yne 243 (88%) 
 
 
 6 6-chlorohex-1-yne 244 (68%) 
 
 
 7 
2-(pent-4-yn-1- yl)- 
isoindoline-1,3-dione 
245 (74%) 
 
 
 61 
 8 227 246 (79%) 
 
 
 9 228 247 (53%) 
 
 
 10 230 248 (64%) 
 
 
 11 ethynylcyclohexane 249 (54%) 
 
 
[a] All reactions were executed on a 2 mmol scale related to the alkyne employing amine (10 mmol), 
CuCl2 (5 mol%), Na2CO3 (4 mmol), CuCl2 (0.4 mmol) and toluene (0.1 M). [b] Yields refer to isolated 
product after column chromatography. [c]Product quickly degradated after purification. 
2.6 Synthesis of α ,β-unsaturated imides and vinylogous 
carbimates 
The optimised conditions for the formation of α,β-unsaturated imides (System A and B) were 
applied to the selection of previously prepared ynamides. Good to excellent yields were 
achieved when sulfonylynamide substrates 235, 236 and 238 were employed and in all cases 
the E-isomer was formed as the major product (Table 5). Interestingly, excellent 
chemoselectivity and tolerance were displayed when a pendant silyl-acetylene framework was 
present in the starting material (Entries 1 and 3). 
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Table 5. Synthesis of α ,β-unsaturated imides. 
  
 Entry Ynamide System Product Yield (E:Z ratio)[a],[b] α,β-unsaturated imide  
 
1 235 
A 
B 
250 
66% (2.8:1) 
68% (3.2:1) 
 
 
 
2 236 
A 
B 
251 
87% (3.6:1)[c] 
85% (4.5:1)[c] 
 
 
 
3 238 
A 
B 
252 
34% (4.1:1)[c] 
31% (6.1:1)[c] 
 
 
[a]Reactions were executed on ynamide (0.3 mmol), catalyst (5 mmol%), piridinium N-oxide (1.5 eq), 
solvent (0.1 M). [b]Yields refer to isolated product after column chromatography. E:Z ratio 
calculated on isolated products. Reactions were monitored by TLC. [c]Mixture of inseperable 
isomers. 
To further stress the chemoselectivity aspect, ynamide 235 was desilylated to reveal its terminal 
alkyne position (Scheme 56).  
 
Scheme 56. Desilylation of ynamide 253. 
Surprisingly, the reaction onto ynamide 253 took place under both sets of conditions, but a 
lower product yield was observed compared to the one obtained employing the progenitor 
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ynamide (Scheme 57). Formation of unknown by-products and unreacted starting material 
accounted the for poor transformation efficiency. 
 
Scheme 57. Gold-catalysed oxidation for ynamide 112. 
When ynamide 90, 91 and 92 were tested, degradation of the starting material was instead 
observed (Entries 1-3, Table 6). In the case of ynamide 90, competing reactions could be 
envisaged as a result of an intramolecular nucleophilic attack by the acyl framework, resulting in 
complex mixture of unknown products (Entry 1). Also in the case of the cyclopropene 
substituent the reaction proved unsuccessful, leading to the formation of a mixture of unknown 
by-product (Entry 2). It was hyphotised that competing processes, as reported in the literature,71 
could explain the poor reaction outcome. As mentioned in the previous section, silyl ynamide 92 
displayed high instability and degradation occurred while setting up the reaction. This issue 
could not be overcome even when such ynamide was employed immediately after purification.  
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Table 6. Synthesis of α ,β-unsaturated imides. 
 
 Entry Ynamide System Product Yield (E:Z ratio)[a] α,β-unsaturated imide 
 
1 239 
A 
B 
255 (-)[b] 
- 
- 
 
 
2 240 
A 
B 
256 (-)[b] 
- 
- 
 
 
3 241 
A 
B 
257 (-)[b] 
- 
- 
 
 [a]Reactions were executed on ynamide (0.3 mmol), catalyst (5 mmol%), piridinium N-oxide (1.5 eq), 
solvent (0.1 M). [b]Complex mixture of product. [c]Ynamide degradation while setting the reaction. 
The reaction showed tolerance towards a wide variety of functionalities (Table 7): alkyl (Entries 
1 and 2), benzoyl (Entry 3), alkyl chloride (Entry 4), phthalimido (Entry 5) and thioester groups 
(Entry 6) did not affect the oxidation of the ynamido fragment and survived the reaction 
conditions. Synthetically valuable vinylogous carbimate 264 can also be prepared by employing 
substrates with an alkoxy group in the propargylic position (Entry 7). However, for unknown 
reasons, catalytic System B seemed to be ineffective when such propargylic oxygen atoms bore 
a methyl group and led to complex mixtures of unknown products (Entry 7b). The same issue 
was shown also in the case of silyl ether 247 (Entry 8b). Notably, System A proved instead to 
be efficient in both of these two cases and high yields of the desired products were achieved 
(Entries 7a and 8a). Moreover, in the case of ynamide 243 (Entry 7), only E isomer was 
observed. 
Overall, System A was generally superior in comparison to the conditions of System B with 
respect to product yield, although the latter usually provided greater E:Z selectivity.  
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Table 7. Synthesis of α ,β-unsaturated imides. 
 
 Entry Ynamide System Product Yield (E:Z ratio)[a],[b] α,β-unsaturated imide  
 
1 242 
A 
B 
258 
63% (3.2:1) 
70% (5.0:1) 
 
 
 
2 249 
A 
B 
259 
81% 
81% 
 
 
 
3 246 
A 
B 
260 
73% (2.8:1) 
68% (3.1:1) 
 
 
 
4 244 
A 
B 
261 
63% (2.9:1) 
65% (4.0:1) 
 
 
 
5 245 
A 
B 
262 
68% (5.6:1) 
75% (6.7:1) 
 
 
 
6 248 
A 
B 
263 
75% (2.6:1) 
71% (7.7:1) 
 
 
 
7 243 
A 
B 
264 
89%[c] 
-[d]  
 
 
 
8 247 
A 
B 
265 
75% (6.7:1) 
-[d] 
 
 
[a]Reactions were executed on ynamide (0.3 mmol), catalyst (5 mmol%), piridinium N-oxide (1.5 eq), 
solvent (0.1 M). [b]Yields refer to isolated product after column chromatography. E:Z ratio 
calculated on isolated products. Reactions were monitored by TLC. [c]Only E-isomer was observed. 
[d]Degradation occurred during the reaction. 
2-Oxazolidinone derived ynamides proved to be suitable substrates for the gold-catalysed 
oxidation under investigation and it was intriguing to employ commercially available chiral 
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homologous (S)-4-benzyloxazolidin-2-one 267 to prepare optically active vinylogous 
carbimates. The products of catalysis of these substrates would further enhance their utility as 
building blocks for organic synthesis providing a source of chirality for stereoselective 
transformation. Chiral ynamides 269 and 270 were prepared (Scheme 58) and tested under 
both sets of reaction conditions System A and B. 
 
Scheme 58. Preparation of chiral ynamides. 
While simple N-alkynyl oxazolidinone 243 led to the formation of only the E-isomer (Table 7, 
Entry 7), some Z-isomer formation was observed when the chiral analogue 26 was employed 
(Scheme 59). Unexpectedly, the use of a 1:1 mixture of epimers 270 showed significantly 
divergent outcomes depending on the catalysis system utilised in terms of E:Z ratio. Whilst the 
use of moderately elevated temperature of System A consistently led to the formation of the E-
isomer 272 as the major product, the milder reaction conditions of System B yielded 
predominantly the Z-isomer 272. Modulation of the stereochemical outcome by varying the 
conditions employed could represent a significant utility for the use of these transformations in 
organic synthesis.72 
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Scheme 59. 
A series of tests were conducted in order to understand the unusual behaviour of ynamide 270 
under the chosen reaction conditions (Scheme 60). When the major product of System B Z-272 
was submitted to the catalysis conditions of System A, an isomerisation to an E:Z ratio in favour 
of the E-isomer was observed. The olefin geometry conversion was irreversible as shown by the 
resubmission to the System B reaction conditions (Scheme 60, Eq. 1). Subsequently, an 
enriched Z-isomer mixture of 272 was submitted to both System A and B reaction conditions 
and the isomerisation conversion switched the E:Z ratio to a higher E-isomer predominance. 
This effect was more evident with the moderately elevated temperature of the former (System 
A) (Scheme 60, Eq. 2). It was therefore concluded that Z-272 represents the kinetic product 
whilst E-272 the thermodynamic one. It was also proven that the isomerisation occurred even in 
the absence of the catalyst. 
 
Scheme 60. Isomerisation tests on 272. 
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During the course of our studies, Zhang and co-workers published a similar transformation, 
where substituted pyridine N-oxides were involved in a regio-specific oxidation on terminal 
alkynes catalysed by gold. 73  The new transformation allowed the synthesis of different 
dihydrofuran-3-ones 276 and oxetan-3-ones 279 (Scheme 61). Similar to the reaction described 
on ynamides, the alkyne-gold complex undergoes site-specific nucleophilic addition from the N-
oxide, and subsequent O-N bond cleavage gives a gold carbenoid species of type 275. 
Intramolecular trapping by the pendant hydroxyl group of the gold intermediate and subsequent 
protodeauration led to the products with good to excellent yield.  
 
Scheme 61. 
A broad range of functionalities were found to be compatible with the reaction conditions (e.g. 
azides, aromatic systems, halogenated alkyl chains). Notably, this method required the 
synthesis of non-commercially available oxidant and the use of an acid in the reaction mixture 
which could represent an issue for acid-sensitive substrates. It was suggested that the pyridine 
formed as by-product would deactivate the gold catalyst and low yields were reported when the 
acid was absent. On the contrary, such unwelcome effect related to the pyridine formation was 
not observed in the gold catalysed oxidation of ynamides reported herein. 
After publication of our results, Zhang and co-workers showed that internal alkynes can undergo 
regioselective gold catalysed oxidative reactions with pyridine N-oxide (Scheme 62).74 This 
latter transformation overcomes the problem of restricted employment of terminal or electron-
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withdrawing group substituted alkynes. Although good to excellent regioselectivity was 
achieved, often the regiocontrolling factor relied on a different steric hindrance or different 
capability to favour the proto-elimination between the acetylene substituents. Conversely, the 
predictable and reliable regioselectivity offered by the nitrogen substitution in ynamides allowed 
us to regioselectively obtain the oxidation on the carbon next to the nitrogen. 
 
Scheme 62. 
2.6 Synthesis of vinylogous carbonates and α ,β ,γ ,δ-
unsaturated carboxylic esters 
Subsequently, the generality of this approach was explored to see if unsaturated carboxylic acid 
derivatives other than imides could be prepared through the same strategy. In this regard, 
oxygen substituted alkynes possess some almost superimposable electronic characteristics 
with ynamides and therefore it was possible to envisage a similar behaviour when engaged in 
oxidation reactions with pyridinium N-oxide catalysed by a gold catalyst (Scheme 63). Although 
oxygen substituted alkynes have been far less extensively investigated due to the relatively few 
methods currently available for their synthesis,75,76 it is worthy of mention that they have already 
be employed in some gold-catalysed reactions.77  
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Scheme 63. 
For these reasons, ynol ethers 288-290 were prepared. Commercially available ethoxy 
acetylene was deprotonated with n-BuLi in THF and treated with cyclohexyl aldehyde to form 
propargyl alcohol 287 in good yield. Alkylation and benzylation with the appropriate bromides in 
the presence of sodium hydride allowed the isolation of the desired ynol ethers 288 and 289. 
Propargylic ynol ether 290 was prepared from (E)-cinnamyl bromide under copper-promoted 
coupling conditions. While ynamides are usually bench-stability due to the presence of their 
electron-withdrawing substituent, ynol ethers are normally unstable and suffer the tendency to 
undergo hydrolysis or degradation reactions. Therefore, alkoxyl alkynes thus prepared were 
engaged in catalysis immediately after purification or stored for a short period of time under 
appropriate conditions (argon atmosphere, low temperature).  
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Scheme 64. Preparation of ynol ethers 288, 289 and 290. 
Although ynol ethers are by nature generally more reactive in comparison to ynamides, the 
same catalytic systems previously optimised for ynamides were employed. Under gold catalysis 
conditions propargylic ynol ether 288 and 289 successfully underwent the oxidation/1,2-
insertion reaction and yielded β-substituted vinylogous carbonates 291 and 292 respectively in 
good yield (Entries 1 and 2,Table 8). 
Extended π-systems can also be prepared by this method as shown in the synthesis of α,β,γ,δ-
unsaturated carboxylic ester 293 when 1,4-ynene 290 is oxidised by pyridine N-oxide (see table 
below). In all the cases, catalytic System A afforded the desired product in higher yield while 
catalytic System B provided a higher E:Z ratio.  
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Table 8. Synthesis of α ,β-unsaturated carbonates. 
 
 Entry Ynol ether System Product Yield (E:Z ratio)[a],[b] α,β-unsaturated carbonate  
 1 288 
A 
B 
291 
77% (1:0) 
72% (3.9:1)  
 
 2 289 
A 
B 
292 
89% (2.8:1)[c] 
85% (5.1:1)[c]  
 
 3 290 
A 
B 
293 
75% (4.3:1) 
88% (6.1:1)  
 
[a] Reactions were executed on ynamide (0.3 mmol), catalyst (5 mmol%), piridinium N-oxide (1.5 eq), 
solvent (0.1 M). [b]Yields refer to isolated product after column chromatography. E:Z ratio 
calculated on isolated products. Reactions were monitored by TLC. [c]Minor product Z in a mixture. 
2.7 Summary 
A new gold catalysed oxidation reaction has been developed employing ynamides and ynol 
ethers to access a site-specific oxygen transfer process from commercially available pyridine N-
oxide. This reactivity has been used in the synthesis of a variety of α,β-unsaturated carboxylic 
acid derivatives such as vinylogous carbonates and carbamates. The mild gold catalysis 
reaction conditions are tolerant towards a wide range of functional groups including other alkyne 
moieties. The access to α-oxo gold carbenoid reactivity from ynamides and ynol ethers as direct 
equivalent to α-oxo diazo compounds has also been shown. Therefore, the gold-catalysed 
methods described above might lead to further significant developments in organic synthesis 
when alternative α-oxo carbene reactivity is needed. 
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Chapter 3: Gold-catalysed synthesis of 2,4,5-
trisubstituted oxazoles 
  
 74 
3.1 Introduction 
The previously reported successful intermolecular transfer reaction of an oxygen atom onto gold 
activated ynamides and ynol ethers has shown pyridinium N-oxides to be an extremely valid 
oxygen atom delivery system. The organometallic intermediate of this transformation is trapped 
intramoleculary in the presence of a γ-hydrogen through elimination, leading to the formation of 
α,β-unsaturated carboxylic acid derivatives (Figure 9, Eq.1). It was also shown that in the 
absence of hydrogen atoms in the γ-position, a second oxidation step proved to be faster than 
any of the other intramolecular processes that could have taken place (Figure 9, Eq. 2).  
 
Figure 9. Gold catalysed oxidation of ynamides with pyridine N-oxide. 
In Chapter 1, it was demonstrated that α-oxo gold carbenoid intermediates can undergo 
intramolecular nucleophilic attack by a nitrogen, sulfur, carbon or oxygen atom preinstalled in 
the molecule. In order to divert the reactivity shown in the previous chapter and summarised in 
the figure above, it was envisaged that while the pyridinium delivering system drives the 
installation of the nucleophilic heteroatom, it could also introduce a second reactive centre 
capable of promoting an alternative destiny for the gold carbenoid intermediate (Figure 10). 
According to this strategy, it should be possible to introduce an additional intramolecular 
process and, under optimised conditions, the appropriate functionality Z could react with the 
gold carbenoid intermediate rapidly enough that other possible reactions would be largely 
suppressed.  
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Figure 10. 
Maintaining a pyridine system as nucleofuge, N-amino pyridonium derivatives of type J 
appeared to be suitable for the concept due to the additional valence allowed by the nitrogen 
atom (Figure 11). These reagents would allow access to a nitrene transfer rather than oxygen 
transfer reported in the previous chapter for pyridine N-oxides.  
 
Figure 11. 
Nitrene transfer promoted by gold onto alkynes has only been reported intramolecularly by 
Toste using either a tethered azido alkynes (CHAPTER 1 Scheme 10, Eq. 2,)26 or a tethered 
sulfimine alkyne (CHAPTER 1, Scheme 12).29 Notably, no intermolecular cases have been 
published and the proposed gold-catalysed nitrene transfer processes would be different from 
other nitrene transfer modes present in the literature. 78  Such reactivity was of interest 
considering the possible access to α-imino carbenoid equivalents, which are similarly or more 
problematic to prepare than their oxygenated homologous.  
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3.2 Preliminary studies 
Pyridine N-aminides of type M were selected as suitable nitrene-delivering oxidants which also 
bear a second reactive centre represented by the carbonylic oxygen. These robust reagents 
have been employed as 1,3-C,N dipoles in cycloadditions that incorporate the pyridine group.79 
Under our catalytic proposal they would instead react as 1,3-O,N-dipoles. The aminides are 
readily prepared by acylation of commercially available N-amino pyridonium iodide in the 
presence of a strong base which after acylation promotes the final deprotonation to form the 
corresponding ylide. Aminide 295 was obtained employing benzoyl chloride in a 10% aqueous 
solution of sodium hydroxide and was isolated in decent yield as a bench-stable white 
crystalline solid. 
 
Scheme 65. Preparation of aminide 295. 
It was decided to employ nitrogen-substituted alkynes as the acetylenic framework in reaction 
development in order to ensure a regioselective installation of the nucleophilic heteroatom as 
previously demonstrated. Previously prepared sulfonyl amide 212 was submitted to a coupling 
reaction with phenyl acetylene under the optimised Stahl copper-catalysis conditions led to 
ynamide 296 in 73% yield. 
 
Scheme 66. Preparation of ynamide 296. 
The previously optimised catalytic conditions System A, which employ dichloro(pyridine-2-
carboxylato)gold(III) precatalyst Au-III in ClCH2CH2Cl at 70 °C, were chosen as a starting point 
 77 
for the study. Under these unoptimised conditions, the reaction between N-ylide 295 and 
ynamide 296 afforded oxazole 297 as a single regioisomeric product in 53% yield along with 
recovered unreacted starting material (Scheme 67). The structure of the 4-amino oxazole 
product was confirmed by single-crystal X-ray diffraction analysis.80 
 
 
Scheme 67. Gold-catalysed formation of oxazole 297. 
From the outcome of this preliminary reactivity study, it was concluded that under gold catalysis 
conditions an aminide can act as an equivalent to an acylnitrene unit, which is regioselectively 
installed onto π-activated ynamides by the pyridinium carrier. 
The acyl carbonyl group installed during the ‘nitrene transfer’ promoted the quench of the gold 
intermediate, in place of other intra- and inter-molecular processes which is consistent with the 
proposal made at the beginning of this chapter.  
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Overall, this novel transformation for the oxazole core formation can be seen as a formal [3+2]-
cycloaddition between a carbon-carbon triple bond and an acyl-nitrene 1,3-N,O dipole. 
Although [3+2] cycloadditions across π-systems have been widely exploited for the preparation 
of heterocyclic five membered rings, examples where this strategy has been applied to the 
synthesis of 1,3-oxazoles are very limited.81  
Besides the different manipulations available to functionalise around an intact 1,3-oxazole,82 
classical methods for the de novo synthesis of trisubstituted oxazoles usually require multistep 
reaction processes. Moreover, they often require harsh conditions or highly reactive reagents 
which can be incompatible with sensitive functional groups.83 Metal-promoted methodologies 
(e.g. Cu, Ag, and Rh) seem to be more beneficial and can overcome the drawbacks of the 
classical procedures, although in most cases they display significant substrate-scope limitations 
and poor overall efficiency. 84  
The synthesis of oxazoles through the cycloaddition of an acylnitrene, obtained from 
photochemical or thermal decomposition of acyl azides, as a 1,3-N,O-dipole across an alkyne 
usually suffer from poor chemoselectivity.85 Remarkably, it was very recently shown during the 
course of our studies, 2,5-disubstituted oxazoles have been successfully synthesised through a 
one-pot regioselective copper (I)-catalysed reaction between acyl azides of type 298 and 
terminal alkynes 299 (Scheme 68).86 Rather than the direct formation of an acyl nitrene, the 
reaction was proposed to proceed through the formation of copper acetylide followed by a 
[3+2]-cycloaddition with the azide derivatives leading to triazolyl copper-intermediate 301. This 
further evolved by extrusion of dinitrogen to copper ketenimid-intermediate 302 which, through 
subsequent cyclisation and rearrangement, yielded disubstituted oxazole 300 (Scheme 68). The 
formation of byproduct 305, incorporating an additional alkyne unit was proposed to derive from 
a copper-coupling reaction between intermediate 304 and a second copper acetylide unit. 
Although different acyl azides were explored, only aromatic alkynes were employed while 
reporting disappointing results were recorded with alkyl alkynes. 
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Scheme 68. 
While this study was in progress, Zhang et al. also reported a new synthesis of 2,5-disubstituted 
oxazoles while working on the formation of α-oxo-gold carbenes from terminal alkynes using N-
oxides. 87  In their case, the gold carbenoid intermediate derived from the gold-catalysed 
oxidation reacted intermoleculary with different nitriles and underwent a 2+2+1 annulation 
reaction to yield the 1,3-oxazole of type 307 (Scheme 69). Although this new transformation 
afforded different oxazoles in good yield under mild conditions, a major limitation of this process 
is the required use of a large nitrile reagent excess. When the nitrile was not use as the solvent, 
3 equivalents were employed giving a reduced yield. 
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Scheme 69. Intermolecular synthesis of oxazoles via gold catalysed alkyne oxidation. 
Oxazoles are an important motif found in many natural products, ligand frameworks, materials 
and biologically active compounds.88 However, the employment of tri-substituted derivatives in 
organic synthesis is strongly limited by the lack of mild and widely applicable methods for their 
preparation. For these reasons, the novel reactivity of the aminide as a potentially controllable 
N-acyl nitrene equivalent to form 2,4,5-trisubstituted oxazoles when reacted with gold activated 
ynamides were studied in greater detail. 
3.3 Optimisation studies 
The study of the novel formation of tri-substituted oxazoles from formal acyl-nitrene transfer 
onto ynamides was started by submitting ynamide 269 to different sets of gold catalysis 
conditions (Table 9). The analysis of the 1H NMR of the crude reaction mixture containing a 
known amount of 1,2,4,5-tetramethylbenzene as an internal standard was carried in order to 
establish the performance of the reaction. No reaction occurred in the absence of a gold-
complex (Entry 2) or on its replacement with a Brønsted acid (Entry 3). The use of 1.5 
equivalents of aminide 295 improved the efficiency of the transformation (Entry 9) but a further 
increase of the quantity used was not beneficial (Entry 11). MsOH and p-TsOH•H2O were also 
employed as acidic additives to exclude the possibility that by-product pyridine formed during 
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the reaction acts to lower the catalyst efficiency as shown in Zhang’s work.73 Their use not only 
did not provide any improvement in the formation of the 4-amino oxazole, but also led to 
degradation products in the crude reaction mixture (Entries 12 and 13). The use of toluene as 
high boiling solvent allowed the reaction to be conducted at 90 °C which resulted in complete 
consumption of the starting material only when Au-III was used (Entry 16). The use of an 
electrophilic iodide source in replace of the gold catalyst (Entry 17), promoted the degradation 
of the starting material with no product detected. Silver, copper and ruthenium species also 
proved to be ineffective at promoting the reaction and no product formation was observed 
(Entries 18-20). 
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Table 9. Optimised reaction conditions survey. 
 
 Entry Catalyst Aminide 295 
(eq) 
Solvent (Temperature, °C) 296 (%)[b] 297 Yield[a],[b]  
 
       
 1 Au-III 1.1 ClCH2CH2Cl (70) 37% 53%[c]  
 2 - 1.1  ClCH2CH2Cl (70) 95% -[d]  
 3 p-TsOH•H2O 1.1 ClCH2CH2Cl (70) 100% -[d]  
 4 AuPPh3/AgSbF6 1.1 ClCH2CH2Cl (70) 47% 53%  
 5 AuPPh3/AgOTf 1.1 ClCH2CH2Cl (70) 27% 70%  
 6 AuBr3 1.1 ClCH2CH2Cl (70) 34% 59%  
 7 NaAuCl4 1.1 ClCH2CH2Cl (70) 57% 40%  
 8 AuPPh3/AgOTs 1.1 ClCH2CH2Cl (70) 72% 25%  
 9 Au-III 1.5 ClCH2CH2Cl (70) 6% 79%  
 10 AuPPh3/AgOTf 1.5 CH2Cl2 (40) 37% 55%  
 11 Au-III 2 ClCH2CH2Cl (70) 22% 65%  
 12 Au-III 1.5[f] ClCH2CH2Cl (70) -[d] -[e]  
 13 Au-III 1.5[g] ClCH2CH2Cl (70) -[d] 33%[e]  
 14 AuPPh3/AgOTf 1.5 ClCH2CH2Cl (70) 21% 70%  
 15 PPh3AuNTf2 1.5 toluene (90) -[d] 37%  
 16 Au-III 1.5 toluene (90) -[d] 95%  
 17 NIS 1.5 toluene (90) -[d] -[e]  
 18 AgOTf 1.5 toluene (90) 100% -[d]  
 19 Rh2(OAc)4[h] 1.5 toluene (90) 96% -[d]  
 20 Cu(MeCN)4BF4 1.5 toluene (90) 98% -[d]  
[a]Reactions were performed employing 0.1 mmol of ynamide 296, aminide 295 (as shown), Catalyst 
(5 mol%), Solvent (0.1 M), 24 h. [b]1H-NMR yields were calculated against a known amount of 
internal standard.[c]Isolated yield. [d]Not observed in the crude mixture. [e]Complex mixture of 
unknown products or degradation. [f]MsOH, 1.1 eq. [g]p-TsOH•H2O, 1.1 eq. [h]2.5 mol%. 
It was shown by Lidia Dumitrescu of the Davies' group that thermal reactions carried in o-xylene 
at 140 °C in absence of the catalyst saw only trace amounts of oxazole product formed.89  
The optimised conditions were identified as the air-stable dichloro(pyridine-2-carboxylato)gold 
(III) Au-III precatalyst in toluene at 90 °C with 1.5 equivalents of aminide relative to the ynamide 
(Table 9, Entry 9). 
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3.4 Starting material preparation 
In order to explore the scope of this novel intermolecular gold catalysed nitrene transfer 
reaction, a series of different aminide 298-301 were prepared in a straightforward manner by 
the slow addition of the appropriate acyl chloride to a 10% sodium hydroxide water solution of 
commercially available N-amino pyridonium iodide 294 at 0 °C (Scheme 70). The products were 
then simply extracted from the aqueous solution with CH2Cl2 and purified by recrystallisation 
(Scheme 70). 
 
 Scheme 70. Preparation of aminides 298-301. 
In addition to the amides prepared in the previous chapter, N-tosyl amide 304 was prepared 
following the standard tosylation protocol for the synthesis of sulfonamides (Scheme 71). The 
hydroxyl group was then protected by treatment with TBSCl in the presence of triethyamine and 
DMAP affording the desired silylether amide 304 in good yield. Tosyl sulfonyl amide 305 was 
prepared in good yield following the previous by reported methodology. 
 
Scheme 71. Sulfonamides 304 and 305 preparation. 
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Tosyl amides 306 and 307 were also prepared and isolated in excellent yield. It was also 
decided to explore amides bearing an o-nitrophenylsulfonyl protecting group as it is more labile 
than other sulfonyl groups employed in this study and might therefore be useful for further 
functionalisations at the 4-amino position.90 
 
Scheme 72. 
Terminal alkyne 229 was also prepared by treatment of 4-pentynyl-1-ol with TBDPSCl with 1-H 
imidazole in THF (Scheme 73). 
 
Scheme 73. Preparation of alkyne 161. 
Along with silylether 309, a series of commercially available alkynes were utilised in the 
coupling with different amides to synthesise various ynamides under Stahl's copper catalysis 
methodology shown in the previous chapter. Moderate to good yields were obtained in all cases 
and the pool of functional groups borne by the ynamide framework allowed a wide exploration of 
reaction tolerance for alkyl, alkyl bromide, alkyl, silyl ether, aryl, ketal and allyl functional groups 
(Table 10). 
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Table 10. Preparation of ynamides 
 
 Entry Amide Alkyne Product 
(Yield)[a],[b] 
Ynamide  
 1 221 phenylacetylene 310 (74%) 
 
 
 2 304 phenylacetylene 311 (58%) 
 
 
 3 305 phenylacetylene 312 (69%) 
 
 
 4 215 phenylacetylene 313 (51%) 
 
 
 5 221 1-hexyne 314 (78%) 
 
 
 6 221 2-(pent-4-yn-1-yloxy)tetrahydro-
2H-pyran 
315 (50%) 
 
 
 7 308 1-hexyne 316 (94%) 
 
 
 8 308 309 317 (74%) 
 
 
 9 212 4-bromo-but-1-yne 318 (69%) 
 
 
 10 306 phenylacetylene 319 (44%) 
 
 
 11 307 trimethylsilylacetylene 320 (82%) 
 
 
[a]All reactions were executed on a 2 mmol scale in relation to the alkyne, employing amine (10 
mmol), Na2CO3 (4 mmol), CuCl2 (0.4 mmol) and toluene (20 mL, 0.1 M). [b]Isolated yield. 
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Desilylation of silyl ynamide 320 by the action of TBAF in THF led to the formation of ynamide 
321 in 88% of yield (Scheme 74). This compound showed thermal instability and so heating 
processes had to be avoided in its manipulation. Copper coupling with brominated alkyne 160 at 
room temperature allowed the isolation of dialkyne 322 in modest yield. 
 
Scheme 74. Preparation of dialkyne 322. 
3.5 Synthesis of 4-amino-2,5-disubstituted oxazoles 
The optimised conditions for the formation of trisubstituted oxazoles were applied to the 
selection of ynamides previously prepared using aminide 295.  
In almost all the tested substrates, when the desired oxazole product was formed, good to 
almost quantitative yield and no side products in the reaction mixture were observed (Table 11, 
Entries 1-6 and 8-10). Benzyl, aryl, and alkyl substituents at the nitrogen atom were all well-
tolerated Entries 1-3). Remarkably, N-allyl ynamide 312 afforded the product in good yield 
(Entry 4) despite its susceptibility toward Claisen rearrangement.91 Acid labile silyl ether 311 
and tetrahydropyranyl ketal 315 survived the reaction conditions and led to the product in very 
good yield (Entries 5 and 6). However, in the case of ynamide 320 bearing a labile silyl group at 
the terminal position of the triple bond, a mixture of unknown products was obtained (Entry 7). 
N-propargyl ynamide 313 showed great chemoselectivity for the oxazole formation 
distinguishing between the two different acetylenic units present in the substrate (Entry 8). 
Moreover, when conjugated N-substituted dialkyne 322 was employed, remarkable chemo- and 
regioselectivity was observed and the additional triple bond did not interfere with the outcome of 
the transformation (Entry 9). Notably, o-nitrobenzenesulfonyl ynamide 316 was tested and the 
geometrically favourable intramolecular redox reaction between the nitro group and the gold-
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activated π-system did not take place.92 Instead, under the optimized gold catalysis conditions, 
the intermolecular nitrene-oxidation afforded desired oxazole 331 in 74% yield (Entry 10). 
Table 11. Synthesis of 2-phenyl-4,5-disubstituted oxazoles. 
 
 
 Entry Ynamide Yield (time) [a],[b] Product Oxazole  
 1 296 93% (24 h) 297 
 
 
 2 310 96% (4 h) 323 
 
 
 
 3 314 82% (2 h) 324 
 
 
 
 4 312 68% (4 h) 325 
 
 
 
 5 311 81% (12 h) 326 
 
 
 
 6 315 91% (1.5 h) 327 
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 7 320 -
[c](24 h) 328 
 
 
 
 8 313 80% (24 h) 329 
 
 
 
 9 322 83% (18 h) 330 
 
 
 
 10 316 74% (1 h) 331 
 
 
[a]All reactions were executed on ynamide (0.1 mmol), 295 (0.15 mmol) and Au-III (5 mol%) in 
toluene (1 mL, 0.1 M) at 90 °C. Reactions were monitored by TLC. [b]Isolated yield. [c]Mixture of 
unknown products. 
As shown, alkyl substituents on the C-terminus of the ynamide were well tolerated in this 
reaction (Table 11, Entries 6-8). This was unexpected, when compared against the results 
shown in chapter 2 where the incipient gold carbenoid formed by atom transfer underwent facile 
1,2-insertion to form an alkene. These results led to re-evaluation of the mechanistic analysis 
where different pathways can be proposed to explain the reaction outcome. Nucleophilic attack 
by the ylide occurred on the sp-carbon adjacent to the nitrogen of the ynamide to give gold vinyl 
species A. This is consistent with the conceived proposal and the regioselectivity always 
observed for gold-activated ynamide nucleophile addition (Scheme 69).89-93 Evolution of A by 
pyridine release prior to cyclisation could be followed by 4π-electrocyclisation of the extensively 
delocalized gold-stabilized carbocation B’ to access C’ or an attack of the acyl oxygen onto the 
electrophilic gold carbenoid carbon centre in B to the cyclised intermediate C (Figure 12).94 
However, a more concerted cyclisation alongside fission of the pyridine-N bond might also, 
through transition state D, provide gold species C. In the absence of competing 1,2-insertion 
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when possible (vide supra), which would be associated with the formation of a distinct metal 
carbenoid, this ‘concerted’ cyclisation mechanism was considered more likely than the 
alternatives. Final elimination of the gold-catalyst from C yields the oxazole product and closes 
the catalytic cycle. A mechanism involving the formation of a gold nitrene and an initial 
chelotropic reaction with the ynamide was excluded since formation of regioisomer 4-amino 
oxazoles was not observed.95 Moreover, the absence of product formation in the optimisation 
study when silver, copper and rhodium catalysts were employed corroborates such assumption. 
 
Figure 12. Proposed mechanisms for the formation of 1,3-oxazoles under gold catalysis 
conditions. 
To further explore the reaction scope regarding variation at the 2-position on the oxazole core, 
different previously prepared aminides 298-301 were employed (Table 12). Remarkably, in 
almost all the cases the transformation led regioselectively and chemioselectively to the 
formation of the expected trisubstituted oxazoles (Entries 1-3 and 5-9). The acyl o-
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bromobenzene group substitution on the aminide was tolerated well by the reaction conditions 
and allowed access to 2-(o-bromobenzene) oxazoles in high yield (Entries 1-3). Aryl bromide 
could be useful if further funtionalisations at the ring system are desired. Disappointingly, 
ynamide 321 did not provide the corresponding oxazole under optimised reaction conditions 
(Entry 4). The starting material thermal instability is thought to be accountable of the 
transformation inefficiency. Heteroaromatic substitution, as in the case of furan aminide 299 
was also explored and behaved consistently in regard to other aminides (Entries 5 and 6). 
Notable, methoxy aminide 300 was also exploited and efficiently allowed access to 2-methoxy-
4-amino-5-substituted oxazoles 310-313 in near quantitative yield (Entries 7-9). This latter 
pyridinium N-ylide proved to be more reactive in comparison to the other systems used, leading 
to a faster and higher yield in the reaction. It could be suggested that the cyclisation step, as 
seen in the proposed mechanism, is assisted by the heteroatom substituent although a smaller 
steric hindrance of the methoxy group might also provide some beneficial influence. With the 
use of an electron-withdrawing p-nitrobenzene substitution as in the case of substituted aminide 
301, formation of the desired product was not observed (Entry 10). Effect of nitro group on the 
ylide negative charge decreases the nucleophilic character of the nitrogen atom; this is essential 
to initiate the nitrogen attack onto the activated C-C triple bond. 
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Table 12. Synthesis of 2,4,5-trisubstituted oxazoles. 
 
 Entry Aminide Ynamide Yield (time)[a],[b] Product Oxazole  
 
1 298 310 90% (3 h) 333 
 
 
 
2 298 317 77% (1 h) 334 
 
 
 
3 298 318 63% (24 h) 335 
 
 
 
4 298 321 -[c] (24 h) 336 
 
 
 
5 299 310 87% ( 4 h) 337 
 
 
 
6 299 315 97% (1 h) 338 
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7 300 310 98% (0.5 h) 339 
 
 
 
8 300 312 87% (0.5 h) 340 
 
 
 
9 300 313 93% (5 min) 341 
 
 
 
10 301 311 -[d] (24 h) 342 
 
 
[a]Reactions were executed on ynamide (0.1 mmol), aminide (0.15 mmol) and Au-III (5 mol%) in 
toluene (1 mL, 0.1 M) at 90 °C. Reactions were monitored by TLC. [b]Yields refer to isolated product 
after column chromatography. [c]Degradation. [d]Unreacted starting material. 
To test the reaction efficiency on a large scale and with a lower catalyst loading, 3.56 mmol of 
ynamide 310 and 1.5 equivalent of aminide ylide 310 were reacted with only 1 mol% of gold 
catalyst Au-III (in comparison to the 5 mol% previously employed). Remarkably, purification of 
product by simple filtration through silica followed by recrystallisation from CH2Cl2/hexane led to 
isolated oxazole 333 in high yield (Scheme 75) showing the robust nature of the protocol.  
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Scheme 75. Large scale test for the preparation of 333. 
As demonstrated by Lidia Dumitrescu, a former colleague in the Davies’s group, the developed 
reaction also proved to be efficient for the preparation of 1,3-oxazoles bearing alkynyl, vinyl, 
crotonyl groups (Scheme 76). Notably, cyclopropyl substitution was also tolerated by the 
oxazole formation reaction, in contrast with what was observed in the gold-promoted oxygen 
transfer process onto ynamides reported in the previous chapter. 
 
 
Scheme 76. Additional oxazoles synthesised. 
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3.6 Preliminary studies on the synthesis of highly 
functionalised amino-substituted thiazoles and furans from 
ynamides 
In order to explore the potential of the approach presented in the previous sections for the 
preparation of heteroaromatic systems in more depth, different X-Y ylides of type B were 
designed in order to mimic the reactivity of 1,3-O,N dipoles observed for aminides (Figure 13). 
  
Figure 13. General concept for [3+2] cyclisation of 1,3-Y-Z dipole onto ynamides catalysed by gold 
complexes. 
The new Y-Z dipole should, under appropriate catalysis condition, lead to the formal [3+2] 
cycloaddition product of type S and allow access to different amino-5-membered aromatic 
derivatives such as aminothiazoles (with ylide 348 and 349) and furans (with ylide 350-354) 
(Scheme 77). 
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Scheme 77. Designed ylides to be used in test gold catalysis reaction with ynamides. 
3.6.1 Preparation of ylides 
To prepare the required ylides, methylthionochloroformate was freshly prepared and reacted 
with N-amino pyridinium iodide in the presence of potassium carbonate in THF to afford 
thiourea ylide derivative 348 in 97% yield. Thiourea ylide 349 was prepared employing 
dimethylthiocarbonyl chloride in a freshly made solution of sodium ethoxide (Scheme 78). 
 
Scheme 78. Preparation of ylides 33, 34 and 35. 
Ylide precursors 350 and 351 were prepared by a straightforward substitution reaction between 
methyl bromoacetate and the corresponding pyridine in CH2Cl2 at room temperature. Both 
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ammonium salts were isolated by filtration of the crude mixture in moderate yields (Scheme 79). 
Pyridinium acetate salts where at least one of the two pyridine ortho positions are unsubstituted 
have already been reported to behave as Cα-Co dipoles in a [3+2]-cycloaddition with alkynes to 
synthesise various nitrogen-containing heterocycles.96 For this reason, it was reasoned that an 
o,o’-disubstituted derivative also needed to be tested. The same protocol was applied for the 
preparation of sulfonium salt 352, starting from bromoacetophenone derivatives 357 and 
dimethylsulfide in good yield (Scheme 79). Disappointingly, attempts for the preparation of 
diphenyl sulfur ylide precursor 353 under the same reaction conditions were unsuccessful. In 
the effort to prepare ylide precursor 354, thiophenyl acetophenone 359 was prepared by 
substitution with thiophenol on the bromo ester 358 in the presence of triethylamine. 
Unfortunately, attempts to obtain the methylated sulfonium salt derivative 354 were 
unsuccessful. 
 
Scheme 79. Preparation of ylide precursors 352-354. 
 97 
3.6.2 Attempted catalysis to prepare thiazoles 
Ynamide 310 was chosen as test substrate for the evaluation of the amino pyridinium ylides 348 
and 349. It was thought that an isosteric relationship between oxygen and sulfur would allow 
access to thiazoles in a similar fashion to the above reported synthesis of oxazoles. 
Disappointingly, under the optimised condition for oxazoles, no formation of the desired thiazole 
was observed with full starting material recovery (Scheme 80). 
 
Scheme 80. Attempts of thiazole formation with ynamides under gold catalysis. 
To explore the possibility of using ylides as C-O dipoles in gold-catalysis, a series of test 
reactions were carried out employing ynamide 310. In the case of pyridinium derivatives 348, 
potassium carbonate and sodium hydride were employed to promote the deprotonation and the 
consequent ylide formation in situ. Under gold catalysis conditions, the formation of amino 
indolizine of type 362 was observed leading to the conclusion that the ylide produced during the 
reaction behaved as a 1,3-C,C dipoles (Scheme 81). This reactivity pathway is consistent to 
similar reactions observed between pyridinium acetyl ylides and alkynes. 
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Scheme 81. 
In order to avoid reaction at the pyridine ring, ylide precursor 351 was then assessed. The 
substitution at both ortho positions of the pyridine should prevent the formation of undesired 
indolizine products. Unfortunately, under the preliminary gold catalysis test conditions, only 
unreacted starting material was observed in the crude mixture after 24 h (Table 13). 
Table 13. 
 
 Entry Catalyst R Conditions Solvent 
(temperature) 
Yield[a],[b]  
        
 1 Au-III Ph (296) nBu (314) NaH (1.6 eq) toluene (90 °C) 
-[b] 
-[b]  
 2 PPh3AuNTf2 Ph (296) nBu (314) K2CO3 (1.6 eq) CH2Cl2 (RT) 
-[b] 
-[b]  
 3 Me2SAuCl 
Ph (296) 
nBu (314) K2CO3 (1.6 eq) ClCH2CH2Cl (RT) 
-[b] 
-[b]  
[a]Reactions were performed employing 0.1 mmol of ynamide, pyridine acetate 351 (0.15 mmol), 
Catalyst (5 mol%), base (as shown), Solvent (0.1 M), 24 h. [b]Unreacted starting material. 
The ortho substitution on the pyridine could have prevented ylide formation or more likely 
inhibited nucleophilic attack onto the gold activated ynamide. A similar study was also 
performed using S-ylide precursor 353 but comparably disappointing results were recorded 
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(Table 14). Under the tested gold catalysis conditions (Table 14, Entries 1-3) only unreacted 
starting material was recovered. 
Table 14. 
 
 Entry Catalyst R Conditions Solvent 
(temperature) 
Yield (%)[a],[b]  
        
 1 Au-III Ph (296) nBu (314) NaH (1.6 eq) toluene (90 °C) 
-[b] 
-[b]  
 2 PPh3AuNTf2 
Ph (296) 
nBu (314) K2CO3 (1.6 eq) CH2Cl2 (RT) 
-[b] 
-[b]  
 3 Me2AuCl Ph (296) nBu (314) K2CO3 (1.6 eq) ClCH2CH2Cl (RT) 
-[b] 
-[b]  
[a]Reactions were performed employing 0.1 mmol of ynamide, 353 (0.15 mmol), Catalyst (5 mol%), base (as 
shown), Solvent (0.1 M), 24 h. [b]Unreacted starting material. 
Recently, Skrydstrup et al.97 reported the use of acyl sulfonium ylide 364 as a C-O dipole to be 
engaged in a [3+2]-cycloaddition with terminal alkynes to access 2,4-disubstituted furans in an 
analogous fashion to the oxazole synthesis reported above. According to the study, the 
substitutions on the sulfur atom proved to be crucial in order to efficiently promote the 
transformation; in particular, S-aryl ylides gave significantly better yields than dimethyl sulfonium 
derivates. The regioselectivity of the reaction is controlled by the use of terminal alkyne. 
Although different 2,4-disubstituted furans were obtained in modest to good yield, only aromatic 
substituents for position 2 and aliphatic substituents for position 4 on the furan ring were 
explored, representing a major limitation of this methology. 
 
Scheme 82. 
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3.7 Preliminary studies for the synthesis 4-oxy-2,5-
disubstituted oxazoles 
In the previous chapter it was shown that ynol ethers can undergo similar reaction pathways to 
ynamides due to the structural and electronic similarity between these two heteroatom-
substituted alkynes. To further explore the generality of using acyliminopyridinium ylide to obtain 
2,4,5-trisubstituted oxazole derivatives, it was decided to employ ynol ethers as the π-system. It 
was envisaged that under the previously developed protocol, a gold-catalysed acyl-nitrene 
transfer reaction onto ynol ethers would lead to the formation of 4-oxy-2,5-disubstituted 
oxazoles (Scheme 83). 
 
Scheme 83. 
In this study, the previously prepared ynol ethers 290, 287, 288 and commercially available 
ethoxyacetylene were tested. In addition, ynol ether 371 was prepared by a CuI/PdCl2(PPh3)2 
coupling procedure with ethoxyacetylene and iodobenzene (Scheme 84). 
 
Scheme 84. Preparation of ethoxy phenyl acetylene 371. 
Positive results were observed when O-substituted alkynes 371 and 298 were tested. In the 
case of phenylacetylene ether 371, cycloaddition with aminide 298 afforded 4-ethoxyoxazole 
369
CuI, Pd(Ph3)4
iPr2NH
11%
370 371
+EtO EtO
I
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372 in moderate yields proving that the reactivity can be extended beyond ynamides (Scheme 
85).  
 
Scheme 85. Gold catalysed acyl-nitrene transfer reaction on ynol ether 371. 
Interestingly, skipped enyne 290 reacted with aminide 300 to give the α,β,γ,δ-unsaturated 
ethylimmidate 373 rather than the expected oxazole product (Scheme 86). Formation of the 
latter results from a gold-catalysed acyl-nitrene transfer followed by 1,2-insertion, in keeping 
with the oxidation reactions of alkyl substituted ynamides and ynol ethers presented in the 
previous chapter. It could be hypothesised that the overall 1,2-hydride shift is rendered 
favourable over the cyclisation pathway because it leads to a stable extended unsaturated 
system. Notably, only the E,E ethylimmidate stereoisomer 373 was observed. 
 
Scheme 86 
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Conversely, under the same conditions employed for the synthesis of 372 and 373, degradation 
of the starting material occurred when ethoxyacetylene, 287, and 288 were tested and no traces 
of the desired product were recorded by 1H-NMR analysis (Scheme 87). 
 
Scheme 87. 
In order to determine whether the moderately high temperature employed in the protocol could 
be responsible for the failure of the test reactions shown above, it was decided to briefly survey 
milder conditions (Table 15). Different gold species were employed to promote the 
transformation at room temperature (Entries 1 and 2) or at 40 °C (Entries 3-5). In all the 
conditions tested no product formation was detected and only degradation of the propargylic 
ether was observed. Ynol ethers are known to be highly reactive/unstable and this aspect is 
thought to be responsible for the lack of success in the acyl-nitrene transfer promoted by gold 
complexes on such reactive substrates even at milder temperature. 
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Table 15. Survey of reaction conditions on ynol ether 288. 
 
 Entry Catalyst Solvent  Temperature  1 Yield%[a]  
 1 Au-III ClCH2CH2Cl RT -[b]  
 2 AuPPh3/AgOTf ClCH2CH2Cl RT -[b]  
 3 AuBr3 CH2Cl2  40 °C -[b]  
 4 PPh3AgNTf2 CH2Cl2 40 °C -[b]  
 5 AuPPh3/AgOTs CH2Cl2 40 °C -[b]  
[a]Reactions were executed on ynol ether 288 (0.1 mmol), aminide 295 (0.15 mmol), Catalyst (as 
shown, 5 mol%) at solvent (as shown, 1 mL, 0.1 M). Reactions were monitored by TLC. [b]Complex 
mixture of unknown products or degradation. 
3.7 Summary 
A new strategy to achieve the [3+2] cycloaddition reaction by addition of a 1,3-N,O dipole 
equivalent across an ynamide triple bond has been achieved. The simultaneous nitrene addition 
along with the acyl unit installation, that quench the reaction, represents one of the novelty 
aspects of the reported reaction. Notably, this strategy was unprecedented in the literature for 
intermolecular gold-catalysed atom-transfer processes.  
The optimised catalysis protocol has been used in the synthesis of different trisubstituted 
oxazoles. The mild gold catalysis reaction conditions proved tolerant towards a wide range of 
functional groups including other alkyne, alkene and silyl ether moieties. 
By this approach, it has also been shown that access to α-imido gold carbenoid intermediate 
reactivity is possible from ynamides and ynols, which can then be seen as direct equivalents to 
α-imido diazo compounds. A novel strategy to execute gold-promoted [3+2]-cyclisation was 
developed and literature examples have already been followed. 
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Experimental Part 
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4.1 Instruments 
The solvents used were purified using a Pure Solv-MD Solvent Purification System (alumina 
columns) from Innovative Technology98 and were transferred under Ar. Asynt DrySyn heating 
blocks on stirrer hotplates were employed with temperature control via an external probe. Flash 
chromatography: Fluorochem silica gel 60 (43-63 µm). Thin layer chromatography (TLC): 
Macherey Nagel silica gel 60F254 analytical plates (plastic support) which were developed using 
standard visualizing agents: UV fluorescence (254 and 366 nm), phosphomolybdic acid /∆, and 
potassium permanganate /∆. IR: Perkin-Elmer Spectrum 100 FTIR spectrometer, only selected 
absorbences (νmax) are reported in cm-1. MS and HRMS (EI): VG ProSpec or VG-ZabSpec at 70 
eV. High resolution EI spectra were measured using perfluorokerosene (PFK) as an internal 
calibrant. MS and HRMS (ES): Micromass LCT using a methanol mobile phase. HRMS was 
obtained using a lock-mass to adjust the calibrated mass scale. MS data are reported as m/z 
(relative intensity). Commercially available compounds were purchased from Aldrich, Fluka, 
Acros, Strem, Alfa Aesar and used without further purification. NMR: Spectra were recorded on 
Bruker AVIII300 (1H = 300 MHz, 13C = 75.5 MHz), Bruker AVIII400 (1H = 400 MHz, 13C = 101 
MHz) in the solvents indicated; CDCl3 was purchased from Aldrich (no TMS) and Cambridge 
Isotope Laboratory (0.05% v/v TMS); Chemical shifts (δ) are given in ppm relative to TMS. In 
the absence of TMS, solvent signals were used as references and the chemical shifts converted 
to the TMS scale (CDCl3: δC = 77.0 ppm; residual CHCl3 in CDCl3: δH = 7.26 ppm). Coupling 
constants (J) are reported in Hz. 1D 13C NMR spectra were recorded using the JMOD or 
PENDANT pulse sequences from the Bruker standard pulse program library. JMOD were 
combined with DEPT 135 to assign quaternary carbons. Melting points were recorded using 
open glass capillaries on a Stuart Scientific apparatus and are uncorrected.  
4.2 Reactions 
Reactions were followed by thin layer chromatography (TLC) using Macherey Nagel silica gel 
60F254 analytical plates (plastic support) which were developed using standard visualising 
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agents: UV fluorescence (254 and 366 nm), and potassium permanganate/Δ. Purification by 
flash chromatography was performed using Fluorochem silica gel 60 (0.043-0.063 nm). 
All reactions in non-aqueous solvents were conducted in flame-dried glassware under an argon 
atmosphere with magnetic stirring. Volumes of less than 0.2 mL were measured and dispensed 
with gas-tight syringes. Evaporation and concentration under reduced pressure was performed 
at 10-700 mbar at 40 °C. All pure products of the reactions were dried under high vacuum (1 
mbar). 
4.3 Chemicals and reagents 
All reagents were obtained from commercial sources and used without further preparation. 
Dichloroethane used were purified by distillation over calcium hydride as a drying agent and 
transferred under argon. Pyridine was distilled over calcium hydride and used directly. The 
following cooling baths were used: 0 °C (ice/water) and -78 °C. 
4.4 Procedure and Characterisation 
General procedures 
Formation of ynamides: General procedure 1 (GP1)49 
Potassium carbonate (2.5 mmol), copper sulphate pentahydrate (0.15 mmol) and 1,10-
phenanthroline (0.3 mmol) were added consecutively to a mixture of the corresponding amide 
(1 mmol) in toluene (1.6 mL). The reaction mixture was added to the bromoacetylene derivate 
(1.25 mmol) and heated to 65-­‐75 °C and monitored through TLC analysis. Upon completion the 
reaction mixture was cooled to room temperature before being diluted with EtOAc and filtered 
through a pad of Celite. The organic solution was concentrated under reduced pressure to 
provide the crude product. The residue was purified by flash chromatography with the 
appropriate eluent to afford the desired ynamide. 
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Formation of ynamides: General procedure 2 (GP2)50 
CuCl2 (0.2 eq), an appropriate amide (5 eq) and Na2CO3 (2 eq) were added to a flame-dried 
500 mL three-necked round-bottomed flask. The flask was purged with oxygen for 15 min and a 
solution of pyridine (2 eq) in dry toluene (0.4 M) was added. A balloon filled with oxygen was 
connected to the flask and the stirred mixture was heated to 70 °C. After 15 min, a solution of 
alkyne (1 eq) in dry toluene (0.2 M) was added by syringe pump at a rate of 1.25 mL/h. The 
mixture was allowed to stir at 70 °C for another 8h and was then cooled to RT. The reaction 
mixture was then filtered through a pad of silica and concentrated under reduced pressure. The 
crude mixture was purified by flash chromatography. 
Catalytic oxidative reaction: General procedure 3 (GP3) 
A solution of PPh3AuCl (2.5 mg, 0.005 mmol, 5 mol%), AgSbF6 (1.7 mg, 0.005 mmol, 5 mol%) 
in CH2Cl2 (1 mL) was stirred for 5 min before the corresponding ynamide (0.1 mmol, 1 eq) and 
p-methoxy pyridine-N-oxide monohydrate (13.7 mg, 1.1 eq) were added to the mixture. The 
reaction mixture was stirred at room temperature until either the complete consumption of the 
starting material was observed or a period of 24 h had passed. The reaction mixture was then 
filtered through a pad of silica. The filtrate was then concentrated under reduced pressure and 
purification of the residue was performed by flash chromatography. 
Optimised gold catalytic oxidative reaction with ynamides and ynol ethers: General 
procedure 4 (GP4): 
System A (GP4A) 
A solution of the corresponding ynamide (0.3 mmol, 1 eq) in ClCH2CH2Cl (1.5 mL) was added to 
a mixture of dichloro(2-pyridinecarboxylato)gold (5.9 mg, 0.015 mmol, 5 mol%) and pyridine N-
oxide (32 mg, 0.34 mmol, 1.1 eq). The reaction mixture was stirred at 70 °C until complete 
consumption of the starting material was observed before being filtered through a pad of silica. 
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The filtrate was then concentrated under reduced pressure and purification of the residue was 
performed by flash chromatography. 
System B (GP4B) 
A solution of the corresponding ynamide (0.3 mmol, 1 eq) in THF (1.5 mL) was added to a 
mixture of gold tribromide (6.6 mg, 0.015 mmol, 5 mol%) and pyridine-N-oxide (32 mg, 0.34 
mmol, 1.1 eq). The reaction mixture was stirred at RT until complete consumption of the starting 
material was observed before being filtered through a pad of silica. The filtrate was then 
concentrated under reduced pressure and purification of the residue was performed by flash 
chromatography. 
General alkylation of 1-cyclohexyl-3-ethoxyprop-2-yn-1-ol: General procedure 5 (GP5) 
To a solution of propargyl alcohol 287 (182 mg, 1mmol) in dry THF (2 mL, 0.5 M) an appropriate 
alkylating reagent (1.2 mmol) was added under an Argon atmosphere. The solution was cooled 
to 0 °C in an ice bath and sodium hydride (57% suspension in oil, 50 mg, 1.2 mmol) was then 
added. After stirring for 30 min at 0 °C, the mixture was stirred for a further 3 h at room 
temperature. The reaction was then quenched with a saturated solution of ammonium chloride 
(10 mL) and the organic phase was extracted with EtOAc (3 x 10 ml). The combined organic 
extracts were dried over Na2SO4, filtered and concentrated under reduced pressure. The 
residue was purified by flash chromatography. 
General procedure for formation of N-Substituted Iminopyridinium Ylides (GP6): 
The corresponding acyl chloride (2 eq) was added to a solution of N-aminopyridinium iodide 
(444 mg, 2 mmol) in 20 mL of aqueous NaOH (10%) at 0 °C and stirred overnight. The 
suspension was then extracted with dichloromethane (3 × 25 mL) and consecutively treated 
with activated carbon and Na2SO4. The organic mixture was filtered through celite and the 
solvent was removed under reduced pressure. The solid residue was recrystallised to afford the 
desired ylide. 
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Optimised gold catalytic reaction for the formation of oxazole from ynamides (GP7)  
A solution of the corresponding ynamide or ynol ether (1 eq) in toluene (0.1 M) was added to a 
mixture of dichloro(2-pyridinecarboxylato)gold (5 mol%) and pyridinium-1-ylamide (1.5 eq). The 
reaction mixture was stirred at 90 °C until complete consumption of the starting material was 
observed. The mixture was filtered through a pad of silica and the filtrate concentrated under 
reduced pressure. If required the residue was purified by flash chromatography. 
Characterisation for chapter 2 
3-([1',1''-Biphenyl]-2-ylethynyl)oxazolidin-2-one (153) 
 
Following GP2 using 2-oxazolidinone 170 (878 mg) and phenylacetylene derivative 173 (356 
mg, 2 mmol). After purification by flash chromatography [hexanes:EtOAc (4:1)] ynamide 153 
was isolated as a light yellow solid (447 mg, 85%): mp: 91-93 °C; νmax (neat)/cm-1= 3064, 2251 
1477, 1403, 1197, 1164, 1029, 745, 702; 1H-NMR (300 MHz; CDCl3): δH= 7.63-7.53 (m, 3H), 
7.46-7.27 (m, 6H), 4.40 (t, J 8.0, 2H), 3.79 (t, J 8.0, 2H); 13C-NMR (101 MHz; CDCl3): δC= 155.5, 
143.5, 140.4, 132.5, 129.4, 129.2 (2C), 128.2, 127.9 (2C), 127.4, 127.0, 120.6, 81.7, 71.2, 62.9, 
46.6; HRMS m/z (TOF MS ES+): calculated for C17H13NO2Na: 286.0844, found: 286.0842 
[M+Na]. 
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3-((2'-((Allyloxy)methyl)phenyl)ethynyl)oxazolidin-2-one (156) 
 
Following GP2 using 2-oxazolidinone 170 (878 mg) and phenylacetylene derivative 176 (344 
mg, 2 mmol). After purification by flash chromatography [hexanes:EtOAc (5:1)] ynamide 156 
was isolated as a light yellow oil (655 mg, 85%): νmax (neat)/cm-1= 3072, 2984, 2915, 2855, 
2251, 1764, 1451, 1407, 1195, 1072, 1031, 757, 746; 1H-NMR (300 MHz; CDCl3): δH= 7.46 (dd, 
J 7.3, 1.2, 1H), 7.44 (t, J 7.3, 1.2, 1H), 7.32 (td, J 7.6, 1.2, 1H), 7.23 (td, J 7.6, 1.2, 1H), 5.99 
(ddt, J 17.2, 10.4, 5.6, 1H), 5.34 (ddt, J 17.2, 1.5 and 1.5, 1H), 5.20 (ddt, J 10.4, 1.5 and 1.5, 
1H), 4.68 (s, 2H), 4.50 (t, 7.4, 2H), 4.10 (dt, J 5.6, 1.5, 2H), 4.01 (t, 7.4, 2H); 13C-NMR (101 
MHz; CDCl3): δc= 155.7, 139.9, 134.8, 131.7, 128.3, 127.6, 127.2, 120.9, 117.0, 83.2, 71.6, 
70.3, 69.1, 63.0, 47.0; HRMS m/z (TOF MS ES+): calculated for C15H15NO3Na: 280.0950, 
found: 280.0944 [M+Na]. 
N-Allyl-p-toluenylsulfonamide (158) 
 
Allyl amine 157 (4.17 mL, 33 mmol) and triethylamine (4.17 mL, 30 mmol) in 140 mL of CH2Cl2 
was added dropwise to a solution of 4-methylbenzene sulfonyl chloride (5.70 g, 30 mmol) in 10 
mL of CH2Cl2. After 1 h at reflux and 30 min at room temperature, the crude reaction was added 
of a saturated aqueous solution of NaHCO3 (150 mL). The organic layer was extracted with 
CH2Cl2 (3 × 70 mL) and the combined organic layers were washed with brine and dried over 
Na2SO4. The solution was then concentrated to provide the crude product. After purification by 
re-crystallisation with CH2Cl2/hexane, amide 158 was isolated as a white solid (3.73 g, 59%): 
mp: 63-65 °C; νmax (neat)/cm-1 = 3247, 1595, 1422, 1318, 1156, 1091, 1061, 810, 664; 1H-NMR 
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(300 MHz; CDCl3): δH= 7.84 (d, J 8.3, 1H), 7.40-7.24 (m, 4H), 5.79 (ddt, J 16.8, 10.1 and 6.3, 
1H), 5.29 (dd, J 16.8 and 1.2, 1H), 5.24 (dd, J 10.1 and 1.2, 1H), 4.05 (d, J 6.3, 2H), 2.45 (s, 
3H); 13C-NMR (101 MHz; CDCl3): δc= 143.5, 136.9, 132.9, 129.7 (2C), 127.1 (2C), 117.7, 45.7, 
21.5. 
Data were in agreement with those reported in the literature.99 
Bromohex-1-yne (160) 
 
A solution of hex-1-yne 159 (1.15 mL, 10 mmol) in acetone (50 mL) was added to N-
bromosuccinimide (1.30 g, 11 mmol) and silver nitrate (340 mg, 2 mmol). The solution was left 
under stirring overnight in the dark. The solvent was removed under reduced pressure and the 
remaining oil was dissolved in n-pentane and filtered through a pad of silica. The organic 
solution was then concentrated under reduced pressure to afford bromoalkyne 160 (789 mg, 
49%) as a light yellow oil: νmax (neat)/cm-1= 2930, 2900, 2840, 2180, 1460, 1420, 1370, 1320, 
1100, 920, 740; 1H-NMR (300 MHz; CDCl3): δH= 2.21 (t, J 6.9, 2H), 1.55-1.35 (m, 4H), 0.91 (t, J 
7.2, 3H); 13C-NMR (101 MHz; CDCl3): δC= 80.4, 37.4, 30.4, 21.9, 19.4, 13.5. 
Data were in agreement with those reported in the literature.100 
N-Allyl-N-(hex-1-yn-1-yl)-4-methylbenzenesulfonamide (161) 
 
Following GP1 using bromoalkyne 160 (201 mg) and tosylamide 158 (211 mg). Purification by 
flash chromatography [hexanes:EtOAc (12:1)] gave ynamide 161 (171 mg, 59%) as a light 
yellow oil: νmax (neat)/cm-1= 3051, 2957, 2931, 2872, 2254, 1706, 1361, 1166, 821, 660; 1H-
NMR (300 MHz; CDCl3): δH= 7.78 (d, J 8.3, 2H), 7.33 (d, J 8.0, 2H), 5.72 (ddt, J 16.4, 10.1 and 
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6.3, 1H), 5.26-5.15 (m, 2H), 3.91 (dt, J 6.3 and 1.1, 2H), 2.44 (s, 3H), 2.24 (t, J 6.8, 2H), 1.50-
1.29 (m, 4H), 0.88 (t, J 7.2, 3H); 13C-NMR (101 MHz; CDCl3): δC= 144.3, 134.7, 131.2, 129.5, 
127.7, 119.6, 72.9, 70.4, 54.2, 30.9, 21.7, 21.6, 18.0, 13.5. 
Data were in agreement with those reported in the literature.101 
(Bromoethynyl)benzene (163) 
 
A solution of phenylacetylene 162 (0.55 mL, 5 mmol) in acetone (25 mL) was added to N-
bromosuccinimide (643 mg, 5.5 mmol) and silver nitrate (169 mg, 1 mmol). The solution was left 
stirring overnight in the dark. The solvent was removed under reduced pressure and the 
remaining oil was dissolved in hexane and filtered through a pad of silica. The organic solution 
was then concentrated under reduced pressure affording bromoalkyne 163 (479 mg, 53%) as a 
light yellow oil: 1H-NMR (300 MHz; CDCl3): δH= 7.47-7.43 (m, 2H), 7.32 (m, 3H); 13C-NMR (101 
MHz; CDCl3): δC= 132.0 (2C), 128.7, 128.3 (2C), 122.7, 80.0, 49.7. 
Data were in agreement with those reported in the literature.102 
N-Allyl-N-(phenylethynyl)-p-toluenylsulfonamide (164) 
 
Following GP1 using bromoalkyne 163 (226 mg) and tosylamide 158 (211 mg). Purification by 
flash chromatography [hexanes:EtOAc (7:1)] gave ynamide 164 (183 mg, 59%) as a light yellow 
oil: νmax (neat)/cm-1= 3031, 2923, 1699, 1350, 1164, 1084, 812, 730, 700; 1H-NMR (300 MHz; 
CDCl3): δH= 7.84 (d, J 8.3, 2H), 7.39-7.24 (m, 7H), 5.79 (ddt, J 15.5, 10.1 and 6.3, 1H), 5.26 (m, 
2H), 4.09-3.99 (m, 2H), 2.45 (s, 3H); 13C-NMR (101 MHz; CDCl3): δC= 144.7, 134.6, 131.2 (2C), 
130.8, 129.7(2C), 128.6, 128.2(2C), 127.7(2C), 122.7, 120.0, 82.2, 70.9, 54.3, 21.6. 
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Data were in agreement with those reported in the literature.49 
 [1,1'-Biphenyl]-2-carbaldehyde (167) 
 
Phenylboronic acid 166 (1.46 g, 12 mmol) was added to a solution containing 2-
bromobenzaldehyde 165 (1.39 mL, 12 mmol) and sodium carbonate (1.27 g, 12 mmol) in a 2:1 
mixture of DMF/water (25 mL), and stirred for 2 min. Pd(OAc)2 (134 mg, 5 mol%) was then 
added and the flask was flushed with argon, sealed and the mixture was stirred at room 
temperature for 12 h. When all the starting material was consumed, the organic phase was 
extracted with diethyl ether (3 × 25 mL). The combined organic layers were dried over NaSO4, 
filtered and concentrated under reduced pressure. The crude product was purified by flash 
chromatography on silica gel using a mixture [hexanes:toluene (5:1)] to afford biphenyl-2-
carbaldehyde 167 (1.88 g, 86%) as a colourless liquid: νmax (neat)/cm-1= 3061, 2848, 2753, 
1687, 1596, 1473, 1252, 1194, 827, 756, 745, 733, 643; 1H-NMR (300 MHz; CDCl3): δH= 10.00 
(s, 1H), 8.04 (app dd, J 7.7 and 1.4, 1H), 7.64 (dt, J 7.5 and 1.5, 1H), 7.52-7.42 (m, 5H), 7.40-
7.36 (m, 2H); 13C-NMR (101 MHz; CDCl3): δH= 192.3, 145.8, 137.6, 133.6, 133.4, 130.6, 130.0 
(2C), 128.3 (2C), 128.0, 127.6, 127.4; HRMS m/z (TOF MS EI+): calculated for C13H10O: 
182.0727, found: 182.0732, [M]. 
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2-(2,2-Dibromovinyl)-1,1'-biphenyl (168) 
 
CBr4 (7.82 g, 23.6 mmol) was added to a solution of PPh3 (12.4 g, 47.2 mmol) in CH2Cl2 (50 
mL) and the resulting yellow mixture was stirred for 10 min at 0° C. A solution of biphenyl-2-
carbaldehyde 167 (1.72 g, 9.45 mmol) in CH2Cl2 (50 mL) was added slowly with continued 
stirring for 1 h at 0° C. The reaction mixture was then quenched with brine (50 mL) and the 
organic layer was extracted with CH2Cl2 (3 × 50 mL). The combined organic layers were dried 
over Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified 
by flash chromatography on silica gel using a mixture [hexanes:EtOAc (19:1)], affording 
dibromoalkene 168 as a yellow liquid (3.10 g, 98%): νmax (neat)/cm-1= 3059, 3018, 2989, 2973, 
2901, 1471, 1434, 1073, 1008, 886, 857, 795, 745, 735, 698; 1H-NMR (300 MHz; CDCl3): δH= 
7.73-7.63 (m, 1H), 7.48-7.32 (m, 8H), 7.23 (bs, 1H); 13C-NMR (101 MHz; CDCl3): δH= 141.1, 
140.1, 137.5, 133.8, 129.8, 129.5 (2C), 129.2, 128.6, 128.2 (2C), 127.5, 127.1, 90.8; HRMS m/z 
(TOF MS EI+): calculated for C14H10Br2: 337.9129, found: 337.9129 [M].  
2-(Bromoethynyl)-1,1'-biphenyl (169) 
 
A solution of bromoalkyne 168 (670 mg, 2 mmol) in THF (20 mL) was cooled to -78 °C before 
adding tert-butoxide (2.02 g, 18 mmol). After 5 min the reaction mixture was quenched with 
brine (20 mL) and allowed to warm to room temperature. The organic layer was extracted with 
CH2Cl2 (3 × 50 mL) and the combined organic layers were dried over Na2SO4. The solution was 
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then concentrated under reduced pressure to provide the crude product, which was purified by 
flash chromatography [hexane] affording bromoalkyne 169 as a yellow liquid (298 mg, 58%): 
νmax (neat)/cm-1= 3059, 3023, 2198, 1765, 1472, 1449, 1431, 774, 755, 734, 698; 1H-NMR (300 
MHz; CDCl3): δH= 7.66-7.25 (m, 9H); 13C-NMR (101 MHz; CDCl3): δC= 144.4, 140.0, 133.6, 
129.5, 129.1 (2C), 128.8, 128.0 (2C), 127.5, 126.9, 120.9, 79.6, 52.2; HRMS m/z (TOF MS 
EI+): calculated for C14H9Br: 255.9888, found: 255.9886 [M]. 
 (Iodoethynyl)benzene (171) 
 
A solution of phenylacetylene 162 (0.55 mL, 5 mmol) in acetone (25 mL) was added to N-
iodosuccinimide (1.26 g, 5.5 mmol) and silver nitrate (169 mg, 1 mmol). The solution was left 
stirring overnight in the dark. The solvent was removed under reduced pressure and the 
remaining oil was dissolved in hexane and filtered through a pad of silica. The organic solution 
was then concentrated under reduced pressure affording iodoalkyne 171 (855 mg, 75%) as a 
light yellow oil: νmax (neat)/cm-1= 3100, 2170, 1610, 1580, 1490, 1450, 1070, 1025, 915, 755, 
685; 1H-NMR (300 MHz; CDCl3): δH= 7.47-7.41 (m, 2H), 7.35-7.29 (m, 3H); 13C-NMR (101 MHz; 
CDCl3): δC= 132.3 (2C), 128.8, 128.2 (2C), 123.4, 94.1, 6.1. 
Data were in agreement with those reported in the literature.103 
3-(Phenylethynyl)oxazolidin-2-one (172) 
 
Following GP2 using 2-oxazolidinone 170 (878 mg) and phenylacetylene 162 (240 mg, 2 mmol). 
After purification by flash chromatography [hexanes:EtOAc (4:1)] ynamide 172 was isolated as 
a white solid (159 mg, 85%): mp: 81-83 °C; νmax (neat)/cm-1= 3052, 3005, 2965, 2910, 2263, 
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2238, 1752, 1412, 1162, 1211, 1162, 1030, 1021, 744, 688; 1H-NMR (300 MHz; CDCl3): δH= 
7.47-7.40 (m, 2H), 7.32-7.27 (m, 3H), 4.48 (t, J 8.0, 2H), 4.00 (t, J 8.0, 2H); 13C-NMR (101 MHz; 
CDCl3): δC= 155.8, 131.5 (2C), 128.3 (2C), 128.2, 122.1, 78.9, 71.2, 63.0, 47.0; HRMS m/z 
(TOF MS EI+): calculated for C11H9NO2: 187.0633, found: 187.0625 [M]. 
Data were in agreement with those reported in the literature.50 
2-Ethynyl-1,1'-biphenyl (173) 
 
n-BuLi (2.5 M in hexane, 3.4 mL, 7.5 mmol) was added drop-wise to a solution of vinylbromide 
168 (1.01 g, 3 mmol) in THF (16 mL) at -78 °C under an argon atmosphere. The solution was 
left stirring for 5 h and the reaction mixture was then quenched with saturated solution of 
ammonium chloride (20 mL) and allowed to warm to room temperature. The organic layer was 
extracted with ethyl ether (3 × 20 mL) and the combined organic layers were dried over Na2SO4. 
The solution was then concentrated under reduced pressure to provide the crude product, 
which was purified by flash chromatography [hexane] affording alkyne 173 as a colourless liquid 
(481 mg, 90%): νmax (neat)/cm-1= 3284, 3061, 1474, 1432, 757, 737, 698; 1H-NMR (300 MHz; 
CDCl3): δH= 7.67-7.56 (m, 3H), 7.48-7.36 (m, 5H), 7.31 (ddd, J 7.6, 6.6 and 2.2, 1H), 3.04 (s, 
1H); 13C-NMR (101 MHz; CDCl3): δC= 144.4, 140.2, 133.8, 129.5, 129.2 (2C), 128.9, 127.9 (2C), 
127.5, 126.97, 120.4, 83.0, 80.1. 
Data were in agreement with those reported in the literature.104 
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(2-((Trimethylsilyl)ethynyl)phenyl)methanol (175) 
 
A solution of trimethylsilyl acetylene (1.66 mL, 12 mmol) and o-iodobenzyl alcohol 174 (1.46 g, 
6 mmol) in triethylamine (27 mL) was added of Pd(PPh3)4 (63 mg, 1.5 mol%) and copper (I)  
iodide (34 mg, 3 mmol%). The mixture was warmed to 40°C and stirred overnight. The reaction 
mixture was quenched with a saturated solution of ammonium chloride (30 mL) and the 
aqueous layer was extracted with diethyl ether (3 × 20 mL). The combined organic layers were 
dried over Na2SO4, filtered and concentrated under reduced pressure. The crude mixture was 
purified by flash chromatography [hexanes:EtOAc (9:1)] and gave silyl alkyne 175 (1.12g, 92%) 
as a light yellow oil: νmax (neat)/cm-1= 2921, 2878, 1769, 1682, 1361, 1202, 1102, 1037, 754, 
710; 1H-NMR (300 MHz; CDCl3): δH= 7.47 (dd, J 7.5 and 1.3, 1H), 7.41 (dd, J 7.5 and 1.3, 1H), 
7.33 (td, J 7.5 and 1.3, 1H), 7.24 (dt, J 7.5 and 1.3, 1H), 4.82 (d, J 6.6, 2H), 2.24 (t, J 6.6, 1H), 
0.27 (s, 9H); 13C-NMR (101 MHz; CDCl3): δC= 143.1, 132.4, 128.9, 127.3, 127.1, 121.1, 102.6, 
99.6, 64.1, 0.1. 
Data were in agreement with those reported in the literature.105 
1-((Allyloxy)methyl)-2-ethynylbenzene (176) 
 
In a round-bottom flask purged with argon, benzyl alcohol 175 (652 mg, 3.2 mmol) was added 
to potassium hydroxide (85% powder, 422 mg, 6.4 mmol) and tetrabutyl ammonium chloride (59 
mg, 5 mmol%) without the addition of any solvent. The reaction was stirred for 24 h at room 
temperature. The reaction mixture was quenched with a saturated solution of ammonium 
chloride (30 mL). The aqueous layer was extracted with ethyl acetate (3 × 30 mL) and the 
combined organic layers were washed with brine (50 mL), dried over Na2SO4 and concentrated 
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under reduced pressure. The crude mixture was purified by flash chromatography 
[hexanes:toluene (1:1)] and gave alkyne 176 (286 mg, 52%) as a light yellow oil: νmax (neat)/cm-
1= 3070, 3018, 2854, 1646, 1448, 1345, 1077, 922, 757, 649; 1H-NMR (300 MHz; CDCl3): δH= 
7.50 (m, 2H), 7.37 (td, J 7.6 and 1.3, 1H), 7.24 (td, J 7.6 and 1.3, 1H), 5.99 (ddt, J 17.2, 10.4 
and 5.6, 1H), 5.34 (ddt, J 17.2, 3.3 and 1.6, 1H), 5.22 (ddt, J 10.4, 3.3 and 1.6, 1H), 4.71 (s, 
2H), 4.10 (dt, J 5.6, 1.6, 2H), 3.30 (s, 1H); 13C-NMR (101 MHz; CDCl3): δC= 140.8, 134.7, 132.6, 
129.0, 127.4, 127.2, 120.5, 117.1, 81.6, 81.2, 71.6, 70.0; HRMS m/z (TOF MS ES+): calculated 
for C12H12ONa: 195.0786, found: 195.0783 [M+Na]. 
N-Allyl-2-oxo-2-phenyl-N-(4-methylbenzenesulfonyl)acetamide (177)  
 
Following GP3 using ynamide 164 (31.1 mg) for 24 h. After purification by flash chromatography 
[toluene:EtOAc (9:1)], dioxidative 177 was isolated as a cloudy resin (17.5 mg, 93%): νmax 
(neat)/cm-1= 2924, 2235, 1695, 1596, 1494, 1355, 1166, 1087, 986, 972, 812, 754, 680; 1H-
NMR (300 MHz; CDCl3): δH= 7.96-7.87 (m, 4H), 7.65 (tt, J 7.6 and 1.3, 1H), 7.57-7.49 (m, 2H), 
7.38 (d, J 7.6, 2H), 5.76 (ddt, J 16.6, 10.2 and 5.9, 1H), 5.25 (dd, J 16.6 and 1.1, 1H), 5.16 (dd, 
J 10.2 and 1.1, 1H), 4.35 (dt, J 5.9 and 1.1, 2H), 2.46 (s, 3H); 13C-NMR (101 MHz; CDCl3): δc= 
187.7, 166.9, 145.8, 134.4, 132.8, 130.6, 130.0 (2C), 129.7 (2C), 128.8 (2C), 128.6 (2C), 119.4, 
47.2, 21.7; HRMS m/z (TOF MS EI+): calculated for C18H17NO4S: 366.0776, found: 366.0775 
[M]. 
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1-([1',1''-biphenyl]-2'-yl)-2-(2'''-oxooxazolidin-3'''-yl)ethane-1,2-dione (181)  
 
Following GP3 using ynamide 153 (26.3 mg) for 24 h. After purification by flash chromatography 
[toluene:EtOAc (9:1)] dioxidative 181 was isolated as a light yellow resin (13.6 mg, 84%): νmax 
(neat)/cm-1= 3065, 2962, 2917, 2849, 2251, 1760, 1477, 1403, 1185, 1028, 735; 1H-NMR (300 
MHz; CDCl3): δH= 8.17 (dd, J 7.8, 1.4, 1H), 7.64 (td, J 7.6 and 1.4, 1H), 7.54 (td, J 7.6 and 1.4, 
1H), 7.42-7.35 (m, 5H), 7.31 (dd, J 7.6 and 1.4, 1H), 4.30 (t, J 8.0, 2H), 3.43 (t, J 8.0, 2H); 13C-
NMR (101 MHz; CDCl3): δc= 187.5, 165.9, 152.4, 144.1, 139.5, 133.6, 131.6, 131.2, 130.7, 
130.4 (2C), 130.0, 127.9, 127.6 (2C), 63.2, 40.8; HRMS m/z (TOF MS EI+): calculated for 
C17H13NO4: 318.0742, found: 318.0735 [M]. 
3-(4'-Allyl-1H-isochromen-3'-yl)oxazolidin-2-one (191) 
 
Following GP3 using ynamide 156 (24.3 mg) for 24 h. After purification by flash chromatography 
[hexene:EtOAc (7:3)] benzopyrane 191 was isolated as a yellow oil (14.9 mg, 58%): 1H-NMR 
(300 MHz; CDCl3): δH= 7.31-7.16 (m, 3H), 7.06 (dd, J 7.3, 0.6, 1H), 5.90 (ddt, J 17.2, 10.1 and 
5.9, 1H), 5.14 (ddd, J 17.2, 3.5 and 1.7, 1H), 5.09-5.01 (m, 3H), 4.43 (t, J 8.0, 2H), 3.90 (t, J 8.0, 
2H), 3.26 (dt, J 5.9, 1.7, 2H); 13C-NMR (101 MHz; CDCl3): δc= 155.3, 142.4, 136.3, 132.4, 
128.8, 128.1, 126.8, 123.7, 122.4, 115.7, 108.2, 69.6, 62.5, 45.5, 30.3; HRMS m/z (TOF MS 
ES+): calculated for C15H15NNaO3: 280.0950, found: 280.0948 [M+Na]. 
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(E) and (Z)-N-Allyl-N-(4-methylbenzenesulfonyl)hex-2-enamide (195) 
 
Following GP3 using ynamide 161 (29 mg) for 24 h. After purification by flash chromatography 
[gradient: from hexanes:EtOAc (19:1) to hexanes:EtOAc (9:1)] enimide 195 was afforded in 
combined yield of 31% [E:Z (3.3:1)]; enimide (Z)-195, colourless oil: νmax (neat)/cm-1= 2959, 
2926, 2855, 1686, 1351, 1164, 1080, 812, 753, 664; 1H-NMR (300 MHz; CDCl3): δH= 7.81 (d, J 
8.2, 2H), 7.31 (d, J 8.2, 2H), 6.31 (dt, J 11.6 and 1.6, 1H), 6.10 (dt, J 11.6 and 7.5, 1H), 5.92 
(ddt, J 17.1, 10.3 and 5.5, 1H), 5.34-5.22 (m, 2H), 4.47 (dt, J 5.5 and 1.6, 2H), 2.43 (s, 3H), 2.32 
(appqd, J 7.5 and 1.6, 2H), 1.35 (appsept, J 7.5, 2H), 0.84 (t, J 7.5, 3H); 13C-NMR (101 MHz; 
CDCl3): δc= 165.8, 149.3, 144.6, 137.0, 132.9, 129.5 (2C), 128.0 (2C), 120.9, 118.14, 48.4, 
31.5, 22.1, 21.6, 13.7; HRMS m/z (TOF MS ES+): calculated for C16H21NO3NaS: 330.1140, 
found: 330.1153 [M+Na].; enimide (E)-195, colourless oil: νmax (neat)/cm-1= 2961, 2931, 2873, 
1682, 1634, 1349, 1163, 1087, 812, 663; 1H-NMR (300 MHz; CDCl3): δH= 7.81 (d, J 8.2, 2H), 
7.31 (d, J 8.2, 2H), 6.95 (dt, J 15.1 and 7.2, 1H), 6.49 (dt, J 15.1 and 1.5, 1H), 5.91 (ddt, J 17.1, 
10.5 and 5.4, 1H), 5.28 (m, 2H), 4.49 (dt, J 5.4 and 1.5, 2H), 2.42 (s, 3H), 2.14 (dtd, J 7.2, 7.2 
and 1.5, 2H), 1.42 (tq, J 7.2 and 7.2, 2H), 0.88 (t, J 7.2, 3H); 13C-NMR (101 MHz; CDCl3): δc= 
165.7, 151.2, 144.6, 136.9, 132.9, 129.5 (2C), 127.9 (2C), 121.1, 118.1, 48.4, 34.6, 21.6, 21.2, 
13.6; HRMS m/z (TOF MS ES+): calculated for C16H21NO3NaS: 330.1140, found: 330.1138 
[M+Na].  
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3-(4'-Phenylbut-1'-yn-1'-yl)oxazolidin-2-one (202) 
 
Following GP2 using 2-oxazolidinone 170 (878 mg) and alkyne 201 (390 mg). After purification 
by flash chromatography [hexanes:EtOAc (4:1)] ynamide 202 was isolated as a light yellow 
solid (655 mg, 85%): mp: 55-57 °C; νmax (neat)/cm-1= 3027, 2937, 2920, 2854, 2264, 1759, 
1413, 1120, 1032, 742, 699; 1H-NMR (300 MHz; CDCl3): δH= 7.34-7.18 (m, 5H), 4.40 (t, J 8.0, 
2H), 3.83 (t, J 8.0, 2H), 2.85 (t, J 7.5, 2H), 2.60 (t, J 7.5, 2H); 13C-NMR (101 MHz; CDCl3): δc= 
156.5, 140.5, 128.4 (2C), 128.3 (2C), 126.3, 70.8, 70.5, 62.8, 46.9, 35.2, 20.6; HRMS m/z (TOF 
MS ES+): calculated for C13H13NO2Na: 238.0844, found: 238.0848 [M+Na]. 
Data were in agreement with those reported in the literature.106 
(E) and (Z)-3-(4'-Phenylbut-2'-enoyl)oxazolidin-2-one (203) 
 
Following GP4A using ynamide 202 (64.5 mg) for 3 h. After purification by flash 
chromatography [gradient: from hexanes:EtOAc (4:1) to hexanes:EtOAc (13:7)] enimide 203 
was afforded in combined yield of 69% [E:Z (5.5:1)]. Following GP4B using ynamide 202 (64.5 
mg) for 18 h. After purification by flash chromatography [gradient: from hexanes:EtOAc (4:1) to 
hexanes:EtOAc (13:7)] enimide 203 was afforded in combined yield of 61% [E:Z (12.8:1)]; 
enimide (Z)-203, colourless oil: 1H-NMR (300 MHz; CDCl3): δH= 7.34-7.17 (m, 5H), 7.11 (dt, J 
11.5 and 1.7, 1H), 6.50 (dt, J 11.5 and 7.5, 1H), 4.44 (t, J 8.0, 2H), 4.10 (t, J 8.0, 2H), 4.00 (dd, 
J 7.5 and 1.7, 2H); 13C-NMR (101 MHz; CDCl3): δc= 165.8, 149.3, 144.6, 137.0, 132.9, 129.5, 
128.0, 120.9, 118.14, 48.4, 31.5, 22.1, 21.6, 13.7; HRMS m/z (TOF MS ES+): calculated for 
C13H13NNaO3: 254.0793, found: 254.0795 [M+Na]; enimide (E)-203, colourless oil: νmax 
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(neat)/cm-1= 2921, 2852, 1767, 1678, 1632, 1357, 1218, 1111, 1036, 750, 699; 1H-NMR (300 
MHz; CDCl3): δH= 7.35-7.16 (m, 7H), 4.38 (t, J 8.0, 2H), 4.03 (t, J 8.0, 2H), 3.59 (d, J 5.6, 2H); 
13C-NMR (101 MHz; CDCl3): δc= 165.0, 153.4, 149.0, 137.6, 128.7 (2C), 128.6 (2C), 126.6, 
120.9, 62.0, 42.6, 38.9; HRMS m/z (TOF MS ES+): calculated for C13H13NNaO3: 254.0793, 
found: 254.0785 [M+Na]. 
N-(Pyridin-2-yl)pivalamide (208) 
 
A solution of 2-aminopyridine 206 (941 mg, 10 mmol,) and triethylamine (0.17 mL, 12.5 mmol) 
in CH2Cl2 (30 mL) was added drop-wise to a solution of pivaloyl chloride 207 (1.35 mL, 11 
mmol) in CH2Cl2 (10mL). After 1 h at reflux and 30 min at room temperature, the crude reaction 
was added to a saturated aqueous solution of NaHCO3 (50 mL). The aqueous phase was 
extracted with CH2Cl2 (3 × 40 mL) and the combined organic layers were washed with brine and 
dried over Na2SO4. The organic solution was then concentrated to provide the crude product. 
After purification by re-crystallisation with CH2Cl2/hexane, amide 208 was isolated as a white 
solid (1.26 g, 71%): mp: 74-76 °C; νmax (neat)/cm-1= 3304, 3238, 2971, 1674, 1575, 1514, 1429, 
1298, 775; 1H-NMR (300 MHz; CDCl3): δH= 8.30-8.20 (m, 2H), 8.02 (bs, 1H), 7.68 (appt, J 7.9, 
1H), 7.07-6.97 (m, 1H), 1.31 (s, 9H); 13C-NMR (101 MHz; CDCl3): δC= 177.0, 151.5, 147.6, 
138.3, 119.6, 113.9, 39.7, 27.4 (3C). 
Data were in agreement with those reported in the literature.107 
tert-Butylallylcarbamate (209) 
 
A solution of allylamine 157 (0.75 mL, 10 mmol,) in THF (7mL) was added to di-tert-
butyldicarbonate (2.291 g, 10.5 mmol). The reaction mixture was left stirring overnight at room 
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temperature. The reaction solution was concentrated under reduced pressure and the 
purification by flash chromatography [hexanes:EtOAc (4:1)] gave amide 209 (1.50 g, 96%) as a 
white solid: mp: 37-39 °C; νmax (neat)/cm-1= 3342, 2977, 2933, 1689, 1513, 1366, 1248, 1165, 
736; 1H-NMR (300 MHz; CDCl3): δH= 5.84 (m, 1H), 5.14 (m, 2H), 4.57 (br s, 1H), 3.75 (m, 2H), 
1.45 (s, 9H); 13C-NMR (101 MHz; CDCl3): δC= 155.7, 134.9, 115.7, 79.3, 43.1, 28.4 (3C). 
Data were in agreement with those reported in the literature.108 
N-Phenylmethanesulfonamide (211) 
 
A solution of the aniline 143 (2.74 mL, 30 mmol,) and pyridine (15 mL, 30 mmol) in CH2Cl2 (50 
mL) was added drop-wise to a solution of mesyl chloride (2.8 mL, 36 mmol) in CH2Cl2 (10 mL) 
at 0 °C. After stirring overnight at room temperature, the reaction mixture was added to a 
saturated aqueous solution of NaHCO3 (50 mL). The organic phase was extracted with CH2Cl2 
(3 × 40 mL) and the combined organic layers were washed with water (50 mL), brine (50 mL) 
and dried over Na2SO4. Alter filtration and concentration under reduced pressure, the crude 
mixture was purified by flash chromatography [hexanes:EtOAc (4:1)] to give mesyl amine 211 
(4.92 g, 96%) as a white solid: mp: 100-102 °C; νmax (neat)/cm-1= 3253, 3019, 2933, 1595, 
1494, 1471, 1392, 1319, 1300, 1275, 1145, 1075, 1028, 975, 959, 894, 751; 1H-NMR (300 
MHz; CDCl3): δH= 7.36 (t, J 7.8, 2H), 7.28-7.16 (m, 3H), 7.02-6.67 (m, 1H) 3.02 (s, 3H). 13C-
NMR (101 MHz; CDCl3): δC= 136.6, 139.6 (2C), 125.4, 120.8 (2C), 39.2. 
Data were in agreement with those reported in the literature.109 
N-Benzylmethanesulfonamide (212) 
 
A solution of benzylamine 210 (3.27 mL, 30 mmol) and pyridine (15 mL, 30 mmol) in CH2Cl2 (50 
mL) was added drop-wise of a solution of mesyl chloride (2.8 mL, 36 mmol) in CH2Cl2 (10 mL) at 
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0 °C. After stirring overnight at room temperature, the reaction mixture was added to a saturated 
aqueous solution of NaHCO3 (50 mL). The organic phase was extracted with CH2Cl2 (3 × 40 
mL) and the combined organic layers were washed with water (50 mL), brine (50 mL) and dried 
over Na2SO4. Alter filtration and concentration under reduced pressure, the crude mixture was 
purified by flash chromatography [hexanes:EtOAc (3:2)] to give mesyl amine 211 (518 mg, 
96%) as a white solid: mp: 63-66 °C; νmax (neat)/cm-1= 3225, 3020, 1455, 1435, 1379, 1294, 
1132, 1059, 737, 695; 1H-NMR (300 MHz; CDCl3): δH= 7.43-7.29 (m, 5H), 4.75 (brs, 1H), 4.32 
(d, J 6.1, 2H), 2.86 (s, 3H); 13C-NMR (101 MHz; CDCl3): δc= 136.6, 128.9 (2C), 128.1, 127.9 
(2C), 47.2, 41.1. 
Data were in agreement with those reported in the literature.109 
N-Propargyl-N-(4-methylbenzenesulfonyl)amine (214) 
 
A solution of the propargyl amine 213 (1.92 mL, 30 mmol) and triethylamine (4.17 mL, 30 mmol) 
in CH2Cl2 (140mL) was added dropwise of a solution of 4-methylbenzene sulfonyl chloride (5.70 
g, 30 mmol) in CH2Cl2 (10mL). After 1 h at reflux and 30 min at room temperature, the crude 
reaction was added to a saturated aqueous solution of NaHCO3 (150 mL). The organic phase 
was extracted with CH2Cl2 (3 × 70 mL) and the combined organic layers were washed with brine 
and dried over Na2SO4. The solution was then concentrated to provide the crude product. After 
purification by re-crystallisation with CH2Cl2/hexane amide 214 was isolated as a light yellow 
solid (6.21 g, 99%): mp: 62-64 °C; 1H-NMR (300 MHz; CDCl3): δH= 7.77 (d, J 8.3, 1H), 7.31 (d, J 
8.3, 2H), 4.75 (brs, 1H), 3.82 (dd, J 5.8 and 2.5, 2H), 2.43 (s, 3H), 2.10 (t, J 2.5, 1H); 13C-NMR 
(101 MHz; CDCl3): δC= 144.0, 136.6, 129.8 (2C), 127.5 (2C), 78.0, 73.1, 33.0, 21.7.  
Data were in agreement with those reported in the literature.110 
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N-(3-(trimethylsilyl)prop-2-yn-1-yl)-N-p-toluenylsulfonamide (215) 
 
A solution of the propargyl amine 214 (2.09 g, 10 mmol) in THF (20 mL) was added dropwise to 
a solution of n-BuLi (2.5 M in hexane, 7.2 mL, 18mmol) at -78 °C. The solution was warmed to 0 
°C and after 45 min, the crude mixture was added of TMSCl (2.54, 20 mmol) and allowed to 
warm to room temperature and monitored by TLC analysis. Upon completion, 25 mL of water 
were added. The organic phase was extracted with diethyl ether (3 × 50 mL) and the combined 
organic layers were washed with water (50 mL), brine (50 mL) and dried over Na2SO4. Alter 
filtration and concentration under reduced pressure, the crude mixture was purified by flash 
chromatography [hexanes:EtOAc (4:1)] to give silyl propargyl amide 215 (2.08 g, 74%) as a 
white solid: mp: 112-115 °C; νmax (neat)/cm-1= 3266, 2965, 2177, 1432, 1327, 1158, 1083, 838, 
810, 666; 1H-NMR (300 MHz; CDCl3): δH= 7.77 (d, J 8.3, 2H), 7.31 (d, J 8.0, 2H), 4.55 (brs, 1H), 
3.86 (d, J 6.1, 2H), 2.43 (s, 3H), 0.02 (s, J 3.5, 9H); 13C-NMR (101 MHz; CDCl3): δC= 143.7, 
136.8, 129.7 (2C), 127.4 (2C), 99.4, 89.9, 33.9, 21.5, -0.5 (3C). 
Data were in agreement with those reported in the literature.111 
1-cyclohexyl-3-(trimethylsilyl)prop-2-yn-1-ol (217) 
 
n-BuLi (2.5 M in hexane, 1.6 mL, 4 mmol) was added to a solution of ethynyltrimethylsilane 
(0.56, 4 mmol) in dry THF (13.3 mL) at -78 °C under argon atmosphere. After stirring for 30 min 
at -78 °C, the reaction was added to cyclohexyl aldehyde 216 (0.48 mL, 4 mmol) and continued 
stirring for an additional 30 min. The reaction mixture was allowed to warm to room temperature 
and was quenched with a saturated solution of ammonium chloride (15 mL). The aqueous 
phase was extracted with EtOAc (3 x 10 ml) and the combined organic extracts were dried over 
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Na2SO4, filtered and concentrated under reduced pressure. After evaporation of the solvent, the 
crude mixture was purified by flash chromatography [hexanes:EtOAc (4:1)] to give silyl 
propargyl amide 217 (621 mg, 74%) as a colourless liquid: νmax (neat)/cm-1= 3353, 2925, 2853, 
2171, 1450, 1249, 838, 758; 1H-NMR (300 MHz; CDCl3): δH= 4.13 (t, J 5.9, 1H), 1.90-1.61 (m, 
6H), 1.59-0.96 (m, 5H), 0.90 (t, J 7.0, 1H), 0.17 (s, 9H); 13C-NMR (101 MHz; CDCl3): δC= 105.8, 
90.2, 67.6, 44.0, 28.5, 28.1, 26.4, 25.9, 25.8, 0.1 (3C). 
Data were in agreement with those reported in the literature.112 
(1-methoxyprop-2-yn-1-yl)cyclohexane (218) 
 
Iodomethane (0.22 mL, 3.48 mmol) was added to a solution of 217 (610 mg, 2.90 mmol) in dry 
THF (8 mL) under an argon atmosphere. The solution was cooled to 0 °C in an ice bath and 
sodium hydride (57% suspension in oil, 146 mg, 3.48 mmol) was then added. After stirring for 
30 min at 0 °C, the mixture was stirred for further 3 h at room temperature. The reaction was 
quenched with a saturated solution of ammonium chloride (10 mL) and the aqueous phase was 
extracted with diethyl ether (3 x 10 ml). The combined organic extracts were dried over Na2SO4, 
filtered and concentrated under reduced pressure. The residue was purified by flash 
chromatography [hexanes:EtOAc (49:1)] to afford the methylated product as a colourless liquid 
(565 mg, 87%): νmax (neat)/cm-1= 2927, 2854, 2168, 1450, 1371, 1249, 1111, 1090, 842, 760; 
1H-NMR (300 MHz; CDCl3): δH= 3.70 (d, J 6.1, 1H), 3.99 (s, 3H) 1.90-1.40 (m, 6H), 1.35-1.95 
(m, 5H), 0.18 (s, 9H); 13C-NMR (101 MHz; CDCl3): δC= 103.8, 91.2, 76.7, 56.6, 42.4, 28.9, 28.3, 
26.5, 26.0, 25.9, 0.0 (3C); HRMS m/z (TOF MS ES+): calculated for C13H24NOSi: 224.1596, 
found 224.1596 [M+Na]. The product (560 mg, 2.5 mmol) was dissolved in methanol (5 mL) and 
potassium carbonate (862 mg, 6.25 mmol) was added. The reaction mixture was stirred at RT 
for 2 h before being quenched with aqueous ammonium chloride. The water phase was then 
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extracted with EtOAc (3 x 10 ml). The combined organic extracts were dried over Na2SO4, 
filtered and concentrated under reduced pressure to afford the desilylated product 218 (300.2 
mg, 79%) which was employed without further purification to prepare the corresponding 
ynamide. 
4-(Prop-2-yn-1-yloxy)but-1-yne (220) 
 
Sodium hydroxide (1.60 g, 40 mmol) and tetrabutylammonium hydrogen sulphate (170 mg, 0.5 
mmol) were added to a solution of homopropargyl alcohol 219 (0.756 mL, 10 mmol) in water 
(0.8 mL) and toluene (5 mL). The reaction was cooled to 0 °C and added drop-wise to propargyl 
bromide (1.225 mL, 11 mmol). The reaction mixture was then allowed to stir for 24 h, gradually 
warming to room temperature before being quenched with water (10 mL) and diethyl ether (10 
mL). The combined organic phase was separated, washed with 10% HCl soln.(10 mL), 
saturated NaHCO3 solution (10 mL) and brine (10 mL). The organic solution was dried over 
Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by vacuum 
distillation (60 °C, 15 mmHg) and afforded the propargyl ether 75 (1.01 g 93%) as a colourless 
oil: νmax (neat)/cm-1= 2873, 2118, 1358, 1097, 1017, 629; 1H-NMR (300 MHz; CDCl3): δH= 4.27 
(d, J 2.4, 2H), 3.74 (t, J 6.9, 2H), 2.58 (td, J 6.9 and 2.7, 2H), 2.52 (t, J 2.4, 1H), 2.08 (t, J 2.7, 
1H);13C-NMR (101 MHz; CDCl3): δC= 80.9, 79.4, 71.6, 69.4, 67.9, 58.2, 19.7. 
Data were in agreement with those reported in the literature.113 
(3-(But-3’-yn-1’-yloxy)prop-1-yn-1-yl)trimethylsilane (221) 
 
n-BuLi (2.5 M in hexane, 1.44 mL, 3.6 mmol) was added to a solution of propargyl ether 75 
(432, 4 mmol) and 1,10-phenanthroline (catalytic quantity, approx. 2 mg) in dry THF (8 mL) at -
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78 °C under argon atmosphere. After stirring for 30 min at -78 °C, the reaction was added to 
TMSCl (0.46 mL, 4 mmol) and allowed to warm to room temperature. The reaction mixture was 
stirred for a further 3 h before being quenched with a saturated solution of ammonium chloride 
(15 mL). The organic phase was extracted with diethyl ether (3 x 15 ml) and the combined 
organic extracts were dried over Na2SO4, filtered and concentrated under reduced pressure. 
After evaporation of the solvent, the crude mixture was purified was purified by vacuum 
distillation (60 °C, 15 mmHg) and afforded the silylated propargyl ether 76 (480 mg, 74%) as a 
colourless oil: νmax (neat)/cm-1= 2960, 2175, 1353, 1250, 1100, 991, 838, 759; 1H-NMR (300 
MHz; CDCl3): δH= 4.17 (s, 2H), 3.62 (t, J 6.9, 2H), 2.49 (dt, J 6.9 and 2.7, 2H), 1.99 (t, J 2.7, 
1H), 0.16 (s, 9H); 13C-NMR (101 MHz; CDCl3): δC= 101.0, 91.6, 81.0, 69.3, 67.6, 58.8, 193.6, -
0.3 (3C).  
Data were in agreement with those reported in the literature.113 
(E)-(3-(Prop-2-yn-1-yloxy)prop-1-en-1-yl)benzene (223) 
 
Cinnamyl bromide 222 (985 mg, 5 mmol) was added to a solution of propargyl alcohol (0.36 mL, 
6 mmol) and potassium carbonate (828 mg, 6 mmol) in acetone (4 mL) at room temperature 
and the reaction mixture was refluxed for 12 h. The solution was then cooled to room 
temperature, added to water (10 mL). The two phases were separated and the aqueous phase 
was extracted with EtOAc (3 x 15 ml). The combined organic extracts were dried over Na2SO4, 
filtered and concentrated under reduced pressure. The residue was purified by flash 
chromatography [hexanes:EtOAc (19:1)] to afford propargyl ether 223 as a colourless oil (568 
mg, 66%): νmax (neat)/cm-1= 3290, 3028, 2854, 2116, 1702, 1357, 1072, 966, 691; 1H-NMR (300 
MHz; CDCl3): δH= 7.44-7.21 (m, 5H), 6.65 (d, J 15.9, 1H), 6.28 (dt, J 15.9 and 6.2, 1H), 4.25 
(dd, J 6.2 and 1.4, 2H), 4.21 (d, J 2.4, 2H), 2.46 (t, J 2.4, 1H); 13C-NMR (101 MHz; CDCl3): δC= 
136.5, 133.4, 128.5 (2C), 127.8, 126.5 (2C), 125.0, 79.7, 74.5, 70.2, 57.0. 
Data were in agreement with those reported in the literature.114 
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Hex-1-yn-3-yltrimethylsilane (224) 
 
A solution of hex-1-yne 159 (1.15 mL, 10 mmol) in diethyl ether (7 mL) was cooled down at -78 
°C and treated with 8 mL of n-BuLi (2.5 M in hexane, 20 mmol) and the mixture was then 
refluxed for 2 h. The reaction mixture was cooled to -20 °C and TMSCl (1.27 mL, 10 mmol) was 
added over a period of 10 min. The reaction was allowed to warm to 10 °C before being added 
to ice and water (10 mL). The two phases were separated and the aqueous phases were 
extracted with diethyl ether (3 x 15 ml) and the combined organic extracts were dried over 
Na2SO4, filtered and concentrated under reduced pressure. After evaporation of the solvent, the 
crude mixture was purified by vacuum distillation (116 °C, 16 mmHg) and afforded the 
trimethylsilane 224 (601 mg 39%) as a colourless oil: νmax (neat)/cm-1= 2961, 2857, 1715, 1249, 
1177, 840; 1H-NMR (300 MHz; CDCl3): δH= 1.96 (d, J 2.7, 1H), 1.76-1.57 (m, 2H), 1.48-1.29 (m, 
3H), 0.92 (t, J 7.0, 3H), 0.09 (s, 9H); 13C-NMR (101 MHz; CDCl3): δC= 86.9, 68.2, 31.1, 22.6, 
19.4, 13.7, -3.3 (3C). 
Data were in agreement with those reported in the literature.115 
tert-Butyldimethyl((1-phenylprop-2-yn-1-yl)oxy)silane (226) 
 
A solution of 1-phenyl-2-propyn-1-ol 225 (0.62 mL, 5 mmol) and 1-H-imidazole (340 mg, 5 
mmol) in THF (7.5 mL) was added to TBSCl (50% w/w toluene, 2.07 mL, 6 mmol) at room 
temperature and stirred overnight. The reaction mixture was filtered through a pad of celite and 
the organic solution was concentrated under reduced pressure. After evaporation of the solvent, 
the crude mixture was purified by flash chromatography [gradient: from hexane to hexanes: 
EtOAc (99:1)] to give silyl ether 226 (800 mg, 65%) as a light yellow liquid: νmax (neat)/cm-1= 
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2955, 2930, 2886, 2857, 1707, 1252, 1090, 1065, 834, 776; 1H-NMR (300 MHz; CDCl3): δH= 
7.55-7.46 (m, 2H), 7.40-7.28 (m, 3H), 5.50 (d, J 2.1, 1H), 2.56 (d, J 2.2, 1H), 0.94 (s, 9H), 0.19 
(s, 3H), 0.15 (s, 3H); 13C-NMR (101 MHz; CDCl3): δC= 141.3, 128.3, 127.8, 126.0, 73.6, 84.7, 
64.6, 25.8, 18.3, -4.6 (3C), -5.0 (3C). 
Data were in agreement with those reported in the literature.116 
((But-3-yn-1-yloxy)methyl)benzene (227) 
 
A solution of 1-butynyl-1-ol 218 (0.76 mL, 10 mmol) and TBAI (3.70 g, 10 mmol) in THF (7.5 
mL) was added to sodium hydride (57% suspension in oil, 440 mg, 11 mmol) and stirred for 30 
min at 0 °C. Benzyl bromide (1.25 ml, 10.5 mmol) was added and the reaction mixture was 
stirred for 8 h at room temperature. The reaction mixture was quenched by addition of ice and 
water (10 mL). The organic phase was extracted with EtOAc (3 x 15 ml) and the combined 
organic extracts were dried over Na2SO4, filtered and concentrated under reduced pressure. 
After evaporation of the solvent, the crude mixture was purified by vacuum distillation (120 °C, 
17 mmHg) and afforded the benzyl protected alcohol 227 (1.33 g, 83%) as a light yellow oil: νmax 
(neat)/cm-1= 3294, 3031, 2863, 2121, 1721, 1453, 1362, 1098, 736, 696; 1H-NMR (300 MHz; 
CDCl3): δH= 7.41-7.28 (m, 5H), 4.58 (s, J 6.5, 2H), 3.62 (t, J 6.9, 2H), 2.52 (td, J 6.9 and 2.7, 
1H), 2.02 (t, J 2.7, 1H); 13C-NMR (101 MHz; CDCl3): δC= 137.8, 128.3 (2C), 127.6 (2C), 81.2, 
72.9, 69.3, 68.0, 19.8. 
Data were in agreement with those reported in the literature.117 
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(But-3-yn-1-yloxy)(tert-butyl)dimethylsilane (228) 
 
A solution of phenyl 3-butynyl-1-ol 218 (0.76 mL, 10 mmol) and 1-H-imidazole (680 mg, 10 
mmol) in THF (15 mL) was added to TBSCl (50% w/w toluene, 4.16 mL, 12 mmol) at room 
temperature and stirred overnight. The reaction mixture was filtered through a pad of celite and 
the organic solution was concentrated under reduced pressure. After evaporation of the solvent, 
the crude mixture was purified by flash chromatography [hexanes:diethyl ether (39:1)] to give 
silyl ether 228 (1.01 g, 55%) as a colourless liquid: νmax (neat)/cm-1= 2955, 2930, 2858, 1472, 
1254, 1102, 834, 774; 1H-NMR (300 MHz; CDCl3): δH= 3.74 (t, J 7.1, 2H), 2.40 (td, J 7.1 and 
2.7, 2H), 1.96 (t, J 2.7, 1H), 0.89 (s, 9H), 0.07 (s, 6H); 13C-NMR (101 MHz; CDCl3): δC= 81.5, 
69.3, 61.7, 25.9, 22.9 (3C), 18.3, -5.3 (2C). 
Data were in agreement with those reported in the literature.118 
S-Pent-4-yn-1-yl ethanethioate (230) 
 
DIAD (94%, 3.04 g, 15.5 mmol) was slowly added to a solution of triphenyl phosphine (4.01g, 
15.5 mmol) in THF (50 mL) at 0 °C. After 30 min, a solution of 3-butynyl-1-ol 229 (0.76 mL, 10 
mmol) and thioacetic acid (4.0 mL, 15.5 mL) was added and the reaction was allowed to stir at 
room temperature for 16 h. The solvent was reduced to 10 mL and hexane was added until no 
formation of white precipitate was observed. The solution was filtered off and concentrated 
under reduced pressure to a third of its volume. The solution was filtered through a pad of silica 
and concentrated under reduced pressure. After evaporation of the solvent, the crude mixture 
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was purified by vacuum distillation (70 °C, 7 mmHg) and afforded the thioester 230 (853 mg, 
60%) as a light yellow oil: νmax (neat)/cm-1= 2922, 2852, 1687, 1431, 1104, 951; 1H-NMR (300 
MHz; CDCl3): δH= 2.97 (t, J 7.0, 2H), 2.32 (s, J 4.7, 3H), 2.27 (td, J 7.0 and 2.6, 2H), 1.97 (t, J 
2.6, 1H), 1.79 (q, J 7.0, 2H); 13C-NMR (101 MHz; CDCl3): δC= 195.5, 82.9, 69.1, 30.5, 28.2, 
27.9, 17.5. 
Data were in agreement with those reported in the literature.119 
N-Phenyl-N-(4-((3-(trimethylsilyl)prop-2-yn-1-yl)oxy)but-1-yn-1-yl)methanesulfonamide 
(235) 
 
Following GP2 using amide 211 (1.71 g) and alkyne 221 (513 mg, 2 mmol). After purification by 
flash chromatography [hexanes:EtOAc (4:1)] ynamide 235 was isolated as a colourless oil (617 
mg, 59%): νmax (neat)/cm-1= 3021, 2963, 2927, 2842, 2829, 2260, 2174, 1489, 1352, 1247, 
1156, 1097, 990, 969, 840, 760, 697; 1H-NMR (300 MHz; CDCl3): δH= 7.54-7.49 (m, 2H), 7.45-
7.30 (m, 3H), 4.18 (s, 2H), 3.66 (t, J 7.0, 2H), 3.08 (s, 3H), 2.66 (t, J 7.0, 2H), 0.18 (s, 9H); 13C-
NMR (101 MHz; CDCl3): δC= 138.9, 129.3 (2C), 128.0, 125.4 (2C), 101.2, 91.6, 74.2, 68.2, 67.8, 
58.9, 36.3, 19.8, -0.2 (3C); HRMS m/z (TOF MS ES+): calculated for C17H23NO3NaSSi: 
372.1066, found 372.1076 [M+Na]. 
N-benzyl-N-(hex-1-yn-1-yl)methanesulfonamide (236) 
 
Following GP2 using amide 212 (1.85 g) and hex-1-yne (0.23 mL, 2 mmol). After purification by 
flash chromatography [hexanes:EtOAc (17:3)] ynamide 236 was isolated as a colourless oil 
(206 mg, 78%): νmax (neat)/cm-1= 2957, 2932, 2872, 2254, 1684, 1456, 1351, 1159, 1026, 956, 
698; 1H-NMR (300 MHz, CDCl3): δΗ = 7.48-7.33 (m, 5H), 4.57 (s, 2H), 2.86 (s, 3H), 2.26 (t, J 6.9, 
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2H), 1.52-1.25 (m, 4H), 0.88 (t, J 7.2, 3H); 13C-NMR (100 MHz, CDCl3): δC = 134.8, 128.9 (2C), 
128.6 (2C), 128.5, 72.9, 71.4, 55.6, 38.2, 30.9, 21.8, 18.1, 13.5; HRMS m/z (TOF MS ES+): 
calculated for C14H19NNaO2S: 265.1136, found 265.1137 [M+Na]. 
3-(3-((tert-Butyldimethylsilyl)oxy)-3-phenylprop-1-yn-1-yl)oxazolidin-2-one (238) 
 
Following GP2 using amide 215 (1.85 g) and hex-1-yne (0.23 mL, 2 mmol). After purification by 
flash chromatography [hexanes:EtOAc (17:3)] ynamide 238 was isolated as a colourless oil 
(206 mg, 70%): νmax (neat)/cm-1= 2959, 2927, 2862, 2251, 2183, 1597, 1043, 1165, 845, 703, 
666; 1H-NMR (300 MHz; CDCl3): δH= 7.83 (d, J 8.2, 2H), 7.32 (d, J 8.2, 2H), 4.22 (s, 2H), 2.44 
(s, 3H), 2.28 (t, J 6.8, 2H), 1.52-1.30 (m, 4H), 0.88 (t, J 7.2, 3H), 0.02 (s, J 3.6, 9H); 13C-NMR 
(101 MHz; CDCl3): δC= 144.3, 134.4, 129.3 (2C), 128.2 (2C), 97.4, 91.35, 72.5, 70.9, 42.6, 30.9, 
21.7, 21.6, 18.1, 13.6, -0.5 (3C); HRMS m/z (TOF MS ES+): calculated for C19H27NNaO2SSi: 
384.1429, found 384.1434 [M+Na]. 
3-(2-Oxooxazolidin-3-yl)prop-2-yn-1-yl acetate (239) 
 
Following GP2 using oxazolidin-2-one 170 (878 mg) and 3-acetoxyprop-1-yne (0.20 mL, 2 
mmol). After purification by flash chromatography [hexanes:EtOAc (11:9)] ynamide 239 was 
isolated as a thick oil (206 mg, 92%): νmax (neat)/cm-1= 2989, 2923, 2266, 1763, 1735, 1421, 
1192 1112, 1023, 964, 748; 1H-NMR (300 MHz; CDCl3): δH= 4.81 (s, 2H), 4.44 (t, J 8.0, 2H), 
3.93 (t, J 8.0, 2H), 2.07 (s, 3H); 13C-NMR (101 MHz; CDCl3): δC= 170.2, 155.9, 76.5, 66.3, 63.1, 
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52.3, 46.5, 20.7; HRMS m/z (TOF MS ES+): calculated for C8H9NNaO4: 206.0429, found 
206.0424 [M+Na]. 
3-(cyclopropylethynyl)oxazolidin-2-one (240) 
 
Following GP2 using oxazolidin-2-one 170 (878 mg) and cyclopropylacetylene (0.26 mL, 2 
mmol). After purification by flash chromatography [hexanes:EtOAc (3:2)] ynamide 240 was 
isolated as a colourless oil (268 mg, 59%): νmax (neat)/cm-1= 3080, 3020, 2982, 2920, 2268, 
1742, 1470, 1432, 1293, 1213, 1132, 1029, 932, 813, 746; 1H-NMR (300 MHz; CDCl3): δH= 4.39 
(t, J 8.0, 2H), 3.85 (t, J 8.0, 2H), 1.34 (tt, J 8.0 and 5.0, 1H), 0.85-0.74 (m, 2H), 0.74-0.67 (m, 
2H); 13C-NMR (101 MHz; CDCl3): δC= 156.7, 75.1, 65.6, 62.7, 47.0, 8.6, -1.0; HRMS m/z (TOF 
MS EI+): calculated for C8H9NO2: 151.0633, found 151.0632 [M].  
Spectroscopic data were identical to those reported in literature.120 
3-(3-((tert-Butyldimethylsilyl)oxy)-3-phenylprop-1-yn-1-yl)oxazolidin-2-one (241) 
 
Following GP2 using oxazolidin-2-one 170 (878 mg) and propargyl silyl ether 226 (492 mg, 2 
mmol). After purification by flash chromatography [hexanes:EtOAc (7:3)] ynamide 241 was 
isolated as a light yellow oil (463 mg, 70%): 1H-NMR (300 MHz; CDCl3): δH= 7.49 (d, J 7.3, 2H), 
7.39-7.24 (m, 3H), 5.68 (s, 1H), 4.42 (t, J 8.1, 2H), 3.88 (t, J 8.1, 2H), 0.93 (s, J 2.9, 9H), 0.17 
(s, 3H), 0.15 (s, 3H). 
The product was party characterised due to its fast degradation. 
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3-(Hex-1-yn-1-yl)oxazolidin-2-one (242) 
 
Following GP2 using oxazolidin-2-one 170 (878 mg) and hex-1-yne (0.23 mL, 2 mmol). After 
purification by flash chromatography [hexanes:EtOAc (7:3)] ynamide 242 was isolated as a 
colourless oil (143 mg, 43%): νmax (neat)/cm-1= 2959, 2931, 2873, 2273, 1759, 1479, 1413, 
1298, 1201, 1113, 1032, 750, 729; 1H-NMR (300 MHz; CDCl3): δH= 4.41 (t, J 8.2, 2H), 3.87 (t, J 
8.2, 2H), 2.30 (t, J 6.9, 2H), 1.58-1.34 (m, 4H), 0.91 (t, J 7.2, 3H); 13C-NMR (101 MHz; CDCl3): 
δC= 156.6, 71.1, 70.0, 62.7, 47.0, 30.8, 21.9, 18.0, 13.5; HRMS m/z (TOF MS EI+): calculated 
for C9H13NO2: 167.0946, found 167.0947 [M]. 
3-(3-Methoxyprop-1-yn-1-yl)oxazolidin-2-one (243) 
 
Following GP2 using oxazolidin-2-one 170 (878 mg) and 3-methoxyprop-1-yne (0.17 mL, 2 
mmol). After purification by flash chromatography [hexanes:EtOAc (9:11)] ynamide 243 was 
isolated as a light-yellow oil (272 mg, 88%): νmax (neat)/cm-1= 2989, 2926, 2822, 2261, 1759, 
1478, 1415, 1358, 1322, 1187, 1110, 1088, 1030, 931, 893, 748; 1H-NMR (300 MHz; CDCl3): 
δH= 4.44 (t, J 7.9, 2H), 4.23 (s, 2H), 3.91 (t, J 7.9, 2H), 3.36 (s, 3H); 13C-NMR (101 MHz; 
CDCl3): δc= 156.1, 76.3, 67.6, 63.0, 59.8, 57.4, 46.7; HRMS m/z (TOF MS EI+): calculated for 
C7H9NO3: 155.0582, found 155.0584 [M]. 
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3-(6-Chlorohex-1-yn-1-yl)oxazolidin-2-one (244) 
 
Following GP2 using oxazolidin-2-one 170 (878 mg) and 6-chlorohex-1-yne (0.24 mL, 2 mmol). 
After purification by flash chromatography [hexanes:EtOAc (6:4)] ynamide 95 was isolated as a 
light-yellow oil (273 mg, 68%): νmax (neat)/cm-1= 2987, 2949, 2922, 2869, 2268, 1758, 1478, 
1413, 1298, 1200, 1111, 1031, 746; 1H-NMR (300 MHz; CDCl3): δH= 4.41 (t, J 8.0, 2H), 3.86 (t, 
J 8.0, 2H), 3.56 (t, J 6.5, 2H), 2.35 (t, J 6.9, 2H), 1.95-1.82 (m, 2H), 1.73-1.60 (m, 2H); 13C-NMR 
(101 MHz; CDCl3): δc= 156.5, 70.6, 70.2, 62.8, 46.9, 44.5, 31.5, 25.9, 17.7; HRMS m/z (TOF 
MS EI+): calculated for C9H12NO2Cl: 201.0557, found 201.0552 [M]. 
2-(5-(2-Oxooxazolidin-3-yl)pent-4-yn-1-yl)isoindoline-1,3-dione (245) 
 
Following GP2 using oxazolidin-2-one 170 (878 mg) and 2-(pent-4-yn-1-yl)isoindoline-1,3-dione 
(426 mg, 2 mmol). After purification by flash chromatography [hexanes:EtOAc (1:1)] ynamide 
245 was isolated as a white solid (441 mg, 74%): mp: 138-139 ºC; νmax (neat)/cm-1= 2988, 2935, 
2929, 2265, 1771, 1704, 1466, 1422, 1402, 1375, 1341, 1210, 1402, 1088, 1030, 887, 742, 
720; 1H-NMR (300 MHz; CDCl3): δH= 7.88-7.81 (m, 2H), 7.75-7.68 (m, 2H), 4.38 (t, J 8.0, 2H), 
3.86-3.76 (m, 4H), 2.39 (t, J 7.1, 2H), 1.94 (appquint, J 7.1, 2H); 13C-NMR (101 MHz; CDCl3): 
δc= 168.2 (2C), 156.4, 133.9 (2C), 132.0 (2C), 123.2 (2C), 70.8, 69.6, 62.8, 46.8, 37.1, 27.4, 
16.2; HRMS m/z (TOF MS ES+): calculated for C16H14N2O4Na: 321.0851, found 321.0849 
[M+Na] 
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3-(4-(Benzyloxy)but-1-yn-1-yl)oxazolidin-2-one (246) 
 
Following GP2 using oxazolidin-2-one 170 (878 mg) and alkyne 227 (292 mg, 2 mmol). After 
purification by flash chromatography [hexanes:toluene (4:1)] ynamide 246 was isolated as a 
light-yellow oil (387 mg, 79%): νmax (neat)/cm-1= 3031, 2914, 2864, 2272, 1760, 1718; 1478, 
1413, 1270, 1200, 1109, 1030, 738, 698; : νmax (neat)/cm-1= 3051, 2957, 2931, 2872, 2254, 
17036, 1361, 1166, 821, 660; 1H-NMR (300 MHz; CDCl3): δH= 7.37-7.27 (m, 5H), 4.55 (s, 2H), 
4.41 (t, J 7.8, 2H), 3.86 (t, J 7.8, 2H), 3.60 (t, J 7.0, 2H). 2.63 (t, J 7.0, 2H); 13C-NMR (101 MHz; 
CDCl3): δc= 156.5, 145.0, 129.6, 128.3 (2C), 127.6 (2C), 72.9, 70.9, 68.3, 67.9, 62.8, 46.8, 19.8; 
HRMS m/z (TOF MS ES+): calculated for C14H15NO3Na: 268.0950, found 268.0956 [M+Na]. 
3-(4-((tert-Butyldimethylsilyl)oxy)but-1-yn-1-yl)oxazolidin-2-one (247) 
 
Following GP2 using oxazolidin-2-one (878 mg) and alkyne 228 (368 mg, 2 mmol). After 
purification by flash chromatography [hexanes:EtOAc (3:1)] ynamide 247 was isolated as a 
light-yellow oil (428 mg, 53%): νmax (neat)/cm-1= 2954, 2928, 2856, 2268, 1765, 1413, 1252, 
1202, 1101, 1035, 834, 775, 749; 1H-NMR (300 MHz; CDCl3): δH= 4.41 (t, J 8.0, 2H), 3.86 (t, J 
8.0, 2H), 3.72 (t, J 7.1, 2H), 2.52 (t, J 7.1, 2H), 0.89 (s, 9H), 0.06 (s, 6H); 13C-NMR (101 MHz; 
CDCl3): δc= 156.4, 71.0, 68.2, 62.8, 61.9, 46.9, 25.9 (3C), 22.7, 18.3, -5.3 (2C); HRMS m/z 
(TOF MS EI+): calculated for C13H23NO3Si: 269.1447, found 269.1452 [M]. 
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S-(5-(2-Oxooxazolidin-3-yl)pent-4-yn-1-yl) ethanethioate (248) 
 
Following GP2 using oxazolidin-2-one 170 (878 mg) and alkyne 230 (284 mg, 2 mmol). After 
purification by flash chromatography [hexanes:toluene (11:9)] ynamide 248 was isolated as a 
colourless oil (290 mg, 64%): νmax (neat)/cm-1= 2987, 2928, 2854, 2258, 1734, 1449, 1312, 
1247, 1193, 1170, 1135, 1079, 1040, 998, 886, 840; 1H-NMR (300 MHz; CDCl3): δH= 4.42 (t, J 
8.1, 2H), 3.88 (t, J 8.1, 2H), 2.97 (t, J 7.1, 2H), 2.40 (t, J 7.1, 2H), 2.33 (s, 3H), 1.80 (dt, J 7.1 
and 7.1, 2H); 13C-NMR (101 MHz; CDCl3): δc= 195.5, 156.5, 70.9, 69.7, 62.8, 46.9, 30.6, 28.6, 
28.0, 17.6; HRMS m/z (TOF MS ES+): calculated for C10H13NO3NaS: 250.0514, found 250.0511 
[M+Na]. 
3-(Cyclohexylethynyl)oxazolidin-2-one (249) 
 
Following GP2 using oxazolidin-2-one 170 (878 mg) and ethynylcyclohexane (0.26 mL, 2 
mmol). After purification by flash chromatography [hexanes:toluene (3:2)] ynamide 249 was 
isolated as a colourless oil (208 mg, 54%): νmax (neat)/cm-1= 2927, 2853, 2268, 1757, 1479, 
1448, 1413, 1289, 1202, 1111, 1035, 973, 748; 1H-NMR (300 MHz; CDCl3): δH= 4.40 (t, J 8.0, 
2H), 3.86 (t, J 8.0, 2H), 2.47 (tt, J 9.3 and 3.6, 1H), 1.87-1.61 (m, 4H), 1.57-1.21 (m, 6H); 13C-
NMR (101 MHz; CDCl3): δc= 156.5, 75.0, 70.2, 62.7, 47.1, 32.7 (2C), 28.8, 25.8, 24.9 (2C); 
HRMS m/z (TOF MS EI+): calculated for C11H15NO2: 193.1103, found 193.1097 [M]. 
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(E) and (Z)-N-(methylsulfonyl)-N-phenyl-4-((3-(trimethylsilyl)prop-2-yn-1-yl)oxy)but-2-
enamide (250) 
 
Following GP4A using ynamide 235 (105 mg) for 1 h. After purification by flash chromatography 
[hexanes:EtOAc (4:1)] enimide 250 was afforded in combined yield of 66% [E:Z (2.8:1)]. 
Following GP4B using ynamide 235 (105 mg) for 20 h. After purification by flash 
chromatography [hexanes:EtOAc (4:1)] enimide 250 was afforded in combined yield of 68% 
[E:Z (3.2:1)]; enimide (E)-250, light-yellow oil: νmax (neat)/cm-1= 3041, 2960, 2901, 2850, 1687, 
1643, 1351, 1249, 1153, 1119, 961, 840, 761, 694; 1H-NMR (300 MHz; CDCl3): δH= 7.51-7.44 
(m, 3H), 7.31-7.24 (m, 2H), 7.10 (dt, J 15.3 and 4.2, 1H), 5.77 (dt, J 15.3 and 2.1, 1H), 4.11 (dd, 
J 4.2 and 2.1, 2H), 4.02 (s, 2H), 3.47 (s, 3H), 0.14 (s, 9H); 13C-NMR (101 MHz; CDCl3): δc= 
165.8, 145.9, 135.0, 130.0 (2C), 129.9, 129.9 (2C), 120.8, 100.4, 92.3, 67.9, 58.5, 41.9, -0.3 
(3C); HRMS m/z (TOF MS ES+): calculated for C17H23NO4NaSSi: 388.1015, found 388.1006 
[M+Na]; enimide (Z)-250, light-yellow oil: νmax (neat)/cm-1= 3061, 2961, 2898, 2849, 1683, 1356, 
1250, 1156, 1094, 964, 842, 733, 695; 1H-NMR (300 MHz; CDCl3): δH= 7.51-7.45 (m, 3H), 7.31-
7.26 (m, 2H), 6.32 (dt, J 11.7 and 4.6, 1H), 5.52 (dt, J 11.7 and 2.5, 1H), 4.70 (dd, J 4.6 and 2.5, 
2H), 4.18 (s, 2H), 3.47 (s, 3H), 0.17 (s, 9H); 13C-NMR (101 MHz; CDCl3): δc= 166.1, 150.3, 
135.3, 130.1, 130.0 (2C), 129.9 (2C), 119.0, 100.9, 91.9, 68.8, 59.0, 41.9, -0.2 (3C); HRMS m/z 
(TOF MS ES+): calculated for C17H23NO4NaSSi: 388.1015, found 388.1027 [M+Na]. 
(E) and (Z)-N-benzyl-4-methyl-N-(methylsulfonyl)pent-2-enamide (251) 
 
Following GP4A using ynamide 236 (79 mg) for 3 h. After purification by flash chromatography 
[hexanes:EtOAc (3:1)] enimide 251 was obtained as a mixture in yield of 87% [E:Z (3.6:1)]. 
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Following GP4B using ynamide 235 (79 mg) for 24 h. After purification by flash chromatography 
[hexanes:EtOAc (3:1)] enimide 251 was obtained as a mixture in yield of 85%  [E:Z (4.5:1)]; 
enimide (E)-251, light-yellow oil: 1H-NMR (300 MHz; CDCl3): δH= 7.42-7.27 (m, 5H), 7.16 (dt, J 
14.9 and 7.2, 1H), 6.49 (dt, J 14.9 and 1.5, 1H), 5.06 (s, 2H), 3.16 (s, 3H), 2.21 (qd, J = 7.2 and 
1.5 Hz, 2H), 1.48 (appsext, J 7.2, 2H), 0.92 (t, J = 7.2, 3H); enimide (Z)-251, light-yellow oil: 1H-
NMR (300 MHz; CDCl3): δH= 7.38-7.30 (m, 5H), 6.33-6.20 (m, 2H), 5.04 (s, 2H), 3.17 (s, 3H), 
2.58-2.48 (m, 2H), 1.49 (qt, J 7.4 and 7.4, 2H), 0.95 (t, J = 7.4 Hz, 3H). 
(E) and (Z)-N-(4-methylbenzenesulfonyl)-N-(3-(trimethylsilyl)prop-2-yn-1-yl)hex-2-enamide 
(252) 
 
Following GP4A using ynamide 238 (108 mg) for 4 h. After purification by flash chromatography 
[hexanes:EtOAc (4:1)] enimide 252 was obtained as a mixture in yield of 87% [E:Z (4.1:1)]. 
Following GP4B using ynamide 238 (108 mg) for 24 h. After purification by flash 
chromatography [hexanes:EtOAc (6.1:1)] enimide 252 was obtained as a mixture in yield of 
85%  [E:Z (3.2:1)]; enimide (E)-251, light-yellow oil: 1H-NMR (300 MHz; CDCl3): δH= 7.94 (d, J 
8.3, 2H), 7.29 (d, J 8.3, 2H), 6.96 (dt, J 15.1 and 7.6, 1H), 6.52 (dt, J 15.1 and 1.3, 1H), 4.71 (s, 
2H), 2.42 (s, 3H), 2.15 (dtd, J 7.6, 7.6 and 1.3, 2H), 1.42 (qt, J = 7.6 and 7.6, 2H), 0.87 (t, J 7.6, 
3H), 0.15 (m, 9H); enimide (Z)-251, light-yellow oil: 1H-NMR (300 MHz; CDCl3): δH= 7.94 (d, J 
8.3, 2H), 7.29 (d, J 8.3, 2H), 6.32 (dt, J 11.6 and 1.5, 1H), 6.11 (dt, J 11.6 and 7.4, 1H), 4.68 (s, 
2H), 2.42 (s, 3H), 2.31 (qd, J 7.4 and 1.5, 2H), 1.33 (appsext, J = 7.4, 3H), 0.82 (s, 9H). 
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(E) and (Z)-N-phenyl-N-(4-(prop-2-yn-1-yloxy)but-1-yn-1-yl)methanesulfonamide (253) 
Ph
N
OMs
 
Potassium carbonate was added to a solution of 235 (305 mg, 0.87 mmol) in methanol (1.5 mL) 
(301 mg, 2.18 mmol). The reaction mixture was stirred at RT for 2 h before being quenched with 
aqueous ammonium chloride. The two phases were separated and the aqueous layer was 
extracted with EtOAc (3 x 10 ml).The combined organic extracts were dried over Na2SO4, 
filtered and concentrated under reduced pressure. The residue was purified by flash 
chromatography [hexanes:EtOAc (7:3)] to afford ynamide 253 as a light yellow oil (315 mg, 
86%): νmax (neat)/cm-1= 3101, 2987, 2929, 2835, 2258, 1593, 1489, 1360, 1159, 1097, 959, 
734, 692; 1H-NMR (300 MHz; CDCl3): δH= 7.54-7.48 (m, 2H), 7.44-7.30 (m, 3H), 4.19 (d, J 2.4, 
2H), 3.68 (t, J 6.9, 2H), 3.08 (s, 3H), 2.66 (t, J 6.9, 2H), 2.44 (t, J 2.4, 1H); 13C-NMR (101 MHz; 
CDCl3): δc= 138.9, 129.3 (2C), 128.1, 125.4 (2C), 79.5, 74.6, 74.2, 68.1, 67.7, 58.1, 36.3, 19.8; 
HRMS m/z (TOF MS EI+): calculated for C15H15NO3NaS: 300.0670, found 300.0674 [M+Na]. 
(E) and (Z)-N-(methylsulfonyl)-N-phenyl-4-(prop-2-yn-1-yloxy)but-2-enamide (254) 
 
Following GP4A using ynamide 253 (83 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (3:2)] enimide 254 was afforded in combined yield of 53% [E:Z (7.5:1)]. 
Following GP4B using ynamide 112 (83 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (3:2)] enimide 113 was afforded in combined yield of 40% [E:Z (2.8:1)]; 
enimide (E)-113, light yellow oil: νmax (neat)/cm-1= 3279, 2937, 2861, 1644, 1686, 1644, 1489, 
1348, 1151, 960, 765, 649; 1H-NMR (300 MHz; CDCl3): δH= 7.51-7.44 (m, 3H), 7.31-7.24 (m, 
2H), 7.08 (dt, J 15.3 and 4.2, 1H), 5.79 (dt, J 15.3 and 2.1, 1H), 4.12 (dd, J 4.2 and 2.1, 2H), 
4.02 (d, J 2.4, 2H), 3.46 (s, 3H), 2.39 (t, J 2.4, 1H); 13C-NMR (101 MHz; CDCl3): δc= 165.8, 
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145.6, 135.0, 130.0 (2C), 130.0 (2C), 129.9, 120.8, 78.7, 75.1, 68.0, 57.8, 41.8; HRMS m/z 
(TOF MS ES+): calculated for C14H15NO4NaS: 316.0619, found 316.0617 [M+Na]; enimide (Z)-
113, light yellow oil: 1H-NMR (300 MHz; CDCl3): δH= 7.52 -7.46 (m, 3H), 7.32 -7.27 (m, 2H), 6.31 
(dt, J 11.7 and 4.6, 1H), 5.53 (dt, J 11.7 and 2.5, 1H), 4.72 (dd, J 4.6 and 2.5, 2H), 4.18 (d, J 
2.4, 2H), 3.48 (s, 3H), 2.46 (t, J 2.4, 1H); 13C-NMR (101 MHz; CDCl3): δc= 195.5, 164.7, 
carbamate CO not observed, 148.2, 120.3, 62.0, 42.5, 30.6, 29.6, 28.1; HRMS m/z (TOF MS 
ES+): calculated for C14H15NO4NaS: 316.0619, found 316.0609 [M+Na]. 
(E) and (Z)- 3-(Hex-2-enoyl)oxazolidin-2-one (258) 
 
Following GP4A using ynamide 242 (35 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (7:3)] enimide 258 was afforded in combined yield of 63% [E:Z (3.2:1)]. 
Following GP4B using ynamide 242 (35 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (7:3)] enimide 258 was afforded in combined yield of 63% [E:Z (5.0:1)]; 
enimide (E)-258, light-yellow oil: νmax (neat)/cm-1= 2961, 2930, 2874, 1769, 1680, 1633, 1384, 
1357, 1197, 1101, 1031, 968, 757, 704; 1H-NMR (300 MHz; CDCl3): δH= 7.22-7.09 (m, 2H), 4.41 
(t, J 8.1, 2H), 4.06 (t, J 8.1, 2H), 2.25 (appsext, J 7.2 and 7.2, 2H), 1.51 (qt, J 7.4 and 7.4, 2H), 
0.93 (t, J 7.4, 3H); 13C-NMR (101 MHz; CDCl3): δc= 165.3, 153.5, 151.5, 120.1, 62.0, 42.7, 34.6, 
21.3, 13.7; HRMS m/z (TOF MS EI+): calculated for C9H13NO3: 183.0895, found 183.0899 [M]; 
enimide (Z)-258, light-yellow oil: νmax (neat)/cm-1= 2961, 2928, 2873, 1767, 1679, 1384, 1361, 
1284, 1261, 1198, 1122, 1002, 1039, 1023, 952, 796, 758, 717; 1H-NMR (300 MHz; CDCl3): δH= 
7.00 (dt, J 11.6 and 1.7, 1H), 6.37 (dt, J 11.6 and 7.4, 1H), 4.41 (t, J 8.4, 2H), 4.06 (t, J 8.4, 2H), 
2.61 (tdd, J 7.4, 7.4 and 1.7, 2H), 1.49 (qt, J 7.4 and 7.4, 2H), 0.95 (t, J 7.4, 3H); 13C-NMR (101 
MHz; CDCl3): δc= 165.0, 153.3, 152.2, 118.7, 61.9, 42.5, 31.9, 22.2, 13.8; HRMS m/z (TOF MS 
EI+): calculated for C9H13NO3: 183.0895, found 183.0892 [M]. 
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3-(2-Cyclohexylideneacetyl)oxazolidin-2-one (259) 
 
Following GP4A using ynamide 249 (58 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (7:3)] enimide 259 was afforded in yield of 81%. Following GP4B using 
ynamide 249 (58 mg) for 20 h. After purification by flash chromatography [hexanes:EtOAc (7:3)] 
enimide 259 was afforded in yield of 81%; enimide 259, colourless oil: νmax (neat)/cm-1= 2926, 
2852, 1756, 1666, 1621, 1390, 1621, 1390, 1368, 1281, 1258, 1222, 1188, 1111, 1045, 967, 
854, 756, 708; 1H-NMR (300 MHz; CDCl3): δH=  6.78 (s, 1H), 4.37 (t, J 7.7, 2H), 4.01 (t, J 7.7, 
2H), 2.77 (t, J 5.2, 2H), 2.26 (t, J 5.2, 2H), 1.71-1.54 (m, 6H); 13C-NMR (101 MHz; CDCl3): δc= 
165.8, 165.3, 153.3, 112.4, 61.7, 42.6, 38.3, 30.7, 28.6, 27.8, 26.1; HRMS m/z (TOF MS EI+): 
calculated for C11H15NO3: 209.1052, found 209.1051 [M]. 
(E) and (Z)-3-(4-(Benzyloxy)but-2-enoyl)oxazolidin-2-one (260) 
 
Following GP4A using ynamide 246 (74 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (1:1)] enimide 260 was afforded in combined yield of 73% [E:Z (2.8:1)]. 
Following GP4B using ynamide 246 (74 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (1:1)] enimide 260 was afforded in combined yield of 68% [E:Z (3.1:1)]; 
enimide (E)-260, light-yellow solid: mp: 81-83 ºC; νmax (neat)/cm-1= 3061, 3024, 2924, 2873, 
2852, 1762, 1672, 1633, 1424, 1368, 1356, 1275, 1115, 1020, 958, 800, 759, 729, 693; 1H-
NMR (300 MHz; CDCl3): δH= 7.51 (dt, J 15.5 and 1.9, 1H), 7.40-7.23 (m, 5H), 7.15 (dt, J 15.5 
and 4.4, 1H), 4.57 (s, 2H), 4.40 (t, J 7.5, 2H), 4.23 (dd, J 4.4 and 1.9, 2H), 4.05 (t, J 7.5, 2H); 
13C-NMR (101 MHz; CDCl3): δc=  164.8, 153.3, 146.1, 137.6, 129.6, 128.4 (2C), 127.7 (2C), 
120.0, 72.7, 68.9, 62.0, 42.6; HRMS m/z (TOF MS ES+):calculated for C14H15NO4Na: 284.0899, 
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found 284.0895 [M+Na]; enimide (Z)-260, waxy white solid: mp: 90-91 ºC; νmax (neat)/cm-1= 
3061, 3024, 2921, 2874, 1762, 1672, 1634, 1424, 1387, 1356, 1276, 1213, 1117, 1102, 958, 
799, 759, 728, 711, 693; 1H-NMR (300 MHz; CDCl3): δH= 7.38-7.27 (m, 5H), 7.16 (dt, J 11.8 and 
2.5, 1H), 6.60 (dt, J 11.8 and 4.6, 1H), 4.63 (dd, J 4.6 and 2.5, 2H), 4.56 (s, 2H), 4.41 (t, J 7.9, 
2H), 4.03 (t, J 7.9, 2H): 13C-NMR (101 MHz; CDCl3): δc=  164.7, 153.2, 150.5, 137.9, 129.7, 
128.5 (2C), 127.8 (2C), 117.9, 72.9, 69.4, 61.9, 42.4; HR-MS (ES-TOF): m/z: calculated for 
C14H15NO4Na: 284.0899, found 284.0890 [M+Na].  
(E) and (Z)-3-(6-Chlorohex-2-enoyl)oxazolidin-2-one (261) 
 
Following GP4A using ynamide 244 (60 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (13:7)] enimide 261 was afforded in combined yield of 63% [E:Z (2.9:1)]. 
Following GP4B using ynamide 244 (60 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (13:7)] enimide 261 was afforded in combined yield of 65% [E:Z (4.0:1)]; 
enimide (E)-261, light-yellow oil: νmax (neat)/cm-1= 2960, 2920, 2850, 1767, 1677, 1627, 1423, 
1384, 1361, 1284, 1216, 1195, 1111, 1038, 797, 757, 716; 1H-NMR (300 MHz; CDCl3): δH= 7.26 
(dt, J 15.2 and 1.4, 1H), 7.10 (dt, J 15.2 and 6.6, 1H), 4.42 (t, J 8.1, 2H), 4.05 (t, J 8.1, 2H), 3.55 
(t, J 6.5, 2H), 2.44 (dtd, J 6.6, 6.5 and 1.4, 2H), 1.96 (tt, J 6.5 and 6.5, 2H); 13C-NMR (101 MHz; 
CDCl3): δc= 164.9, 153.4, 149.0, 121.0, 62.0, 43.9, 42.6, 30.7, 29.7; HRMS m/z (TOF MS ES+): 
calculated for C9H12NO3NaCl: 240.0403, found 240.0400 [M+Na]; enimide (Z)-261, light-yellow 
oil: νmax (neat)/cm-1= 2991, 2961, 2923, 2871, 1767, 1679, 1634, 1385, 1359, 1277, 1217, 1110, 
1037, 977, 757, 705; 1H-NMR (300 MHz; CDCl3): δH= 7.06 (dt, J 11.6 and 1.7, 1H), 6.33 (dt, J 
11.6 and 7.5, 1H), 4.43 (t, J 8.1, 2H), 4.06 (t, J 8.1, 2H), 3.57 (t, J 6.7, 2H), 2.78 (dtd, J 7.5, 7.1 
and 1.7, 2H), 1.96 (tt, J 7.1 and 6.7, 2H); 13C-NMR (101 MHz; CDCl3): δc= 164.9, Carbamate 
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CO not observed, 149.3, 120.0, 62.0, 44.3, 42.5, 31.8, 27.2; HRMS m/z (TOF MS ES+): 
calculated for C9H12NO3NaCl: 240.0403, found 240.0410 [M+Na]. 
(E) and (Z)-2-(5-Oxo-5-(2-oxooxazolidin-3-yl)pent-3-en-1-yl)isoindoline-1,3-dione (262) 
 
Following GP4A using ynamide 245 (89 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (11:9)] enimide 262 was afforded in combined yield of 68% [E:Z (5.6:1)]. 
Following GP4B using ynamide 245 (89 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (7:3)] enimide 262 was afforded in combined yield of 75% [E:Z (6.7:1)]; 
enimide (E)-262, white solid: mp: 146-149 ºC; νmax (neat)/cm-1= 3090, 2923, 2959, 2984, 2852, 
1771, 1705, 1680, 1398, 1680, 1357, 1337, 1193, 1147, 957, 761, 721, 705; 1H-NMR (300 MHz; 
CDCl3): δH= 7.85-7.80 (m, 2H), 7.73-7.68 (m, 2H), 7.26 (dt, J 15.4 and 1.5, 1H), 7.07 (dt, J 15.4 
and 7.0, 1H), 4.39 (t, J 8.0, 2H), 4.03 (t, J 8.0, 2H), 3.84 (t, J 7.0, 2H), 2.66 (tdd, J 7.0, 7.0 and 
1.5); 13C-NMR (101 MHz; CDCl3): δc= 168.0 (2C), 164.6, 153.3, 146.1, 133.9 (2C), 131.9 (2C), 
123.3 (2C), 122.1, 62.0, 42.6, 36.3, 31.6; HRMS m/z (TOF MS ES+): calculated for 
C16H14N2O4Na: 337.0800, found 337.0808 [M+Na]; enimide (Z)-262, white solid: mp: 136-138 
ºC; νmax (neat)/cm-1= 2991, 2926, 2856, 170, 1706, 1680, 1437, 1392, 1360, 1291, 1210, 1041, 
1018, 720; 1H-NMR (300 MHz; CDCl3): δH= 7.86-7.82 (m, 2H), 7.73-7.69 (m, 2H), 7.06 (td, J 
11.6 and 1.7, 1H), 6.36 (td, J 11.6 and 7.5, 1H), 4.37 (t, J 8.0, 2H), 3.99 (t, J 8.0, 2H), 3.87 (t, J 
7.5, 2H), 3.02 (tdd, J 7.5, 7.5 and 1.7, 2H); 13C-NMR (101 MHz; CDCl3): δc= 168.3 (2C), 164.6, 
153.2, 146.0, 133.9 (2C), 132.1 (2C), 123.2 (2C), 121.4, 61.9, 42.4, 36.8, 29.1; HRMS m/z (TOF 
MS ES+): calculated for C16H14N2O4Na: 337.0800, found 337.0806 [M+Na]. 
 
 
 146 
(E) and (Z)-S-(5-Oxo-5-(2-oxooxazolidin-3-yl)pent-3-en-1-yl) ethanethioate (263) 
 
Following GP4A using ynamide 248 (68 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (3:2)] enimide 263 was afforded in combined yield of 75% [E:Z (2.6:1)]. 
Following GP4B using ynamide 248 (68 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (3:2)] enimide 263 was afforded in combined yield of 71% [E:Z (7.7:1)]; 
enimide (E)-263, colourless oil: νmax (neat)/cm-1= 2982, 2925, 2859, 1768, 1679, 1634, 1385, 
1356, 1218, 1133, 1108, 1037, 954, 757, 705; 1H-NMR (300 MHz; CDCl3): δH= 7.25 (dt, J 15.4 
and 1.4, 1H), 7.05 (dt, J 15.4 and 7.0, 1H), 4.41 (t, J 7.9, 2H), 4.05 (t, J 7.9, 2H), 2.99 (t, J 7.0, 
2H), 2.54 (tdd, J 7.0, 7.0 and 1.4), 2.31 (s, 3H); 13C-NMR (101 MHz; CDCl3): δc= 195.2, 164.7, 
153.4, 147.7, 121.4, 62.0, 42.6, 32.3, 30.5, 27.3; HRMS m/z (TOF MS ES+): calculated for 
C10H13NO4NaS: 266.0463, found 266.0468 [M+Na]; enimide (Z)-263, colourless oil: νmax 
(neat)/cm-1= 2989, 2924, 2854, 1769, 1679, 1627, 1422, 1384, 1360, 1285, 1219, 1196, 1040, 
1012, 955, 797, 757, 701; 1H-NMR (300 MHz; CDCl3): δH=  7.09 (dt, J 11.6 and 1.7, 1H), 6.32 
(dt, J 11.6 and 7.1, 1H), 4.42 (t, J 8.0, 2H), 4.05 (t, J 8.0, 2H), 3.05-3.00 (m, 2H), 2.95-2.88 (m, 
2H), 2.33 (s, 3H); 13C-NMR (101 MHz; CDCl3): δc= 195.5, 164.7, carbamate CO not observed, 
148.2, 120.3, 62.0, 42.5, 30.6, 29.6, 28.1; HRMS m/z (TOF MS ES+): calculated for 
C10H13NO4NaS: 266.0463, found 266.0464 [M+Na]. 
(E)-3-(3-Methoxyacryloyl)oxazolidin-2-one (264) 
 
Following GP4A using ynamide 243 (46 mg) for 12 h. After purification by flash chromatography 
[hexanes:EtOAc (7:3)] enimide (E)-264 was afforded in 89% yield; enimide (E)-264, colourless 
oil: νmax (neat)/cm-1= 3124, 2985, 2924, 2850, 1761, 1672, 1594, 1386, 1358, 1197, 1169, 1036, 
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970, 928, 845, 821, 757, 704; 1H-NMR (300 MHz; CDCl3): δH= 7.81 (d, J 12.3, 1H), 6.69 (d, J 
12.3, 1H), 4.38 (t, J 8.7, 2H), 4.04 (t, J 8.7, 2H), 3.75 (s, 3H); 13C-NMR (101 MHz; CDCl3): δc= 
165.8, 164.9, 153.7, 95.4, 61.8, 57.6, 42.6; HRMS m/z (TOF MS EI+): calculated for C7H9NO4: 
171.0532, found 171.0526 [M]. 
A NOE contact is evident between the vinylic proton at 7.81 ppm and the methyl protons at 3.75 
ppm. No NOE contacts were observed between the vinylic protons or between the 
vinylicprotons at 6.69 and the methyl protons at 3.75 ppm. This confirms the stereochemistry 
assigned. 
(E) and (Z)-3-(4-((tert-Butyldimethylsilyl)oxy)but-2-enoyl)oxazolidin-2-one (265) 
 
Following GP4A using ynamide 247 (81 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (13:7)] enimide 265 was afforded in combined yield of 75% [E:Z (6.7:1)]; 
enimide (E)-265, light-yellow oil: νmax (neat)/cm-1= 2954, 2927, 2885, 2856, 1767, 1680, 1637, 
1359, 1393, 1217, 1107, 1035, 948, 829, 776, 755, 709, 682; 1H-NMR (300 MHz; CDCl3): δH= 
7.52 (dt, J 15.2 and 2.2, 1H), 7.19 (dt, J 15.2 and 3.4, 1H), 4.4  6-4.38 (m, 4H), 4.07 (t, J 8.0, 
2H), 0.94 (s, 9H), 0.10 (s, 6H); 13C-NMR (101 MHz; CDCl3): δc= 165.1, 153.3, 149.5, 118.4, 
62.9, 61.9, 42.6, 25.8 (3C), 18.2, -5.5 (2C); HRMS m/z (TOF MS EI+): calculated for 
C13H23NO4Si: 285.1396, found 285.1398 [M]; enimide (Z)-265, light-yellow oil: νmax (neat)/cm-1= 
2955, 2927, 2888, 2856, 1767, 1681, 1637, 1393, 1330, 1217, 1107, 1035, 948, 829, 776, 756, 
708, 682; 1H-NMR (300 MHz; CDCl3): δH= 7.10 (dt, J 11.8 and 2.5, 1H), 6.54 (dt, J 11.8 and 4.5, 
1H), 4.75 (dd, J 4.5 and 2.5, 2H), 4.42 (t, J 8.0, 2H), 4.05 (t, J 8.0, 2H), 0.90 (s, 9H), 0.07 (s, 
6H); 13C-NMR (101 MHz; CDCl3): δc= Carbamate CO not observed, 164.7, 155.1, 116.3, 62.7, 
61.9, 42.4, 25.9 (3C), -5.3 (2C), tbutyl quaternary carbon not observed; HRMS m/z (TOF MS 
EI+): calculated for C13H23NO4Si: 285.1396, found 285.1392 [M]. 
 148 
(S)-4-benzyl-3-(3-methoxyprop-1-yn-1-yl)oxazolidin-2-one (269) 
 
Following GP2 using amide (S)-4-benzyloxazolidin-2-one 267 (1.77 g) and 3-methoxyprop-1-
yne 268 (0.17 mL, 2 mmol). After purification by flash chromatography [hexanes:EtOAc (11:9 
then 2:3)] ynamide 269 was isolated as a light-yellow oil (289 mg, 59%) and unreacted (S)-4-
benzyloxazolidin-2-one (1.45 g) was recovered; ynamide 269: νmax (neat)/cm-1= 2930, 2821, 
2257, 1765, 1453, 1413, 1352, 1209, 1182, 1110, 1090, 1029, 895, 733, 701; 1H-NMR (300 
MHz; CDCl3): δH= 7.38-7.28 (m, 3H), 7.24-7.18 (m, 2H), 4.38-4.22 (m, 4H), 4.16-4.10 (m, 1H), 
3.41 (s, 3H), 3.24 (dd, J 13.8 and 3.8, 1H), 2.93 (dd, J 13.8 and 8.2, 1H); 13C-NMR (101 MHz; 
CDCl3): δc= 155.7, 134.1, 129.3 (2C), 129.0 (2C), 127.5, 75.3, 69.8, 67.4, 59.9, 58.1, 57.4, 37.9 
HRMS m/z (TOF MS ES+): calculated for C14H15NO3Na: 268.0950, found 268.0949 [M+Na]. 
(4S)-4-Benzyl-3-(3-cyclohexyl-3-methoxyprop-1-yn-1-yl)oxazolidin-2-one (270) 
 
Following GP2 using amide (S)-4-benzyloxazolidin-2-one 267 (1.77 g) and (1-methoxyprop-2-
yn-1-yl)cyclohexane 218 (304 mg, 2 mmol). After purification by flash chromatography 
[hexanes:EtOAc (3:2)] unreacted (S)-4-benzyloxazolidin-2-one (1.37 g) was recovered along 
with ynamide 270 was isolated as a white solid (365 mg, 56%, dr ~1:1); mp: 73-74 ºC; νmax 
(neat)/cm-1= 2982, 2924, 2853, 2820, 2253, 1769, 1451, 1410, 1179, 1102, 1083, 750, 737, 
701; 1H-NMR (300 MHz; CDCl3): Both diastereoisomers δH= 7.39-7.27 (m, 6H), 7.71-7.24 (m, 
4H), 4.37-4.21 (m, 4H), 4.17-4.09 (m, 2H), 3.95 (d, J 6.2, 1H), 3.94 (d, J 6.2, 1H), 3.43 (s, 3H), 
3.42 (s, 3H), 3.23 (dd, J 13.7 and 2.7, 2H), 2.95 (dd, J 13.7 and 8.1, 2H), 1.92-1.62 (m, 12H), 
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1.34-1.06 (m, 10H); 13C-NMR (101 MHz; CDCl3): Both diastereoisomers δc= 155.6 (2C), 134.1, 
134.1, 129.3 (4C), 129.0 (2C), 129.0 (2C), 127.5, 127.4, 76.4, 76.4, 75.4, 75.3, 71.3, 71.2, 67.3, 
67.2, 58.2, 58.2, 56.6, 56.6, 42.6, 42.6, 37.8, 37.7, 29.1, 29.0, 28.5 (2C), 26.4 (2C), 25.9 (4C); 
HRMS m/z (TOF MS ES+): calculated for C20H25NO3Na: 350.1732, found 350.1720 [M+Na]. 
(E) and (Z)-(S)-4-Benzyl-3-(3-methoxyacryloyl)oxazolidin-2-one (271) 
 
Following GP4A using ynamide 269 (74 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (1:1)] 271 was afforded in combined yield of 81% [E:Z (1.5:1)]. Following GP4B 
using ynamide 269 (74 mg) for 20 h. After purification by flash chromatography [hexanes:EtOAc 
(1:1)] 271 was afforded in combined yield of 91% [E:Z (1.9:1)]; enimide (E)-271, white solid: mp: 
117-119 ºC; νmax (neat)/cm-1= 3066, 3034, 2997, 2939, 2867, 1767, 1669, 1606, 1387, 1347, 
1309, 1206, 1171, 1107, 1076, 1019, 978, 798, 753, 702; 1H-NMR (300 MHz; CDCl3): δH= 7.91 
(d, J 12.4, 1H), 7.40-7.21 (m, 5H), 6.77 (d, J 12.4, 1H), 4.81-4.71 (m, 1H), 4.26-4.14 (m, 2H), 
3.81 (s, 3H), 3.34 (dd, J 13.4 and 3.3, 1H), 2.82 (dd, J 13.4 and 9.5, 1H); 13C-NMR (101 MHz; 
CDCl3): δc= 162.8, 162.6, 153.4, 135.6, 129.4 (2C), 128.8 (2C), 127.1, 95.1, 65.8, 63.1, 55.2, 
38.0; HRMS m/z (TOF MS EI+): calculated for C14H15NO4: 261.1001, found 261.1008 [M]; (Z)-
271, colourless oil: νmax (neat)/cm-1= 3063, 3029, 2981, 2940, 1769, 1677, 1599, 1388, 1355, 
1202, 1171, 1054, 823, 811, 730, 699; 1H-NMR (300 MHz; CDCl3): δH= 7.41-7.24 (m, 5H), 6.69 
(d, J 7.1, 1H), 6.43 (d, J 7.1, 1H), 4.79-4.70 (m, 1H), 4.24-4.14 (m, 2H), 4.02 (s, 3H), 3.42 (dd, J 
13.2 and 3.0, 1H), 2.79 (dd, J 13.2 and 9.8, 1H); 13C-NMR (101 MHz; CDCl3): δc= 165.6, 165.2, 
153.6, 135.5, 129.4 (2C), 128.9 (2C), 127.2, 95.8, 65.9, 57.7, 55.2, 38.0; HRMS m/z (TOF MS 
EI+): calculated for C14H15NO4: 261.1001, found 261.0998 [M]. 
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(E) and (Z)-(S)-4-Benzyl-3-(3-cyclohexyl-3-methoxyacryloyl)oxazolidin-2-one (272) 
 
Following GP4A using ynamide 270 (98 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (4:1)] 272 was afforded in combined yield of 79% [E:Z (10.9:1)]. Following 
GP4B using ynamide 270 (98 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (4:1)] 272 was afforded in combined yield of 88% [E:Z (1:6.1)]; (E)-272, 
colourless oil: νmax (neat)/cm-1= 2926, 2853, 1764, 1673, 1588, 1384, 1347, 1286, 1196, 1170, 
1069, 1037, 822, 810, 728, 699; 1H-NMR (300 MHz; CDCl3): δH= 7.32-7.17 (m, 5H), 6.43 (s, 
1H), 4.77-4.66 (m, 1H), 4.14-4.02 (m, 2H), 3.74-3.58 (m, 1H), 3.67 (s, 3H) 3.31 (dd, J 13.4 and 
3.4, 1H), 2.74 (dd, J 13.4 and 9.6, 1H), 1.81-1.59 (m, 5H), 1.53-1.06 (m, 5H); 13C-NMR (101 
MHz; CDCl3): δc= 182.8, 164.8, 153.8, 135.7, 129.5 (2C), 128.8 (2C), 127.1, 89.2, 65.5, 55.9, 
55.2, 40.6, 38.2, 29.8, 29.5, 26.1, 26.0, 25.9; HRMS m/z (TOF MS ES+): calculated for 
C20H25NO4Na: 366.1681, found 366.1672 [M+Na]; (Z)-272, colourless oil: νmax (neat)/cm-1= 
2930, 2855, 1768, 1668, 1600, 1451, 1385, 1347, 1246, 1194, 1077, 1006, 826, 735, 732, 700; 
1H-NMR (300 MHz; CDCl3): δH= 7.32-7.16 (m, 5H), 6.29 (s, 1H), 4.71-4.61 (m, 1H), 4.14-4.00 
(m, 2H), 3.89 (s, 3H), 3.32 (dd, J 13.3 and 3.2, 1H), 2.70 (dd, J 13.3 and 9.8, 1H), 2.30-2.16 (m, 
1H), 1.96-1.60 (m, 5H), 1.42-1.09 (m, 5H); 13C-NMR (101 MHz; CDCl3): δc= 179.7, 163.2, 153.6, 
135.7, 129.4 (2C), 128.8 (2C), 127.1, 93.2, 65.6, 58.8, 55.2, 43.1, 38.1, 31.2, 31.2, 26.1 (2C), 
25.8; HRMS m/z (TOF MS ES+): calculated for C20H25NO4Na: 366.1681, found 366.1688 
[M+Na]. 
(E)-272: a NOE contact is evident between the vinylic proton at 6.43 ppm and the methyl 
protons at 3.67 ppm. No NOE contacts were observed between the vinylic proton and the 
proton at 1.82-3.67 ppm, or between the vinylic proton and the methylene protons at 1.81-1.59 
ppm or 1.53-1.06 ppm. This confirms the stereochemistry assigned. 
 
 151 
1-Cyclohexyl-3-ethoxyprop-2-yn-1-ol (287) 
 
To a solution of ethoxyacetylene (40% w/w h  exanes, 1.05 mL, 4.4 mmol)) in dry THF (15 mL) 
at -78 °C under argon atmosphere was added n-BuLi (2.5 M in hexane, 1.8 mL, 4.4 mmol). After 
stirring for 30 min at -78 °C, the reaction was added of cyclohexyl aldehyde 216 (0.54 mL, 4.4 
mmol) and kept stirring for additional 30 min. The reaction mixture was allowed to warm up to 
room temperature and quenched with a saturated solution of ammonium chloride (15 mL). The 
aqueous layer was separated and extracted with EtOAc (3 x 10 ml). The combined organic 
extracts were dried over Na2SO4, filtered and concentrated under reduced pressure. After 
evaporation of the solvent, the crude mixture was purified by flash chromatography 
[hexanes:EtOAc (4:1)] to give alcohol 287 (621 mg, 84%) as a colourless liquid: νmax (neat)/cm-
1= 3461, 2926, 2853, 2262, 2225, 1731, 1654, 1226, 1449, 1177, 1093, 994; 1H-NMR (300 
MHz; CDCl3): δH= 4.18 (t, J 5.6, 1H), 4.09 (q, J 7.1, 2H), 1.91 -1.41 (m, 6H), 1.37 (t, J 7.1, 3H), 
1.33 -0.95 (m, 6H); 13C-NMR (101 MHz; CDCl3): δc= 94.4, 74.6, 67.1, 44.7, 38.4, 28.7, 28.1, 
26.5, 25.9 (2C), 14.4; HRMS m/z (TOF MS EI+): calculated for C11H18O2: 182.1307, found: 
182.1309 [M]. 
Data were in agreement with those reported in the literature.121 
(3-Ethoxy-1-methoxyprop-2-yn-1-yl)cyclohexane (288) 
 
Following GP5 using iodomethane (74 µL). After purification by flash chromatography 
[hexanes:EtOAc (19:1)] to give ynol ether 288 as a light-yellow oil (182 mg, 93%): νmax 
(neat)/cm-1= 2928, 2854, 2259, 1734, 1449, 1373, 1274, 1170, 1135, 1108, 1085, 1040, 999, 
OH
EtO
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955, 886, 841, 757 1H-NMR (300 MHz; CDCl3): δH= 4.10 (q, J 7.1, 2H), 3.74 (d, J 5.9, 1H), 3.66 
(s, 3H), 1.88-1.48 (m, 5H), 1.38 (t, J 7.1, 3H), 1.31-1.00 (m, 6H); 13C-NMR (101 MHz; CDCl3): 
δc= 95.1, 76.3, 74.5, 56.2, 43.1, 35.7, 29.1, 28.4, 26.5, 26.0, 26.0, 14.4; HRMS m/z (TOF MS 
EI+): calculated for C12H20O2: 196.1463, found 196.1460 [M]. 
(((1-Cyclohexyl-3-ethoxyprop-2-yn-1-yl)oxy)methyl)benzene (289) 
 
Following GP5 using benzyl bromide (0.15 mL,) and a catalytic amount of n-
tetrabutylammonium iodide (36.9 mg, 0.1 mmol). After purification by flash chromatography 
[hexanes:EtOAc (19:1)] gave ynol ether 289 as a colourless oil (248 mg, 91%): νmax (neat)/cm-1= 
2925, 2852, 2258, 1182, 1164, 1451, 1243, 1101, 1085, 996, 1027, 996, 842, 734, 696; 1H-
NMR (300 MHz; CDCl3): δH= 7.39-7.23 (m, 5H), 4.77 (d, J 12.0, 1H), 4.47 (d, J 12.0, 1H), 4.11 
(q, J 7.1, 2H), 3.99 (d, J 6.2, 1H), 1.92-1.56 (m, 5H), 1.40 (t, J 7.1, 3H), 1.34-0.90 (m, 6H); 13C-
NMR (101 MHz; CDCl3): δc= 138.8, 128.2 (2C), 127.8 (2C), 127.3, 95.1, 74.5, 73.6, 70.0, 43.3, 
36.1, 29.2, 28.7, 26.6, 26.0 (2C), 14.4; HRMS m/z (TOF MS ES+) calculated for C18H24NO2Na: 
295.1674, found 295.1670 [M+Na];  
(E)-(5-Ethoxypent-1-en-4-yn-1-yl)benzene (290) 
 
To a solution of ethoxyacetilene (40% in hexanes, 0.72 mL, 3 mmol) in dry THF (1.9 mL, 1.6 M) 
at -78 °C was added n-butyl lithium (2.5 M in hexane, 1.26 mL, 3.15 mmol). After stirring for 30 
min at -78 °C, cynnamyl bromide (650 mg, 3.3 mmol) and a catalytic amount of copper bromide 
(24 mg, 0.17 mmol) were added and the mixture was stirred at 50 °C for 5 h. The reaction was 
quenched with EtOAc (5 mL) and the organic mixture was quickly washed with water (10 mL). 
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The organic phase was dried over Na2SO4, filtered and concentrated under reduced pressure. 
The residue was purified by flash chromatography [hexanes:toluene (9:1)] gave ynol ether 8 as 
a colourless oil (492mg, 44%): νmax (neat)/cm-1= 3038, 3060, 3028, 2982, 2899, 2270, 1495, 
1448, 1221, 1011, 963, 868, 844, 750, 729, 691; 1H-NMR (300 MHz; CDCl3): δH= 7.33-7.14 (m, 
5H), 6.58 (dt, J 15.7 and 1.8, 1H), 6.15 (dt, J 15.7 and 5.5, 1H), 4.05 (q, J 7.1, 2H), 3.04 (dd, J 
5.5 and 1.9), 1.35 (t, J 7.1, 3H); 13C-NMR (101 MHz; CDCl3): δc= 137.4, 130.3, 128.5 (2C), 
127.1, 126.3, 126.2 (2C), 91.4, 74.1, 34.3, 20.9, 14.4; HRMS m/z (TOF MS EI+): calculated for 
C13H14NO: 186.1045, found 186.1053 [M]. 
(E)-Ethyl 3-cyclohexyl-3-methoxyacrylate (291) 
 
Following GP4A using ynol ether 288 (59 mg) for 20 h. After purification by flash 
chromatography [hexanes:EtOAc (24:1)] ester (E)-291 was afforded in yield of 77%. Following 
GP4B using ynol ethers 288 (59 mg) for 20 h. After purification by flash chromatography 
[hexanes:EtOAc (24:1)] ester 291 was afforded in yield of 72% [E:Z (3.9:1)]; ester (E)-291, 
colourless oil: νmax (neat)/cm-1= 2927, 2853, 1705, 1612, 1449, 1381, 1276, 1231, 1133, 1065, 
1042, 821; 1H-NMR (300 MHz; CDCl3): δH= 4.99 (s, 1H), 4.12 (q, J 7.1, 2H), 3.88 (s, 3H), 2.19-
2.06 (m, 1H), 1.89-1.63 (m, 4H), 1.33-1.15 (m, 6H), 1.26 (t, J 7.1, 3H); 13C-NMR (101 MHz; 
CDCl3): δc= 176.7, 165.8, 94.4, 59.5, 59.4, 43.4, 31.1 (2C), 26.2 (2C), 26.0, 14.3; HRMS m/z 
(TOF MS EI+):calculated for C12H20O3: 212.1412, found 212.1408 [M]; ester (Z)-291, colourless 
oil: νmax (neat)/cm-1= 2927, 2854, 1707, 1611, 1449, 1381, 1277, 1232, 1131, 1065, 1042, 820; 
1H-NMR (300 MHz; CDCl3): δH= 4.88 (s, 1H), 4.12 (q, J 7.1, 2H), 3.72-3.56 (m, 1H), 3.59 (s, 3H), 
1.81-1.60 (m, 4H), 1.52-1.04 (m, 6H), 1.27 (t, J 7.1, 3H); 13C-NMR (101 MHz; CDCl3): δc= 180.1, 
167.6, 89.0, 59.2, 55.4, 39.5, 29.8 (2C), 26.2 (2C), 26.0, 14.4; HRMS m/z (TOF MS EI+): 
calculated for C12H20O3: 212.1412, found 212.1415 [M]. 
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Ethyl 3-(benzyloxy)-3-cyclohexylacrylate (292) 
 
Following GP4A using ynol ether 289 (82 mg) for 20 h. After purification by flash 
chromatography [hexanes:EtOAc (3:2)] ester 292 was afforded in combined yield of 89% [E:Z 
(2.8:1)]. Following GP4B using ynol ether 289 (82 mg) for 20 h. After purification by flash 
chromatography [hexanes:EtOAc (3:2)] ester 292 was afforded in combined yield of 85% [E:Z 
(5.1:1)]; ester (E)-292, colourless oil: νmax (neat)/cm-1= 2980, 2927, 2854, 1706, 1609, 1450, 
1377, 1276, 1229, 1130, 1058, 819, 733, 695; 1H-NMR (300 MHz; CDCl3): δH= 7.43-7.28 (m, 
5H), 5.01 (s, 1H), 4.81 (s, 2H), 4.12 (q, J 7.1, 2H), 3.74 (tt, J 11.5 and 3.0, 1H), 1.82-1.13 (m, 
13H); 13C-NMR (101 MHz; CDCl3): δc= 178.9, 167.5, 136.0, 128.5 (2C), 128.0, 127.1 (2C), 90.2, 
69.9, 59.2, 39.7, 29.9 (2C), 26.1 (2C), 25.9, 14.4; HRMS m/z (TOF MS ES+): calculated for 
C18H24O3Na: 311.1623, found 311.1634 [M+Na]. 
(E,E) and (E,Z)-ethyl 5-phenylpenta-2,4-dienoate (293) 
 
Following GP2A using ynol ether 290 (56 mg) for 20 min. After purification by flash 
chromatography [hexanes:EtOAc (24:1)] ester 293 was afforded in combined yield of 75% [E:Z 
(4.3:1)]. Following GP2B using ynol ether 290 (56 mg) for 1 h. After purification by flash 
chromatography [hexanes:EtOAc (24:1)] ester 293 was afforded in combined yield of 88% [E:Z 
(4.1:1)]; ester (E,E)-293, colourless oil: νmax (neat)/cm-1= 3059, 3027, 2981, 2935, 2904, 1703, 
1625, 1366, 1258, 1235, 1175, 1130, 1035, 996, 754, 713, 689; 1H-NMR (300 MHz; CDCl3): δH= 
7.50-7.28 (m, 6H), 6.90 (s, 1H), 6.88 (d, J 5.2, 1H), 5.98 (d, J 15.3, 1H), 4.23 (q, J 7.2, 2H), 1.32 
(t, J 7.2, 3H); 13C-NMR (101 MHz; CDCl3): δc= 167.0, 144.5, 140.3, 136.0, 129.0, 128.8 (2C), 
127.1 (2C), 126.2, 121.3, 60.3, 14.3; HRMS m/z (TOF MS EI+): calculated for C13H14O2: 
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202.0994, found 202.0986 [M]; ester (E,Z)-293, colourless oil: νmax (neat)/cm-1= 3063, 3027, 
2981, 2932, 2871, 1709, 1622, 1601, 1450, 1419, 1175, 1233, 1030, 999, 960, 755, 698; 1H-
NMR (300 MHz; CDCl3): δH= 8.15 (ddd, J 15.7, 11.4 and 0.9, 1H), 7.56-7.49 (m, 2H), 7.39-7.27 
(m, 3H), 6.82 (d, J 15.7, 1H), 6.74 (td, J 11.4 and 0.9, 1H), 5.72 (d, J 11.4, 1H), 4.23 (q, J 7.2, 
2H), 1.33 (t, J 7.2, 3H); 13C-NMR (101 MHz; CDCl3): δc= 166.6, 144.7, 141.1, 136.4, 128.9, 
128.7 (2C), 127.5 (2C), 125.0, 117.5, 60.0, 14.3; HRMS m/z (TOF MS EI+): calculated for 
C13H14O2: 202.0994, found 202.0988 [M]. 
Characterisation for chapter 3 
N-Benzoyliminopyridinium ylide (295) 
 
Following GP6 using N-aminopyridinium iodide 294 (444 mg, 2 mmol) and benzoyl chloride 
(0.46 mL, 4 mmol). After recrystallisation from dichloromethane-diethylether ylide 295 was 
isolated as a white solid (190 mg, 48%): mp:187-189 ºC; νmax (neat)/cm-1= 3098, 3064, 2944, 
1618, 1590, 1547, 1464, 1332, 1295, 1180, 904, 710; 1H-NMR (300 MHz; CDCl3): δH= 8.85-8.81 
(m, 2H), 8.18-8.13 (m, 2H), 7.97-7.91 (m, 1H), 7.73-7.66 (m, 2H), 7.46-7.38 (m, 3H); 13C-NMR 
(101 MHz; CDCl3): δc= 170.7, 143.3 (2C), 137.2, 136.6, 130.1, 128.0 (2C), 127.8 (2C), 125.9 
(2C); HRMS m/z (TOF MS EI+): calculated for C12H10N2O: 198.0793, found 198.0795 [M]. 
N-Benzyl-N-phenylethynyl-methanesulfonamide (296) 
N
Ms
Bn
Ph
 
Following GP2 using amide 212 (2.78 g, 15 mmol) and phenylacetylene 162 (0.33 mL, 3 mmol). 
After purification by flash chromatography [hexanes:toluene (4:1)] ynamide 296 was isolated as 
a light-yellow solid (624 mg, 73%): mp: 50-52 ºC; νmax (neat)/cm-1= 3056, 3036, 3008, 2926, 
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2235, 1498, 1457, 1349, 1156, 1121, 966, 944; 1H-NMR (300 MHz; CDCl3): δH= 7.60-7.15 
(stach, 10H), 4.68 (s, 2H), 2.90 (s, 3H); 13C-NMR (101 MHz; CDCl3): δc= 134.5, 131.3 (2C), 
129.0 (2C), 128.8 (2C), 128.7, 128.3 (2C), 128.0, 122.4, 82.0, 71.6, 55.9, 38.9; HRMS m/z (TOF 
MS ES+): calculated for C16H15NO2NaS: 308.0721, found 308.0729 [M+Na]. Spectroscopic data 
were identical to those reported in literature.122 
N-Benzyl-N-(2,5-diphenyl-oxazol-4-yl)-methanesulfonamide (297) 
N
O
Ph
N
Ph
Ms
Bn  
Following GP7 using ynamide 296 (28.5 mg, 0.1 mmol) and ylide 295 (29.7 mg, 0.15 mmol) for 
24 h. After purification by flash chromatography [hexanes:EtOAc (4:1)] oxazole 297 was 
isolated as a white solid (37.7 mg, 93%): mp: 156-158 ºC; νmax (neat)/cm-1= 3064, 3027, 3005, 
2929, 1620 1448, 1345, 1221, 1155, 1053, 1024, 958, 854, 757, 699, 686, 683; 1H-NMR (300 
MHz; CDCl3): δH= 8.13-8.04 (m, 2H), 7.81-7.74 (m, 2H), 7.55-7.49 (m, 3H), 7.39-7.24 (m, 5H), 
7.17-7.12 (m, 3H), 4.84 (s, 2H), 3.23 (s, 3H); 13C-NMR (101 MHz; CDCl3): δc= 158.3, 147.2, 
134.6, 132.7, 130.7, 129.4 (2C), 128.8 (2C), 128.8 (2C), 128.3 (2C), 128.2 (2C), 128.0, 127.0, 
126.5, 126.3 (2C), 125.5, 54.8, 38.5; HRMS m/z (TOF MS ES+):calculated for C23H20N2O3NaS: 
427.1092, found 427.1101 [M+Na]. 
N-2-Bromobenzoyliminopyridinium ylide (298) 
 
Following GP6 using N-aminopyridinium iodide 294 (444 mg, 2 mmol) and 2-bromobenzoyl 
chloride (0.55 mL, 4 mmol). After recrystallisation from dichloromethane-diethylether ylide 298 
was isolated as a white solid (290 mg, 53%): mp: 102-103 ºC; νmax (neat)/cm-1= 3107, 3056, 
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3027, 1582, 1558, 1464, 1344, 1251, 1168, 1020, 774, 748, 677; 1H-NMR (300 MHz; CDCl3): 
δH= 8.92-8.86 (m, 2H), 8.03-7.92 (m, 1H), 7.98-7.90 (m, 2H), 7.65-7.57 (m, 2H), 7.37-7.29 (m, 
1H), 7.24-7.16 (m, 1H); 13C-NMR (101 MHz; CDCl3): δc= 172.5, 143.1 (2C), 140.4, 137.4, 133.0, 
129.5, 129.2, 127.1, 126.2 (2C), 120.7; HRMS m/z (TOF MS ES+): calculated for 
C12H9N2O2NaBr: 298.9796, found 298.9783 [M+Na]. 
N-2-Furoyliminopyridinium ylide (299) 
 
Following GP6 using N-aminopyridinium iodide 294 (444 mg, 2 mmol) and 2-furoyl chloride 
(0.39 mL, 2 mmol). After recrystallisation from dichloromethane-diethylether ylide 299 was 
isolated as a white solid (135 mg, 36%): mp: 184-186 ºC; νmax (neat)/cm-1= 3105, 3057, 3029, 
2930, 2857, 1556, 1530, 1466, 1327, 1172, 1194, 1107, 1005, 754, 683, 622; 1H-NMR (300 
MHz; CDCl3): δH= 8.84 (d, J 6.7, 2H), 7.98-7.88 (m, 1H), 7.68 (t, J 7.0, 2H), 7.49 (br s, 1H), 7.07 
(d, J 3.3, 1H), 6.51-6.40 (m, 1H); 13C-NMR (101 MHz; CDCl3): δc= 163.6, 151.2, 143.4 (2C), 
143.2, 136.9, 126.0 (2C), 112.8, 111.1; HRMS m/z (TOF MS ES+): calculated for C10H8N2O2Na: 
211.0483, found 211.0484 [M+Na]. 
N-Methoxycarbonyliminopyridinium ylide (300) 
 
Following GP1 using N-aminopyridinium iodide 294 (444 mg, 2 mmol) and methyl chloroformate 
(0.31 mL, 4 mmol). After recrystallisation from dichloromethane-diethylether ylide 300 was 
isolated as a white solid (255 mg, 84%): mp: 92-94 ºC; νmax (neat)/cm-1= 3044, 3075, 3010, 
2941, 2912, 2822, 1629, 1597, 1480, 1464, 1434, 1285, 1191, 1065, 772, 682; 1H-NMR (300 
MHz; CDCl3): δH= 8.65-8.60 (m, 2H), 7.70-7.63 (m, 1H), 7.45 (t, J 7.2, 2H), 3.52 (s, 3H); 13C-
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NMR (101 MHz; CDCl3): δc= 163.6, 142.0 (2C), 135.1, 125.6 (2C), 51.3; HRMS m/z (TOF MS 
EI+): calculated for C7H8N2O2: 152.0586, found 152.0580 [M]. 
N-4-nitrobenzoyliminopyridinium ylide (301) 
 
Following GP1 using N-aminopyridinium iodide 294 (444 mg, 2 mmol) and methyl chloroformate 
(0.31 mL, 4 mmol). After recrystallisation from dichloromethane-diethylether ylide 301 was 
isolated as a white solid (255 mg, 84%): mp: 92-94 ºC; νmax (neat)/cm-1= 3112, 3075, 3048, 
2923, 2853, 1554, 1506, 1460, 1308, 870, 852, 772, 712, 674, ; 1H-NMR (300 MHz; CDCl3): δH= 
8.65-8.60 (m, 2H), 7.70-7.63 (m, 1H), 7.45 (t, J 7.2, 2H), 3.52 (s, 3H); 13C-NMR (101 MHz; 
CDCl3): δc= 163.6, 142.0 (2C), 135.1, 125.6 (2C), 51.3; HRMS m/z (TOF MS ES+): calculated 
for C12H9N3O3Na: 266.0542, found: 266.0549 [M+Na]. 
N-(4-methylbenzenesulfonyl)hydroxyethyl amide (303) 
 
A solution of the ethanolamine 302 (4.06 mL, 67.5 mmol) and thiethylamine (10.6 mL, 76.5 
mmol) in CH2Cl2 (100 mL) was added to a solution of 4-methylbenzene sulfonyl chloride (8.59 g, 
45 mmol) in 10 mL of CH2Cl2. After 1 h at reflux and 30 min at room temperature, the crude 
reaction was added to a saturated aqueous solution of NaHCO3 (150 mL). The organic phase 
was extracted with CH2Cl2 (3 × 70 mL) and the combined organic layers were washed with brine 
and dried over Na2SO4, filtered and concentrated to provide the crude product. After purification 
by re-crystallisation with CH2Cl2/Hexane amide 303 was isolated as a white solid (8.47 g, 88%): 
mp: 53-55 °C; 1H-NMR (300 MHz; CDCl3): δH= 7.75 (d, J 8.3, 2H), 7.31 (d, J 8.3, 2H), 5.25 (brs, 
TsHN
OH
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1H), 3.69 (q, J 5.4, 2H), 3.08 (q, J 10.4, 2H), 2.42 (s, 3H); 13C-NMR (101 MHz; CDCl3): δc= 
143.6, 136.6, 129.8 (2C), 127.1 (2C), 61.3, 45.2, 21.5. 
Data were in agreement with those reported in the literature.123 
N-(2-((tert-butyldimethylsilyl)oxy)ethyl)-4-methylbenzenesulfonamide (304) 
 
TBSCl (50% sol. in toluene, 13.4 mL, 38.5 mmol) was added to a solution of the 
ethanolsulfonylamine 303 (7.52 g, 35 mmol), triethylamine (15 mL, 115 mmol) and 
dimethylamino pyridine (213 mg, 5 mol%) in CH2Cl2 (170 mL) at 0 ºC. After 1 h at reflux and 30 
min at room temperature, the crude reaction was added to a saturated aqueous solution of 
ammonium chloride (150 mL). The organic phase was extracted with EtOAc (3 × 100 mL) and 
the combined organic layers were washed with brine and dried over Na2SO4, filtered and 
concentrated to provide the crude product. After purification by flash chromatography 
[hexanes:EtOAc (17:3)] silyl ether 304 was isolated as a light yellow liquid (9.29 g, 81%): νmax 
(neat)/cm-1= 3560, 3262, 2882, 2935, 1597, 1427, 1308, 1150, 1065, 950, 812, 660; 1H-NMR 
(300 MHz; CDCl3): δH= 7.74 (d, J 8.0, 2H), 7.30 (d, J 8.0, 2H), 4.79 (brs, 1H), 3.60 (t, J 5.6, 2H), 
3.02 (q, J 5.6, 2H), 2.42 (s, 3H), 0.83 (s, 9H), -0.02 (s, 6H); 13C-NMR (101 MHz; CDCl3): δc= 
143.3, 136.9, 129.6 (2C), 127.0 (2C), 61.2, 45.1, 25.7 (3C), 21.4, 18.1, -5.5 (2C). 
Data were in agreement with those reported in the literature.124 
4-methyl-N-phenylbenzenesulfonamide (306) 
 
A solution of aniline 143 (2.70 mL, 30 mmol,) and pyridine (15 mL, 30 mmol) in CH2Cl2 (50 mL) 
was added drop-wise to a solution of tosyl chloride (6.86 g, 36 mmol) in CH2Cl2 (10 mL) at 
reflux. After 2 h, the solution is left stirring overnight at room temperature. The reaction mixture 
was added to a saturated aqueous solution of NaHCO3 (50 mL). The organic phase was 
TsHN
OH
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extracted with CH2Cl2 (3 × 40 mL) and the combined organic layers were washed with water (50 
mL), brine (50 mL) and dried over Na2SO4. After purification of the solid by re-crystallisation with 
CH2Cl2/hexanes, sulfonylamide 306 was isolated as a white solid (7.20 g, 97%): mp: 102-104 
°C; νmax (neat)/cm-1= 3237, 3061, 2980, 2899, 1597, 1481, 1414, 1336, 1319, 1291, 1223, 1186, 
1031, 810, 753; 1H-NMR (300 MHz; CDCl3): δH= 7.67 (d, J 8.3, 2H), 7.26-7.20 (m, 4H), 7.12-
7.06 (m, 3H), 6.94 (s, 1H), 2.37 (s, 3H), 13C-NMR (101 MHz; CDCl3): δC= 143.9, 136.5, 136.1, 
129.7 (2C), 129.3 (2C), 127.3 (2C), 125.3, 121.6 (2C). 
Data were in agreement with those reported in the literature.125 
N-benzyl-4-methylbenzenesulfonamide (307) 
 
A solution of benzylamine 210 (2.74 mL, 30 mmol,) and pyridine (15 mL, 30 mmol) in CH2Cl2 
(50 mL) was added drop-wise to a solution of tosyl chloride (6.86, 36 mmol) in CH2Cl2 (10 mL) 
at reflux. After 2 h, the solution is left stirring overnight at room temperature. The reaction 
mixture was added to a saturated aqueous solution of NaHCO3 (50 mL). The organic phase 
was extracted with CH2Cl2 (3 × 40 mL) and the combined organic layers were washed with 
water (50 mL), brine (50 mL) and dried over Na2SO4. After purification of the solid by re-
crystallisation with CH2Cl2/hexanes, sulfonylamide 307 was isolated as a white solid (6.89 g, 
88%): mp: 113-115 °C; νmax (neat)/cm-1= 3361, 3284, 3033, 2925, 2872, 1599, 1456, 1330, 
1162; 1H-NMR (300 MHz; CDCl3): δH= 7.76 (d, J 8.4, 2H), 7.31-7.25 (m, 5H), 7.24-7.17 (m, 2H), 
4.57 (t, J 5.7, 1H), 4.13 (d, J 6.0, 2H), 2.43 (s, 3H); 13C-NMR (101 MHz; CDCl3): δC= 143.6, 
137.0, 136.4, 129.9 (2C), 128.8 (2C), 128.0 (2C), 128.0, 127.3 (2C), 47.4, 21.7. 
Data were in agreement with those reported in the literature.126 
 
 
 
 161 
2-Nitro-N-phenylbenzenesulfonamide (308) 
 
2-nitrobenzenesulfonyl chloride (3.32 g, 15 mmol) was added to a solution of aniline 143 (1.06 
mL, 18 mmol) and sodium acetate (1.72 g, 21) in 15 mL of 1:1 MeOH/water over 30 min. The 
mixture was heated at 60 °C for 1 h. The solution was cooled to room temperature and diluted 
with water (60 mL). The water solution was treated with HCl conc. (36% w/w) until pH = 2 was 
reached and filtered off. After purification of the solid by re-crystallisation with EtOAc/Hexane 
sulfonylamide 308 was isolated as a yellow solid (3.43 g, 68%): mp: 111-113 °C; νmax (neat)/cm-
1= 3319, 3100, 2892, 1538, 1496, 1403, 1358, 1168, 1126, 921, 854, 782, 741, 695, 656.; 1H-
NMR (300 MHz; CDCl3): δH= 7.85 (dd, J 8.1 and 1.4, 1H), 7.82 (dd, J 7.9 and 1.1, 1H), 7.69 (td, 
J 8.1 and 1.4, 1H), 7.57 (td, J 7.9 and 1.1 Hz, 1H), 7.31-7.23 (m, 3H), 7.22-7.13 (m, 3H); 13C-
NMR (101 MHz; CDCl3): δc= 148.2, 135.5, 133.9, 132.5, 132.2, 131.8, 129.4 (2C), 126.6, 125.3 
(2C), 123.3; HRMS m/z (TOF MS EI+): calculated for C14H10Br2: 337.9129, found: 337.9129, 
[M]. 
Data were in agreement with those reported in the literature.127 
tert-Butyl(pent-4-yn-1-yloxy)diphenylsilane (309) 
 
TBDPSCl (3.12 mL, 12 mmol) was added to a solution of 4-Pentyn-1-ol 229 (0.96 mL, 10 mmol) 
and 1-H-imidazole (680 mg, 10 mmol) in THF (15 mL) at room temperature and stirred 
overnight. The reaction mixture was filtered through a pad of celite and the organic solution was 
concentrated under reduced pressure. After evaporation of the solvent, the crude mixture was 
purified. The residue was purified by vacuum distillation (200 °C, 16 mmHg) and afforded the 
silyl ether 309 (2.19 g, 68%) as a colourless oil: νmax (neat)/cm-1= 3307, 3017, 2931, 2857, 
1589, 1472, 1361, 1104, 981, 822, 739, 699; 1H-NMR (300 MHz; CDCl3): δH= 7.70 -7.64 (m, 
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4H), 7.45 -7.35 (m, 6H), 3.75 (t, J 6.0, 2H), 2.35 (td, J 7.2, 2.7, 2H), 1.92 (t, J 2.7, 1H), 1.84 -
1.70 (m, 2H), 1.05 (s, 9 H); 13C-NMR (101 MHz; CDCl3): δc= 135.5 (2C), 133.8, 129.5, 127.6 
(2C), 84.2, 68.2, 62.2, 31.4, 26.8, 19.2, 14.9. 
Data were in agreement with those reported in the literature.128  
N-[2-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-N-phenylethynyl-methanesulfonamide (310) 
N
Ms
Ph
Ph
 
Following GP2 using amide 221 (2.57 g, 15 mmol) and phenylacetylene (0.33 mL, 3 mmol). 
After purification by flash chromatography [hexanes:EtOAc (4:1)] ynamide 310 was isolated as 
a white solid (601 mg, 74%): mp: 75-77 ºC; νmax (neat)/cm-1= 3078, 3009, 2928, 2243, 1588, 
1482, 1365, 1324, 1164, 1156, 962, 893, 744, 689; 1H-NMR (300 MHz; CDCl3): δH= 7.64-7.55 
(m, 2H), 7.51-7.28 (m, 8H), 3.17 (s, 3H); 13C-NMR (101 MHz; CDCl3): δc= 138.7, 131.6 (2C), 
129.5 (2C), 128.3 (3C), 128.2, 125.6 (2C), 122.3, 82.0, 71.0, 36.8; HRMS m/z (TOF MS EI+): 
calculated for C15H13NO2S: 271.0667, found 271.0668 [M]. 
N-[2-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-N-phenylethynyl-methanesulfonamide (311) 
N
Ts
Ph
TBSO  
Following GP2 using amide 304 (4.93 g, 15 mmol) and phenylacetylene (0.33 mL, 3 mmol). 
After purification by flash chromatography [hexanes:EtOAc (23:4)] ynamide 311 was isolated as 
a light-yellow oil (749 mg, 58%): νmax (neat)/cm-1= 2953, 2928, 2856, 2235, 1597, 1365, 1254, 
1169, 1089, 1002, 915, 811, 775; 1H-NMR (300 MHz; CDCl3): δH= 7.89-7.82 (m, 2H), 7.42-7.27 
(m, 7H), 3.87 (t, J 6.1, 2H), 3.54 (t, J 6.1, 2H), 2.45 (s, 3H), 0.86 (s, 9H), 0.05 (s, 6H); 13C-NMR 
(101 MHz; CDCl3): δc= 144.5, 134.9, 131.3 (2C), 129.7 (2C), 128.2 (2C), 127.7 (3C), 122.9, 
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82.7, 70.3, 60.6, 53.6, 25.8 (3C), 21.6, 18.3, -5.4 (2C); HRMS m/z (TOF MS ES+): calculated 
for C23H31NO3NaSiS: 452.1692, found 452.1687 [M+Na]. 
N-Allyl-N-phenylethynyl-methanesulfonamide (313) 
N
Ms
Ph
 
Following GP2 using amide 305 (1.35 g, 10 mmol) and phenylacetylene (0.22 mL, 2 mmol). 
After purification by flash chromatography [hexanes:EtOAc (4:1)] ynamide 312 was isolated as 
a yellow solid (324 mg, 69%): mp: 50-52 ºC; νmax (neat)/cm-1= 3081, 3052, 3029, 3008, 2933, 
2278, 2241, 1596, 1440, 1344, 1330, 1158, 1105, 1023, 932, 915, 754, 691; 1H-NMR (300 MHz; 
CDCl3): δH= 7.43-7.38 (m, 2H), 7.33-7.27 (m, 3H), 6.00 (ddt, J 16.8, 10.1, 6.4, 1H), 5.44 (ddt, J 
16.8, 1.2 and 1.2, 1H), 5.38 (ddt, J 10.1, 1.2 and 1.2, 1H), 4.17 (dt, J 6.4 and 1.2, 2H), 3.14 (s, 
3H); 13C-NMR (101 MHz; CDCl3): δc= 131.5 (2C), 130.9, 128.3 (2C), 128.0, 122.5, 120.5, 81.6, 
71.2, 54.4, 39.0; HRMS m/z (TOF MS ES+): calculated for C12H13NO2NaS: 258.0565, found 
258.0567 [M+Na]. 
4-Methyl-N-phenylethynyl-N-(3-trimethylsilanyl-prop-2-ynyl)-benzenesulfonamide (312) 
 
Following GP2 using amide 215 (4.22 g, 15 mmol) and phenylacetylene (0.33 mL, 3 mmol). 
After purification by flash chromatography [hexanes:EtOAc (19:1)] ynamide 312 was isolated as 
a white solid (582 mg, 51%): mp: 97-99 ºC; νmax (neat)/cm-1= 3084, 3030, 2960, 2899, 2235, 
2185, 1595, 1493, 1421, 1362, 1246, 1171, 1040, 998, 842, 755, 662; 1H-NMR (300 MHz; 
CDCl3): δH= 7.91-7.87 (m, 2H), 7.42-7.28 (m, 7H), 4.35 (s, 2H), 2.46 (s, 3H), 0.04 (s, 9H); 13C-
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NMR (101 MHz; CDCl3): δc= 144.8, 134.3, 131.6 (2C), 129.6 (2C), 128.3 (2C), 128.2 (2C), 
127.9, 122.7, 97.0, 91.9, 81.8, 71.2, 42.7, 21.7, -0.5 (3C); HRMS m/z (TOF MS ES+): calculated 
for C21H23NO2NaSiS: 404.1116, found 404.1120 [M+Na]. 
N-Benzyl-N-hex-1-ynyl-methanesulfonamide (314) 
N
Ms
Bn  
Following GP2 using amide 211 (925 mg, 5 mmol) and hex-1-yne (0.12 mL, 1 mmol). After 
purification by flash chromatography [hexanes:EtOAc (17:3)] ynamide 314 was isolated as a 
colorless oil (206 mg, 78%): νmax (neat)/cm-1= 2957, 2932, 2872, 2254, 1684, 1456, 1351, 1159, 
1026, 956, 698; 1H-NMR (300 MHz; CDCl3): δH= 7.48-7.33 (m, 5H), 4.57 (s, 2H), 2.86 (s, 3H), 
2.26 (t, J 6.9, 2H), 1.52-1.25 (m, 4H), 0.88 (t, J 7.2, 3H); 13C-NMR (101 MHz; CDCl3): δc= 134.8, 
128.9 (2C), 128.6 (2C), 128.5, 72.9, 71.4, 55.6, 38.2, 30.9, 21.8, 18.1, 13.5; HRMS m/z (TOF 
MS ES+): calculated for C14H19NO2NaS: 288.1034, found 288.1024 [M+Na]. 
N-Benzyl-N-[5-(tetrahydro-pyran-2-yloxy)-pent-1-ynyl]-methanesulfonamide (315) 
N
Ms
Bn
O
O
 
Following GP2 using amide 221 (2.78 g, 15 mmol) and 2-pent-4-ynyloxy-tetrahydro-pyran (0.52 
mL, 3 mmol). After purification by flash chromatography [hexanes:EtOAc (7:3)] ynamide 315 
was isolated as a yellow oil (526 mg, 50%): νmax (neat)/cm-1= 2939, 2869, 2259, 2042, 1680, 
1454, 1352, 1305, 1133, 1074, 1030, 954, 758, 699; 1H-NMR (300 MHz; CDCl3): δH= 7.46-7.32 
(m, 5H), 4.57 (s, 2H), 4.54 (t, J 3.5, 1H), 3.88-3.80 (m, 1H), 3.76 (dt, J 9.8 and 6.2, 1H), 3.52-
3.43 (m, 1H), 3.39 (dt, J 9.8, 6.2, 1H), 2.85 (s, 3H), 2.39 (t, J 7.1, 2H), 1.90-1.44 (m, 8H); 13C-
NMR (101 MHz; CDCl3): δc= 134.8, 128.8 (2C), 128.7 (2C), 128.5, 98.8, 73.2, 70.7, 65.8, 62.3, 
55.6, 38.3, 30.7, 29.1, 25.4, 19.6, 15.4; HRMS m/z (TOF MS ES+): calculated for 
C18H25NO4NaS: 374.1402, found 374.1403 [M+Na]. 
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N-Hex-1-ynyl-N-phenyl-2-nitro benzenesulfonamide (316) 
N
Ns
Ph  
Following GP2 using amide 308 (1.39 g, 5 mmol) and hex-1-yne (0.12 mL, 1 mmol). After 
purification by flash chromatography [hexanes:EtOAc (9:1)] ynamide 316 was isolated as a 
light-yellow solid (336 mg, 94%): mp: 77-79 ºC; νmax (neat)/cm-1= 3106, 2961, 2930, 2862, 2256, 
1606, 1588, 1526, 1487, 1376, 1345, 1180, 1157, 1087, 934, 854, 737; 1H-NMR (300 MHz; 
CDCl3): δH= 8.37-8.29 (m, 2H), 7.88-7.79 (m, 2H), 7.41-7.30 (m, 3H), 7.28-7.17 (m, 2H), 2.31 (t, 
J 7.1, 2H), 1.58-1.31 (m, 4H), 0.91 (t, J 7.1, 3H); 13C-NMR (101 MHz; CDCl3): δc= 150.7, 141.1, 
138.6, 129.4 (2C), 129.3 (2C), 128.5, 125.9 (2C), 123.9 (2C), 72.9, 71.3, 30.8, 21.9, 18.1, 13.5; 
HRMS m/z (TOF MS ES+): calculated for C18H18N2O4NaS: 381.0885, found 381.0892 [M+Na]. 
N-[5-(tert-Butyl-diphenyl-silanyloxy)-pent-1-ynyl]-N-phenyl-2-nitro benzenesulfonamide 
(317) 
N
Ns
Ph
OTBDPS
 
Following GP2 using amide 308 (1.39 g, 5 mmol) and tert-butyl-pent-4-ynyloxy-diphenyl-silane 
309 (0.32 g, 1 mmol). After purification by flash chromatography [hexanes:toluene (9:1)] 
ynamide 317 was isolated as a light-yellow oil (442 mg, 74%): νmax (neat)/cm-1= 3108, 3070, 
2694, 2934, 2852, 2255, 1525, 1426, 1374, 1348, 1174, 1089, 972, 733, 697, 604; 1H-NMR 
(300 MHz; CDCl3): δH= 8.25 (d, J 8.7, 2H), 7.83-7.75 (m, 2H), 7.68-7.59 (m, 4H), 7.47-7.27 (m, 
9H), 7.24-7.16 (m, 2H), 3.72 (t, J 6.6, 2H), 2.48 (t, J 6.6, 2H), 1.76 (tt, J 6.6, 6.6, 2H), 1.03 (s, 
9H); 13C-NMR (101 MHz; CDCl3): δc= 150.6, 141.1, 138.6, 135.5 (4C), 134.8, 133.7, 129.6 (2C), 
129.3 (2C), 129.3 (2C), 128.5, 127.7 (4C), 125.9 (2C), 123.9 (2C), 73.0, 70.8, 62.3, 31.7, 26.8 
(3C), 19.2, 15.0; HRMS m/z (TOF MS ES+): calculated for C33H34N2O5NaSiS: 621.1855, found 
621.1859 [M+Na]. 
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N-Benzyl-N-(4-bromo-but-1-ynyl)-methanesulfonamide (318) 
N
Ms
Bn Br  
Following GP2 using amide 212 (1.85 g, 10 mmol) and 4-bromo-but-1-yne (0.19 mL, 2 mmol). 
After purification by flash chromatography [hexanes:EtOAc (4:1)] ynamide 318 was isolated as 
a light yellow oil (432 mg, 69%): νmax (neat)/cm-1= 3067, 3031, 2972, 2930, 2255, 2048, 1738, 
1210, 1351, 1269, 1210, 1158, 956, 979, 756, 699, 581; 1H-NMR (300 MHz; CDCl3): δH= 7.51-
7.36 (m, 5H), 4.61 (s, 2H), 3.42 (t, J 7.0, 2H), 2.90 (s, 3H), 2.87 (t, J 7.0, 2H); 13C-NMR (101 
MHz; CDCl3): δc= 134.5, 128.9 (2C), 128.7 (2C), 128.6, 75.1, 68.5, 55.6, 38.6, 30.2, 23.0; 
HRMS m/z (TOF MS ES+): calculated for C12H14NO2NaBrS: 337.9826, found 337.9820 [M+Na]. 
N-Benzyl-4-methyl-N-phenylethynyl-benzenesulfonamide (319) 
N
Ts
Bn
Ph
 
Following GP2 using amide 306 (3.1 g, 12 mmol) and phenylacetylene (0.25 mL, 2.4 mmol). 
After purification by flash chromatography [hexanes:EtOAc (17:3)] ynamide 319 was isolated as 
a white solid (381 mg, 44%): 1H-NMR (300 MHz; CDCl3): δH= 7.80 (d, J 8.2, 2H), 7.33-7.31 (m, 
6H), 7.26-7.21 (m, 6H), 4.58 (s, 2H), 2.45 (s, 3H); 13C-NMR (101 MHz; CDCl3): δc= 144.6, 
134.9, 134.6, 131.3 (2C), 129.9 (2C), 129.0 (2C), 128.7 (2C), 128.5, 128.3 (2C), 127.9 (2C), 
127.8, 123.0, 82.8, 71.6, 55.9, 21.8; HRMS m/z (TOF MS ES+): calculated for C22H19NO2NaS: 
384.1034, found 384.1022 [M+Na].  
Spectroscopic data were identical to those reported in literature.129 
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4-methyl-N-phenyl-N-((trimethylsilyl)ethynyl)benzenesulfonamide (320) 
 
Following GP2 using amide 307 (3.71 g, 15 mmol) and ethynyltrimethylsilane (0.42 mL, 3 
mmol). After purification by flash chromatography [hexanes:EtOAc (19:1)] 4-methyl-N-phenyl-N-
trimethylsilanylethynyl-benzenesulfonamide 320 was isolated as a white solid (843 mg, 82%): 
mp: 88-91 ºC; νmax (neat)/cm-1= 3069, 3034, 2961, 2904, 2165, 1592, 1490, 1365, 1248, 1160, 
1085, 842, 812, 691, 660; 1H-NMR (300 MHz; CDCl3): δH= 7.58 (d, J 8.3, 2H), 7.38-7.21 (m, 
7H), 2.46 (s, 3H), 0.19 (s, 9H); 13C-NMR (101 MHz; CDCl3): δc= 144.9, 138.6, 132.8, 129.3 (2C), 
129.0 (2C), 128.4 (2C), 128.2, 126.1 (2C), 95.3, 73.2, 21.7, 0.0 (3C); HRMS m/z (TOF MS 
ES+): calculated for C18H21NO2NaSiS: 366.0960, found 366.0959 [M+Na]. 
N-ethynyl-4-methyl-N-phenylbenzenesulfonamide (321) 
 
A solution of tetra-n-butylammonium fluoride (1 M in THF, 2.5 eq) was added to a solution of 
ynamide 320 (832 mg, 2.43 mmol) in THF (18 mL) at 0°C and stirred for 5 min. Saturated 
ammonium chloride solution (20 mL) was added and the aqueous phase was extracted with 
EtOAc (3 × 25 mL). The organic layers were dried over Na2SO4, filtered and the solvent was 
removed under reduced pressure. The residue was purified by flash chromatography 
[hexanes:EtOAc (9:1)] to give N-ethynyl-4-methyl-N-phenyl-benzenesulfonamide 321 as a light 
yellow solid (580 mg, 88%): mp: 76-78 ºC; νmax (neat)/cm-1= 3275, 3060, 3041, 2962, 2923, 
2125, 1595, 1489, 1361, 1164, 1097, 1086, 806, 683, 657; 1H-NMR (300 MHz; CDCl3): δH= 
7.61-7.56 (m, 2H), 7.35-7.23 (m, 7H), 2.83 (s, 1H), 2.44 (s, 3H); 13C-NMR (101 MHz; CDCl3): 
δc= 145.0, 138.3, 133.0, 129.5 (2C), 129.1 (2C), 128.4, 128.3 (2C), 126.3 (2C), 58.9, 21.7; 
HRMS m/z (TOF MS ES+): calculated for C15H13NO2NaS: 294.0565, found 294.0555 [M+Na]. 
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4-methyl-N-(octa-1,3-diyn-1-yl)-N-phenylbenzenesulfonamide (322) 
 
Ynamide 321 (580 mg, 2.13 mmol) was added to 1-bromo-hex-1-yne 160 (443 mg, 2.77 mmol), 
copper iodide (48 mg, 0.15 mmol) and Pd(Ph3)4 (123 mg, 0.11 mmol) in a 2:1 solution of 
diisopropylamine-toluene (50 mL). The reaction was then allowed to stir overnight at room 
temperature. The mixture was then diluted with dichloromethane (40 mL) and filtered through 
celite. The solution was concentrated under reduced pressure and purified by flash 
chromatography [hexanes:EtOAc (9:1)] to give ynamide 322 as a light brown solid (138 mg, 
19%): mp: 59-61 ºC; νmax (neat)/cm-1= 2965, 2933, 2872, 2860, 2258, 2169, 1593, 1486, 1375, 
1169, 1086, 1040, 888, 778, 692, 665, 572; 1H-NMR (300 MHz; CDCl3): δH= 7.58 (d, J 8.3, 2H), 
7.38-7.17 (m, 7H), 2.44 (s, 3H), 2.31 (t, J 6.9, 2H), 1.58-1.33 (m, 4H), 0.91 (t, J 7.2, 3H); 13C-
NMR (101 MHz; CDCl3): δc= 145.1, 138.3, 133.1, 129.6 (2C), 129.2 (2C), 128.5, 128.2 (2C), 
126.3 (2C), 84.5, 67.6, 64.3, 58.1, 30.3, 21.9, 21.7, 19.3, 13.5; HRMS m/z (TOF MS ES+): 
calculated for C21H21NO2NaS: 374.1191, found 374.1182 [M+Na]. 
N-(2,5-Diphenyl-oxazol-4-yl)-N-phenyl-methanesulfonamide (323) 
N
O
Ph
N
Ph
Ms
Ph  
Following GP7 using ynamide 310 (27.1 mg, 0.1 mmol) and ylide 295 (29.7 mg, 0.15 mmol) for 
4 h, oxazole 323 was isolated as a white solid (37.4 mg, 96%): mp: 233-235 ºC; νmax (neat)/cm-
1= 3056, 3021, 2926, 1619, 1595, 1484, 1446, 1348, 1161, 1141, 961, 756, 694, 684; 1H-NMR 
(300 MHz; CDCl3): δH= 8.15-8.12 (m, 2H), 8.02-7.97 (m, 2H), 7.75-7.71 (m, 2H), 7.54-7.49 (m, 
3H), 7.48-7.42 (m, 2H), 7.41-7.33 (m, 3H), 7.32-7.26 (m, 1H), 3.34 (s, 3H); 13C-NMR (101 MHz; 
CDCl3): δc= 158.3, 146.0, 140.1, 134.2, 130.9, 129.3 (2C), 129.0, 128.9 (2C), 128.8 (2C), 127.7, 
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127.0, 126.9 (2C), 126.7, 126.4 (2C), 125.4 (2C), 38.7; HRMS m/z (TOF MS ES+): calculated 
for C22H18N2O3NaS: 413.0936, found 413.0930 [M+Na]. 
N-Benzyl-N-(5-butyl-2-phenyl-oxazol-4-yl)-methanesulfonamide (324) 
N
O
Ph
NMs
Bn  
Following GP7 using ynamide 314 (26.5 mg, 0.1 mmol) and ylide 295 (29.7 mg, 0.15 mmol) for 
2 h. After purification by flash chromatography [hexanes:EtOAc (4:1)] oxazole 324 was isolated 
as a white solid (31.6 mg, 82%); mp: 90-92 ºC; νmax (neat)/cm-1= 2953, 2927, 2869, 1644, 1487, 
1448, 1342, 1150, 1049, 957, 785, 695; 1H-NMR (300 MHz; CDCl3): δH= 7.91-7.86 (m, 2H), 
7.41-7.35 (m, 3H), 7.27-7.16 (m, 5H), 4.67 (s, 2H), 3.06 (s, 3H), 2.32 (t, J 7.5, 2H), 1.19-0.96 
(m, 4H), 0.71 (t, J 7.0, 3H); 13C-NMR (101 MHz; CDCl3): δc= 158.3, 151.6, 135.8, 132.1, 130.0, 
129.3 (2C), 128.7 (2C), 128.4 (2C), 127.9, 127.4, 126.0 (2C), 53.9, 38.0, 29.3, 23.7, 22.3, 13.6; 
HRMS m/z (TOF MS ES+): calculated for C21H24N2O3NaS: 407.1405, found 407.1397 [M+Na]. 
N-Allyl-N-(2,5-diphenyl-oxazol-4-yl)-methanesulfonamide (325) 
N
O
Ph
N
Ph
Ms
 
Following GP7 using ynamide 312 (23.5 mg, 0.1 mmol) and ylide 295 (29.7 mg, 0.15 mmol) for 
4 h. After purification by flash chromatography [toluene:EtOAc (19:1)] oxazole 325 was isolated 
as a white solid (23.6 mg, 67%): mp: 88-90 ºC; νmax (neat)/cm-1= 3062, 3021, 2928, 1614, 1487, 
1449, 1345, 1151, 1069, 959, 764, 701, 688; 1H-NMR (300 MHz; CDCl3): δH= 8.05 (m, 4H), 
7.53-7.41 (m, 5H), 7.41-7.34 (m, 1H), 5.87 (ddt, J 16.9, 10.1 and 6.7, 1H), 5.20 (ddd, J 16.9, 2.5 
and 1.1, 1H), 5.08 (dd, J 10.1 and 1.1, 1H), 4.31 (d, J 6.7, 2H), 3.22 (s, 3H); 13C-NMR (101 
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MHz; CDCl3): δc= 158.3, 146.8, 133.0, 131.7, 130.8, 129.0, 128.8 (2C), 128.7 (2C), 127.0, 
126.8, 126.3 (2C), 125.4 (2C), 120.0, 53.8, 38.8; HRMS m/z (TOF MS ES+): calculated for 
C19H18N2O3NaS: 377.0936, found 377.0938 [M+Na]. 
 
N-[2-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-N-(2,5-diphenyl-oxazol-4-yl)-4-methyl-
benzenesulfonamide (326) 
N
O
Ph
N
Ph
Ts
TBSO  
Following GP7 using ynamide 311 (42.9 mg, 0.1 mmol) and ylide 295 (29.7 mg, 0.15 mmol) for 
12 h. After purification by flash chromatography [hexanes:EtOAc (9:1)] oxazole 326 was 
isolated as a white solid (44.2 mg, 81%): mp: 90-92 ºC; νmax (neat)/cm-1= 3061, 2955, 2928, 
2856, 1598, 1488, 1448, 1357, 1256, 1165, 1088, 1006, 835, 775, 704, 689, 665; 1H-NMR (300 
MHz; CDCl3): δH= 8.15-8.07 (m, 2H), 8.02-7.94 (m, 2H), 7.79 (d, J 8.3, 2H), 7.52-7.42 (m, 5H), 
7.40-7.28 (m, 3H), 3.67 (m, 4H), 2.46 (s, 3H), 0.75 (s, 9H), -0.12 (s, 6H); 13C-NMR (101 MHz; 
CDCl3): δc= 157.8, 146.9, 143.8, 135.6, 133.5, 130.5, 129.3 (2C), 128.8 (3C), 128.6 (2C), 128.6 
(2C), 127.2 (2C), 126.2 (2C), 125.6 (2C), 60.9, 52.1, 25.7 (3C), 21.6, 18.1, -5.6 (2C); HRMS m/z 
(TOF MS ES+): calculated for C30H36N2O3NaSiS: 571.2063, found 571.2057 [M+Na]. 
N-Benzyl-N-{2-phenyl-5-[3-(tetrahydro-pyran-2-yloxy)-propyl]-oxazol-4-yl}-
methanesulfonamide (327) 
N
O
Ph
NMs
Bn
O
O
 
Following GP7 using ynamide 315 (35.2 mg, 0.1 mmol) and ylide 295 (29.7 mg, 0.15 mmol) for 
1.5 h. After purification by flash chromatography [hexanes:EtOAc (3:1)] oxazole 327 was 
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isolated as a yellow oil (42.8 mg, 91%): νmax (neat)/cm-1= 2939, 2868, 1640, 1449, 1343, 1155, 
1118, 1028, 959, 867, 776, 758, 692; 1H-NMR (300 MHz; CDCl3): δH= 8.03-7.93 (m, 2H), 7.52-
7.42 (m, 3H), 7.38-7.24 (m, 5H), 4.76 (s, 2H), 4.54 (t, J 3.5, 1H), 3.85 (m, 1H), 3.61 (dt, J 9.8 
and 6.4, 1H), 3.56-3.47 (m, 1H), 3.23 (dt, J 9.8 and 6.4, 1H), 3.15 (s, 3H), 2.52 (td, J 7.4 and 
2.6, 2H), 1.92-1.46 (m, 8H); 13C-NMR (101 MHz; CDCl3): δc= 158.5, 151.0, 135.7, 132.3, 130.3, 
129.2 (2C), 128.7 (2C), 128.4 (2C), 128.0, 127.3, 126.0 (2C), 98.6, 66.4, 62.1, 53.9, 38.0, 30.6, 
27.4, 25.5, 21.0, 19.5; HRMS m/z (TOF MS ES+): calculated for C25H30N2O5NaS: 493.1773, 
found 493.1750 [M+Na]. 
 
N-(2,5-Diphenyl-oxazol-4-yl)-4-methyl-N-(3-trimethylsilanyl-prop-2-ynyl)-
benzenesulfonamide (329) 
 
Following GP7 using ynamide 313 (38.1 mg, 0.1 mmol) and ylide 295 (29.7 mg, 0.15 mmol) for 
24 h. After purification by flash chromatography [hexanes:EtOAc (9:1)] oxazole 329 was 
isolated as a white solid (40.2 mg, 80%): mp: 141-143 ºC; νmax (neat)/cm-1= 3060, 3028, 2962, 
2181 1596, 1488, 1359, 1252, 1074, 836, 806, 706, 679, 674; 1H-NMR (300 MHz; CDCl3): δH= 
8.15-8.09 (m, 2H), 8.01-7.95 (m, 2H), 7.86-7.79 (m, 2H), 7.47 (m, 5H), 7.41-7.29 (m, 3H), 4.34 
(s, 2H), 2.47 (s, 3H), -0.12 (s, 9H); 13C-NMR (101 MHz; CDCl3): δc= 157.9, 147.7, 144.0, 135.3, 
132.6, 130.5, 129.3 (2C), 128.9, 128.8 (2C), 128.8 (2C), 128.6 (2C), 127.2, 127.0, 126.2 (2C), 
125.6 (2C), 98.3, 91.1, 41.2, 21.6, -0.7 (3C); HRMS m/z (TOF MS ES+): calculated for 
C28H28N2O3NaSiS: 532.1488, found 523.1482 [M+Na]. 
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N-(5-(hex-1-yn-1-yl)-2-phenyloxazol-4-yl)-4-methyl-N-phenylbenzenesulfonamide (330) 
 
Following GP7 using ynamide 322 (35.1 mg, 0.1 mmol) and ylide 295 (29.7 mg, 0.15 mmol) for 
18 h. After purification by flash chromatography [hexanes:EtOAc (4:1)] oxazole 330 was 
isolated as a light yellow oil (39.1 mg, 83%): νmax (neat)/cm-1= 3064, 2957, 2931, 2872, 2234, 
1595, 1485, 1449, 1361, 1166, 1133, 1090, 704, 691, 667; 1H-NMR (300 MHz; CDCl3): δH= 8.31 
(m, 2H), 7.75 (d, J 8.3, 2H), 7.48-7.35 (m, 5H), 7.32-7.24 (m, 5H), 2.47 (t, J 6.9, 2H), 2.44 (s, 
3H), 1.67-1.39 (m, 4H), 0.96 (t, J 7.2, 3H); 13C-NMR (101 MHz; CDCl3): δc= 158.4, 143.7, 141.5, 
139.6, 136.2, 131.5, 130.8, 129.1 (2C), 128.9 (2C), 128.8 (2C), 128.7 (2C), 128.6 (2C), 128.0, 
126.9, 126.5 (2C), 103.1, 66.7, 30.1, 21.9, 21.6, 19.5, 13.6; HRMS m/z (TOF MS ES+): 
calculated for C28H26N2O3NaS: 493.1562, found 493.1557 [M+Na]. 
N-(5-Butyl-2-phenyl-oxazol-4-yl-N-phenyl-2-nitrobenzenesulfonamide (331) 
N
O
Ph
N
Ph
Ns
 
Following GP7 using ynamide 316 (71.6 mg, 0.2 mmol) and ylide 295 (59.4 mg, 0.3 mmol) for 1 
h. After purification by flash chromatography [hexanes:EtOAc (9:1)] oxazole 331 was isolated as 
a light yellow solid (70.8 mg, 74%): mp: 144-146 ºC; νmax (neat)/cm-1= 3114, 3040, 2961, 2932, 
2873, 1638, 1523, 1488, 1447, 1361, 1347, 1089, 853, 736, 698, 607; 1H-NMR (300 MHz; 
CDCl3): δH= 8.31 (dt, J 4.5 and 2.3, 2H), 7.96 (m, 2H), 7.93-7.88 (m, 2H), 7.49-7.38 (m, 5H), 
7.33-7.27 (m, 3H), 2.81 (t, J 7.4, 2H), 1.69 (tt, J 7.4 and 7.4, 2H), 1.35 (tq, J 7.4 and 7.4, 2H), 
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0.91 (t, J 7.4, 3H); 13C-NMR (101 MHz; CDCl3): δc= 158.2, 150.6, 144.2, 139.7, 134.4, 130.5, 
130.2 (2C), 129.2 (2C), 128.8 (2C), 128.2, 127.8 (2C), 127.3, 127.3, 126.0 (2C), 123.5 (2C), 
29.5, 24.1, 22.3, 13.7; HRMS m/z (TOF MS ES+): calculated for C25H23N3O5NaS: 500.1256, 
found 500.1252 [M+Na]. 
N-[2-(2-Bromo-phenyl)-5-phenyl-oxazol-4-yl]-N-phenyl-methanesulfonamide (333) 
N
O
N
Ph
Ms
Ph
Br
 
Following GP7 using ynamide 310 (54.2 mg, 0.2 mmol) and ylide 228 (82.8 mg, 0.3 mmol) for 3 
h. After purification by flash chromatography [hexanes:EtOAc (4:1)] oxazole 333 was isolated as 
a white solid (84.3 mg, 90%): mp: 171-173 ºC; νmax (neat)/cm-1= 3086, 3021, 3004, 2925, 1592, 
1488, 1447, 1353, 1154, 1025, 971, 757, 724, 685; 1H-NMR (300 MHz; CDCl3): δH= 8.10 (dd, J 
7.8 and 1.6, 1H), 8.06-8.00 (m, 2H), 7.81-7.73 (m, 3H), 7.51-7.27 (m, 8H), 3.36 (s, 3H); 13C-
NMR (101 MHz; CDCl3): δc= 156.3, 146.3, 140.1, 134.9, 133.9, 131.5, 130.8, 129.4 (2C), 129.2, 
128.8 (2C), 127.9, 127.5, 127.3, 127.1 (2C), 126.5, 125.5 (2C), 121.0, 38.4; HRMS m/z (TOF 
MS ES+): calculated for C22H17N2O3NaBrS: 491.0041, found 491.0039 [M+Na]. 
N-{2-(2-Bromo-phenyl)-5-[3-(tert-butyl-diphenyl-silanyloxy)-propyl]-oxazol-4-yl}-N-phenyl-
2-nitrobenzenesulfonamide (334) 
N
O
N
Ph
Br
Ns OTBDPS
 
Following GP7 using ynamide 298 (119.6 mg, 0.2 mmol) and ylide 317 (82.8 mg, 0.3 mmol) for 
1 h. After purification by flash chromatography [hexanes:EtOAc (9:1)] oxazole 334 was isolated 
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as a light yellow oil (122.2 mg, 77%): νmax (neat)/cm-1= 3069, 2954, 2929, 2856, 1530, 1471, 
1427, 1370, 1347, 1171, 1088, 956, 853, 734, 694, 608; 1H-NMR (300 MHz; CDCl3): δH= 8.27 
(m, 2H), 8.00 (m, 2H), 7.81 (dd, J 7.9 and 1.7, 1H), 7.71 (dd, J 7.9 and 1.1, 1H), 7.68-7.62 (m, 
4H), 7.45-7.22 (m, 13H), 3.72 (t, J 6.1, 2H), 2.99 (d, J 7.7, 2H), 2.02-1.90 (m, 2H), 1.07 (s, 9H); 
13C-NMR (101 MHz; CDCl3): δc= 156.3, 150.6, 150.2, 144.0, 139.4, 135.5 (4C), 135.5, 134.8, 
134.1, 133.7, 131.2, 130.5, 130.2 (2C), 129.6 (2C), 126.9, 129.3 (2C), 128.3, 127.9 (2C), 127.6 
(4C), 127.4, 123.6 (2C), 120.8, 62.9, 30.3, 29.6 (3C), 21.1, 19.2; HRMS m/z (TOF MS ES+): 
calculated for C40H38N3O6NaBrSiS: 818.1332, found 818.1337 [M+Na]. 
N-[5-(2-Bromo-ethyl)-2-(2-bromo-phenyl)-oxazol-4-yl]-N-phenyl-methanesulfonamide 
(335) 
N
O
NMs
Bn
Br
Br
 
Following GP7 using ynamide 318 (63.0 mg, 0.2 mmol) and ylide 298 (82.8 mg, 0.3 mmol) for 
24 h. After purification by flash chromatography [hexanes:EtOAc (17:3)] oxazole 335 was 
isolated as a light-yellow oil (64.7 mg, 63%): νmax (neat)/cm-1= 3.088, 3030, 2927, 1641, 1456, 
1343, 1155, 1025, 959, 853, 766, 726, 698, 612, 580; 1H-NMR (300 MHz; CDCl3): δH= 7.85 (dd, 
J 7.8 and 1.7, 1H), 7.73 (dd, J 8.0 and 1.2, 1H), 7.42 (m, 1H), 7.36-7.28 (m, 6H), 4.77 (s, 2H), 
3.13 (s, 3H), 3.11-2.96 (m, 4H); 13C-NMR (101 MHz; CDCl3): δc= 157.4, 148.3, 135.4, 134.7, 
133.5, 131.5, 130.8, 129.3 (2C), 128.6 (2C), 128.3, 127.7, 127.4, 121.1, 54.0, 37.9, 27.8, 27.4; 
HRMS m/z (TOF MS ES+): calculated for C19H18N2O3NaBr2S: 534.9303, found 534.9307 
[M+Na]. 
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N-(2-Furan-2-yl-5-phenyl-oxazol-4-yl)-N-phenyl-methanesulfonamide (337) 
N
O
Ph
O
NMs
Ph  
Following GP7 using ynamide 310 (54.2 mg, 0.2 mmol) and ylide 299 (56.4 mg, 0.3 mmol) for 4 
h, oxazole 337 was isolated as a white solid (73.7 mg, 97%): mp: 178-180 ºC; νmax (neat)/cm-1= 
3126, 3064, 3007, 2931, 1633, 1594, 1520, 1490, 1349, 1155, 1128, 962, 899, 743, 687; 1H-
NMR (300 MHz; CDCl3): δH= 8.00-7.95 (m, 2H), 7.74-7.69 (m, 2H), 7.63 (dd, J 1.8 and 0.8, 1H), 
7.49-7.27 (m, 6H), 7.13 (dd, J 3.5 and 0.8, 1H), 6.60 (dd, J 3.5 and 1.8, 1H), 3.31 (s, 3H); 13C-
NMR (101 MHz; CDCl3): δc= 151.1, 145.6, 144.9, 142.5, 139.9, 133.9, 129.4 (2C), 129.2, 128.8 
(2C), 127.8, 126.8 (2C), 126.3, 125.5 (2C), 112.4, 112.1, 38.8; HRMS m/z (TOF MS ES+): 
calculated for C20H16N2O4NaS: 403.0728, found 403.0724 [M+Na]. 
N-Benzyl-N-{2-furan-2-yl-5-[3-(tetrahydro-pyran-2-yloxy)-propyl]-oxazol-4-yl}-
methanesulfonamide (338) 
N
O
NMs
Bn
O
O
O
 
Following GP7 using ynamide 315 (70.2 mg, 0.2 mmol) and ylide 299 (56.4 mg, 0.3 mmol) for 1 
h. After purification by flash chromatography [hexanes:EtOAc (7:3)] oxazole 338 was isolated 
yellow oil (77.6 mg, 84%): νmax (neat)/cm-1= 2941, 2869, 1635, 1544, 1344, 1156, 1029, 959, 
756, 732, 699, 592; 1H-NMR (300 MHz; CDCl3): δH= 7.55 (dd, J 1.7 and 0.6, 1H), 7.33-7.22 (m, 
5H), 6.93 (dd, J 3.5 and 0.6, 1H), 6.53 (dd, J 3.5 and 1.7, 1H), 4.74 (s, 2H), 4.50 (t, J 3.4, 1H), 
3.87-3.76 (m, 1H), 3.56 (dt, J 10.0 and 6.4, 1H), 3.52-3.44 (m, 1H), 3.18 (dt, J 10.0 and 6.4, 
1H), 3.12 (s, 3H), 2.47 (td, J 7.4 and 2.6, 2H), 1.86-1.43 (m, 8H); 13C-NMR (101 MHz; CDCl3): 
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δc= 151.5, 150.8, 144.4, 142.6, 135.6, 131.9, 129.1 (2C), 128.5 (2C), 128.0, 111.8, 111.4, 98.6, 
66.3, 62.1, 53.7, 38.2, 30.6, 27.4, 25.5, 21.0, 19.5; HRMS m/z (TOF MS ES+): calculated for 
C23H28N2O6NaS: 483.1566, found 483.1558 [M+Na]. 
N-(2-Methoxy-5-phenyl-oxazol-4-yl)-N-phenyl-methanesulfonamide (339) 
N
O
OMe
Ph
NMs
Ph  
Following GP7 using ynamide 31 (54.2 mg, 0.2 mmol) and ylide 300 (45.6 mg, 0.3 mmol) for 30 
min. After purification by flash chromatography [hexanes:EtOAc (4:1)] oxazole 339 was isolated 
as a white solid (67.5 mg, 98%): mp: 90-92 ºC; νmax (neat)/cm-1= 3063, 3020, 2951, 2853, 1637, 
1614, 1593, 1489, 1346, 1333, 1245, 1160, 1008, 970, 765, 687, 676; 1H-NMR (300 MHz; 
CDCl3): δH= 7.87-7.77 (m, 2H), 7.75-7.65 (m, 2H), 7.39 (m, 4H), 7.34-7.24 (m, 2H), 4.17 (s, 3H), 
3.25 (s, 3H); 13C-NMR (101 MHz; CDCl3): δc= 159.3, 141.8, 140.1, 131.3, 129.7, 129.3 (2C), 
128.7 (2C), 128.3, 127.3, 126.6 (2C), 124.7 (2C), 58.2, 38.7; HRMS m/z (TOF MS ES+): 
calculated for C17H16N2O4NaS: 367.0728, found 367.0721 [M+Na]. 
N-Allyl-N-(2-methoxy-5-phenyl-oxazol-4-yl)-methanesulfonamide (340) 
N
O
OMe
N
Ph
Ms
 
Following GP7 using ynamide 312 (47.0 mg, 0.2 mmol) and ylide 300 (45.6 mg, 0.3 mmol) for 
30 min. After purification by flash chromatography [hexanes:EtOAc (7:3)] oxazole 340 was 
isolated as a white solid (53.6 mg, 87%): mp: 86-88 ºC; νmax (neat)/cm-1= 3091, 3091, 2946, 
1638, 1613, 1596, 1493, 1352, 1228, 1161, 1006, 943, 766, 689, 576; 1H-NMR (300 MHz; 
CDCl3): δH= 7.86-7.78 (m, 2H), 7.42-7.35 (m, 2H), 7.33-7.25 (m, 1H), 5.83 (ddt, J 16.9 and 10.1, 
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6.6, 1H), 5.20 (ddd, J 16.9, 2.6 and 1.1, 1H), 5.09 (app dd, J 10.1 and 1.1, 1H), 4.20 (dt, J 6.6 
and 1.1, 2H), 4.08 (s, 3H), 3.14 (s, 3H); 13C-NMR (101 MHz; CDCl3): δc= 159.2, 142.6, 131.8, 
130.1, 128.6 (2C), 128.3, 126.8, 124.7 (2C), 119.8, 58.1, 53.5, 38.9; HRMS m/z (TOF MS ES+): 
calculated for C14H16N2O4NaS: 331.0726, found 331.0728 [M+Na]. 
N-(2-Methoxy-5-phenyl-oxazol-4-yl)-4-methyl-N-(3-trimethylsilanyl-prop-2-ynyl)-
benzenesulfonamide (341) 
 
Following GP7 using ynamide 313 (76.2 mg, 0.2 mmol) and ylide 300 (45.6 mg, 0.3 mmol) for 5 
min. After purification by flash chromatography [hexanes:EtOAc (17:3)] oxazole 341 was 
isolated as a white solid (84.4 mg, 93%): mp: 146-148 ºC; νmax (neat)/cm-1= 2953, 2922, 2902, 
2853, 2180, 1613, 1598, 1380, 1354, 1248, 1167, 1012, 839, 679, 568; 1H-NMR (300 MHz; 
CDCl3): δH= 7.86 (m, 2H), 7.79 (app d, J 8.3, 2H), 7.40-7.32 (m, 2H), 7.31-7.23 (m, 3H), 4.26 (s, 
2H), 3.98 (s, 3H), 2.42 (s, 3H), -0.10 (m, 9H); 13C-NMR (101 MHz; CDCl3): δc= 159.0, 144.0, 
143.4, 135.5, 129.7, 129.3 (2C), 128.6 (2C), 128.4 (2C), 128.1, 126.9, 124.9 (2C), 98.4, 90.9, 
58.0, 40.8, 21.5, -0.7 (3C); HRMS m/z (TOF MS ES+): calculated for C23H26N2O4NaSiS: 
477.1280, found 477.1285 [M+Na]. 
(methoxycarbonothioyl)(pyridin-1-ium-1-yl)amide (348) 
 
A solution of MeOH (0.40 mL, 10 mmol) in diethyl ether (40 mL) at 0 °C of sodium hydride (57% 
suspension in oil, 421 mg, 10 mmol) was stirred for 15 minute. The reaction mixture was then 
N
N O
S
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cooled down to -78 °C and thiophosgene (0.76 mL, 10 mmol) was added. The reaction was kept 
stirring at -78 °C for an additional 1 h before being warmed to room temperature and then 
poured into ice-water (40 mL). The organic layer is separated and washed with brine (40 mL). 
The organic layer was then dried over Na2SO4, filtered and concentrated under reduced 
pressure to provide thiono chloroformate which was employed as a crude mixture: 1H-NMR (300 
MHz; CDCl3): δH= 4.17 (s, 3H). Potassium carbonate (1.6 g) was added to a solution of N-amino 
pyridinium iodide 294 (444 mg, 2 mmol) and methyl chlorothioformate (370 mg) in ethanol (20 
mL) at room temperature. The reaction mixture was stirred for 1 day and then filtered through a 
pad of celite. The solution was concentrated under reduced pressure and the solid was 
recrystalised with CH2Cl2/hexanes to provide the thiourea ylide 348 as a light yellow solid (325 
mg, 97%): mp: 128-130 °C; νmax (neat)/cm-1= 3103, 3063, 3047, 2937, 2161, 1613, 1469, 1398, 
1373, 1213, 1122, 1041, 1007, 830, 695; 1H-NMR (300 MHz; CDCl3): δH= 8.49 (dd, J 6.9, 1.3, 
2H), 8.11 (tt, J 8.1, 1.3, 1H), 7.84-7.73 (m, 2H), 4.02 (s, 3H); 13C-NMR (101 MHz; CDCl3): δc= 
195.4, 143.8 (2C), 139.4, 126.6 (2C), 56.25. 
Data were in agreement with those reported in the literature.130  
(dimethylcarbamothioyl)(pyridin-1-ium-1-yl)amide (349) 
 
Sodium ethoxyde (136 mg 2 mmol) in ethanol (10 mL) was added to a solution of N-amino 
pyridinium iodide 294 (444 mg, 2 mmol) and N,N-dimethylthiocarbonyl chloride (270 mg, 2.2 
mmol) in ethanol (10 mL) at room temperature. The reaction mixture was stirred for 1 day and 
then filtered through a pad of celite. The solution is concentrated under reduced pressure to 
provide the thiourea ylide 349 as a light yellow solid (337 mg, 93%): mp: 140-134 °C; νmax 
(neat)/cm-1= 3095, 3071, 3044, 2925, 2212, 1611, 1465, 1369, 1336, 1251, 1121, 943, 828, 
692; 1H-NMR (300 MHz; CDCl3): δH= 8.43 (dd, J 4.2 and 2.5, 2H), 7.96 (ddd, J 9.0, 2.5 and 1.3, 
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1H), 7.69-7.62 (m, 2H), 3.31 (s, 6H); 13C-NMR (101 MHz; CDCl3): δc= 185.3, 144.8 (2 C), 138.0, 
125.7 (2C), 40.0 (2C); HRMS m/z (TOF MS ES+): calculated for C8H11N3NaS: 204.0571, found: 
204.0572 [M+Na]. 
Data were in agreement with those reported in the literature.131 
N-(methoxycarbonyl)pyridinium bromide (350) 
 
Pyridine (0.40 mL, 5 mmol) was added to a solution of methylbromoacetate (0.47 mL, 5 mmol) 
in CH2Cl2 (10 mL) and stirred overnight at room temperature. The reaction mixture was filtered 
and the collected solid was washed 3 times with diethy ether. Pyridinium ylide 350 was isolated 
as a white solid (487 mg, 42%): mp: 169-172 °C; νmax (neat)/cm-1= 3017, 2998, 2952, 2863, 
1746, 1634, 1491, 1360, 1221, 994, 794, 712; 1H-NMR (300 MHz; DMSO): δH= 9.11 (dd, J 6.8, 
1.3, 2H), 8.74 (tt, J 8.0, 1.3, 1H), 8.27 (dd, J 7.7, 6.8, 2H), 5.76 (s, 2H), 3.77 (s, 3H); 13C-NMR 
(101 MHz; DMSO): δc= 166.8, 146.8, 146.2 (2C), 127.8 (2C), 60.2, 53.1; HRMS m/z (TOF MS 
EI+): calculated for C8H10NO2: 152.0712, found: 152.0709 [M]. 
Data were in agreement with those reported in the literature.132 
2,4,6-trimethyl-N-(methoxycarbonyl)pyridinium bromide (351) 
 
Pyridine (0.66 mL, 5 mmol) was added to a solution of methylbromo acetate (0.47 mL, 5 mmol) 
in CH2Cl2 (10 mL) and stirred overnight at room temperature. The reaction mixture was filtered 
N
O
O
Br
N
O
O
Br
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and the collected solid was washed 3 times with diethy ether. Pyridinium ylide 351 was isolated 
as a white solid (950 mg, 70%): mp: 183-185 °C; νmax (neat)/cm-1= 3457, 3404, 3026, 2960, 
2906, 1743, 1637, 1570, 1436, 1361, 1261, 979, 802; 1H-NMR (300 MHz; DMSO): δH= 7.85 (s, 
2H), 5.56 (s, 2H), 3.80 (s, 3H), 2.72 (s, 6H), 2.53 (s, 3H); 13C-NMR (101 MHz; DMSO): δC= 
166.7, 159.5, 155.6 (2C), 128.4 (2C), 53.9, 53.4, 21.6, 21.1 (2C); HRMS m/z (TOF MS EI+): 
calculated for C11H16NO2: 194.1181, found: 194.1182 [M]. 
(2-(4-methoxyphenyl)-2-oxoethyl)(methyl)(phenyl)sulfonium bromide (352) 
 
Dimethylsulphide (0.88 mL, 12 mmol) was added to a solution of 2-bromo-4’-
methoxyphenylacetophenone (2.29 mL, 10 mmol) in CH2Cl2 (10 mL) and stirred overnight at 
room temperature. The reaction mixture was filtered and the collected solid was recrystallised 
with EtOH/AcOEt. Bromonium salt 352 was isolated as a light yellow solid (2.22 g, 77%): νmax 
(neat)/cm-1= 3010, 2947, 2896, 2839, 1660, 1596, 1571, 4550, 1022, 987, 828, 601; 1H-NMR 
(300 MHz; DMSO): δH= 8.01 (d, J 9.0, 2H), 7.15 (d, J 9.0, 2H), 5.47 (s, 2H), 3.89 (s, 3H), 2.97 
(s, 6H); 13C-NMR (101 MHz; DMSO): δC= 189.4, 164.6, 131.2 (2C), 126.7, 114.4 (2C), 55.8, 
52.7, 24.6 (2C); HRMS m/z (TOF MS EI+): calculated for C11H15O2S: 211.0793, found: 
211.0788 [M]. 
1-(4-methoxyphenyl)-2-(phenylthio)ethanone (359) 
O
O
SPh
 
Triethylamine (0.84 mL, 6 mmol) was added to a solution of 2-bromo-4’-
methoxyphenylacetophenone (1.15 mg, 5 mmol) and thiophenol (1.54 mL, 15 mmol) in toluene 
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(7 mL) and stirred overnight at room temperature. The reaction mixture was added to hexane (2 
mL) and EtOAc (2 mL), filtered and the collected solid was washed 4 times with EtOAc to give 
359 as light yellow solid (722 mg, 56%): mp: 87-88 °C; νmax (neat)/cm-1= 3054, 3017, 2980, 
2939, 2906, 1658, 1600, 1571, 1261, 1173, 1023, 817, 734, 689; 1H-NMR (300 MHz; CDCl3): 
δH= 7.94 (d, J 9.0, 2H), 7.43-7.36 (m, 2H), 7.32-7.15 (m, 3H), 6.93 (d, J 9.0, 2H), 4.24 (s, 2H), 
3.88 (s, 3H);13C-NMR (101 MHz; CDCl3): δC= 192.6, 163.7, 135.0, 131.0 (2C), 130.3 (2C), 129.0 
(2C), 128.4, 126.9, 113.8 (2C), 55.5, 41.0. HRMS m/z (TOF MS ES+): calculated for 
C15H14O2NaS: 281.0612, found: 281.0614 [M+Na]. 
Data were in agreement with those reported in the literature.133 
Methyl 1-phenyl-2-(N-phenylmethylsulfonamido)indolizine-3-carboxylate (362) 
N
N
Ph
Ms
Ph
O
O
 
A solution of ynamide 310 (54.2 mg, 0.2 mmol) and ylide 350 (45.6 mg, 0.3 mmol) toluene (2 
ml, 0.1 M) was added sodium hydride (57% suspension in oil, 13 mg, 0.32 mmol) of and 
dichloro(2-pyridinecarboxylato)gold (5 mol%) subsequently. The reaction mixture was stirred at 
90 °C for 8 h. The mixture was filtered through a pad of silica and the filtrate concentrated under 
reduced pressure. The residue was purified by flash chromatography [hexanes:EtOAc (17:3)] to 
afford 341 as a white solid (37.7 mg, 45%): νmax (neat)/cm-1= 3063, 2951, 1684, 1454, 1383, 
1354, 1197, 1157, 967, 730, 697; 1H-NMR (300 MHz; CDCl3): δH= 9.51 (dt, J 7.2 and 0.9, 1H), 
7.52 (dt, J 9.0 and 1.2, 1H), 7.43-7.32 (m, 5H), 7.28-7.21 (m, 5H), 7.15-7.01 (m, 2H), 6.92 (td, J 
7.0, 1.4, 1H), 3.85 (s, 3H), 2.84 (s, 3H); 13C-NMR (101 MHz; CDCl3): δc= 200.89, 193.89, 
161.01, 142.3, 134.1, 132.0, 130.3 (2C), 129.0 (2C), 128.6 (2C), 127.6 (2C), 124.5, 122.8, 
122.0 (2C), 118.0, 117.0, 114.2, 51.0, 40.6; HRMS m/z (TOF MS ES+): calculated for 
C23H20N2O4NaS: 443.1041, found: 443.1055 [M+Na]. 
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Ethoxyethynyl-benzene (371) 
 
Ethoxyacetylene (40% in Hexene) (0.780 mL, 3.2 mmol) in THF (8.6 mL) was added to 
iodobenzene (0.335 mL, 3 mmol), copper iodide (12 mg, 0.64 mmol), PdCl2(Ph3)2 (449 mg, 
0.64 mmol) and diisopropylamine (0.63 mL, 4.5 mmol). The reaction was allowed to stir 
overnight at room temperature. The mixture was then diluted with n-hexane (10 mL) and filtered 
through celite. The solution was carefully concentrated under reduced pressure and purified by 
flash chromatography [hexane] to give ynol ether 371 as a colourless liquid (48 mg, 11%): νmax 
(neat)/cm-1= 3059, 2982, 2901, 2253, 1599, 1441 1315, 1058, 1023, 828, 751, 690; 1H-NMR 
(300 MHz; CDCl3): δH= 7.37-7.31 (m, 2H), 7.29-7.19 (m, 3H), 4.22 (q, J 7.1, 2H), 1.45 (t, J 7.1, 
3H); 13C-NMR (101 MHz; CDCl3): δc= 131.5 (2C), 128.1 (2C), 126.5, 124.1, 98.6, 74.9, 39.9, 
14.5; HRMS m/z (TOF MS EI+): calculated for C10H10O: 146.0732, found 146.0731 [M]. 
 Spectroscopic data were identical to those reported in literature.134 
2-(2-bromophenyl)-4-ethoxy-5-phenyloxazole (372) 
N O
EtO Ph
Br
 
Following GP7 using ynol ether 371 (14.6 mg, 0.1 mmol) and ylide 298 (41.4 mg, 0.15 mmol) for 
30 min. After purification by flash chromatography [hexanes:EtOAc (19:1)] oxazole 372 was 
isolated as a colorless liquid (16.2 mg, 47%): νmax (neat)/cm-1= 3062, 2979, 2929, 2899, 1616, 
1601, 1496, 1407, 1383, 1353, 1335, 1150, 1027, 906, 759, 726, 690; 1H-NMR (300 MHz; 
CDCl3): δH=8.04 (dd, J 7.9, 1.7, 1H), 7.85-7.80 (m, 2H), 7.72 (dd, J 7.9, 1.1, 1H), 7.46-7.37 (m, 
3H), 7.30-7.18 (m, 2H), 4.50 (q, J 7.1, 2H), 1.49 (t, J 7.1, 3H); 13C-NMR (101 MHz; CDCl3): δc= 
154.3, 150.9, 134.8, 131.1, 130.9, 130.8, 128.7 (2C), 128.6, 128.1, 127.3, 126.4, 123.2 (2C), 
PhEtO
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120.4, 66.1, 15.2; HRMS m/z (TOF MS ES+): calculated for C17H14NO2NaBr: 366.0106, found 
366.0103 [M+Na]. 
Ethyl N-methoxycarbonyl-5-phenylpenta-2,4-dienimidate (373) 
N
EtO
O
OMe
Ph 
Following GP7 using ynol ether 290 (18.6 mg, 0.1 mmol) and ylide 300 (22.8 mg, 0.15 mmol) for 
2 h. After purification by flash chromatography [hexanes:EtOAc (19:1)] dienimidate 373 
(geometry across C=N is not assigned) was isolated as a colorless liquid (9.9 mg, 38%): νmax 
(neat)/cm-1= 3026, 2982, 2951, 2904, 1708, 1641, 1623, 1587, 1435, 1370, 1315, 1232, 1056, 
993, 752, 691; 1H-NMR (300 MHz; CDCl3): δH= 7.48-7.42 (m, 2H), 7.40-7.24 (m, 4H), 6.90-6.86 
(m, 1H), 6.24 (d, J 15.0, 2H), 4.26 (q, J 7.1, 2H), 3.82 (s, 3H), 1.37 (t, J 7.1, 3H); 13C-NMR (101 
MHz; CDCl3): δc= 163.3, 162.0, 142.2, 140.2, 136.1, 129.0, 128.8 (2C), 127.1 (2C), 126.7, 
118.3, 63.1, 53.4, 14.0; HRMS m/z (TOF MS ES+): calculated for C15H17NO3Na: 282.1106, 
found 282.1110 [M+Na]. 
Crystal structure of 3aa 
C23H20N2O3S, Mr = 404.47, colourless crystal, crystal dimensions: 0.24 x 0.17 x 0.09 mm, 
monoclinic, space group: P21/c, a = 12.3313(4), b = 10.8475(3), c = 16.0957(5) Å, β = 
110.431(2)°, V = 2017.58(11) Å3, Z = 4, ρcalculated = 1.332 Mg/m3, µ = 1.647 mm-1, λMo-Kα = 
1.54178 Å, T = 120(2) K, 2θmax = 140.08°, 19943 reflections measured, 3533 observed 
reflections, R1 = 0.0327 (observed reflections), wR = 0.0908 (all data), GOF = 1.060, largest diff. 
peak and hole: 0.300 and -0.374 e.Å-3. The dataset was measured on a Bruker SMART 6000 
diffractometer. The data collection was driven by SMART135 and processed by SAINTPLUS.136 
An absorption correction was applied using SADABS. 137  The structure was solved using 
ShelXS-97138 and refined by a full-matrix least-squares procedure on F2 in ShelXL-97.138 All 
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non-hydrogen atoms were refined with anisotropic displacement parameters. All hydrogen 
atoms were added at calculated positions and refined by use of a riding model with isotropic 
displacement parameters based on the equivalent isotropic displacement parameter (Ueq) of the 
parent atom. Figures were produced using OLEX2.139 The CIF has been deposited with the 
CCDC and has been given the deposition number 819432. 
Selected bond lengths (Å) and angles (°): C(2) – N(2) = 1.382(2), N(2) – C(3) = 
1.293(2), C(3) – O(3) = 1.361(1), O(3) – C(4) = 1.378(1), C(4) – C(2) = 1.354(2), C(2) – 
N(1) = 1.409(2), C(3) – C(5) = 1.456(2), C(4) – C(11) = 1.453(2), C(2) – N(2) – C(3) = 
104.2(1), N(2) – C(3) – O(3) = 113.8(1), C(3) – O(3) – C(4) = 105.36(9), O(3) – C(4) – 
C(2) = 106.0(1), C(4) – C(2) – N(2) = 110.7(1), N(1) – C(2) – N(2) = 121.4(1), N(2) – 
C(3) – C(5) = 128.2(1), O(3) – C(4) – C(11) = 117.1(1).  
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